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The early and accurate detection of age-related cognitive declines, such as mild cognitive 
impairment (MCI), represents an important but elusive research goal. Previous screening 
techniques have demonstrated only limited effectiveness for identifying older adults with 
MCI, and these diagnoses have tended to be unreliable over time. Such screening approaches 
have traditionally either been expensive and time consuming, or brief but inaccurate. The 
objective of this thesis was to explore the utility of a multi-stage screening approach, 
including a range of postal screening tools as a novel way of identifying cases of MCI within 
a community sample of older adults (N = 114). Multi-stage screening was validated through 
assessing all participants with a neuropsychological testing battery. Cognitive decline was 
identified by the screening tools at a statistically significant rate, demonstrating the value of 
self- and informant-reports in the early detection of MCI. The screening measures also 
demonstrated strong psychometric properties, and validity for use as postal screening 
measures. Subtypes of MCI were explored, but the reliability of these diagnoses was limited. 
Instead, generalised cognitive profiles demonstrated that individuals experiencing early 
cognitive impairment were able to be differentiated from those of cognitively intact older 
adults. The present results demonstrated the utility of multi-stage cognitive screening for 
detecting cognitive impairment, and for overcoming previous limitations in this area. 
Furthermore, conceptualising early cognitive declines generally, rather than focusing on 
subtypes, was shown to aid diagnostic reliability. 
ix 
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1. Introduction and Literature Review 
1.1 Impact of Cognitive Decline 
 Life expectancy is increasing throughout the developed world, and as a result age-
related cognitive declines are becoming an increasingly significant burden on society 
(Anderson & Hussey, 2000).  In developing countries life expectancy is also increasing 
(Kalaria et al., 2008) and consequently there has been an increase in the prevalence of age-
related health concerns worldwide, including dementia. By 2025 the World Health 
Organisation estimates that 75% of older adults will be living in developing countries (World 
Health Organization, 2002), and by 2040, 71% of individuals with dementia will live in these 
nations (Ferri et al., 2006). Current estimates further posit that by 2040 there will be 81 
million people worldwide suffering from varied dementias (Ferri et al., 2006; Rizzi, Rosset, 
& Roriz-Cruz, 2014), rising to 115.4 million by 2050 (Prince et al., 2013). Whilst these will 
increasingly become a problem for developing nations there are already significant costs 
associated with age-related declines in developed nations. For example, older adults presently 
account for 29% of government health expenditure in New Zealand (NZ)  (Bryant, Teasdale, 
Tobias, Cheung, & McHugh, 2004) despite comprising only 12.1% of the population 
(Statistics New Zealand, 2013). During 1995 a mid-range estimate in the United States of 
America (USA) indicated the cost of each case of dementia was US$38,000 annually (Sloane 
et al., 2002); in 2005 the median health cost for each case of dementia in Europe was €28,000 
annually (range €6614 - €64426) (Jönsson & Wimo, 2009), and worldwide in 2009 the 
estimated total cost of dementia, including informal care, was US$422 billion (Wimo, 
Winblad, & Jönsson, 2010). Although these financial costs are significant, the social costs of 
age-related cognitive declines are potentially even more severe. In particular due to the 
progressive nature of dementia causing increasing impairment and eventually death, those 




and often become responsible for their care (Mohamed, Rosenheck, Lyketsos, & Schneider, 
2010).  
1.2 Overview of Thesis  
The present thesis aimed to explore the early detection of Mild Cognitive Impairment (MCI) 
in a representative community sample of older adults living in Canterbury, NZ. This was 
explored using multi-stage screening including self-report and informant-report postal 
screening measures, followed by more comprehensive neuropsychological testing. The 
present research aimed to demonstrate the diagnostic utility of this varied screening approach 
as an efficient means of determining community-dwelling older adults most likely to be 
experiencing early cognitive decline. There are a number of benefits to early detection of 
cognitive decline, but current screening methodologies have significant limitations including 
being inefficient and expensive.  
The organisation of the thesis is as follows. First a literature review is presented 
(Chapter 1) which describes the theoretical perspectives of cognitive decline leading to the 
present conceptualisation of MCI, along with the progression of cognitive decline and 
neurological underpinnings of this process. Common neurocognitive disorders are briefly 
discussed, particularly in relation of disparate presentations of MCI, and some of the 
consequent diagnostic issues currently seen, including those who appear to revert from 
impaired to normal cognition. Commonly used screening tools are discussed, including the 
rationale for including measurement of subjective declines and objective deficits for 
determining those most likely to be suffering from MCI. Current theories regarding the 
prevention of cognitive declines and maintaining intact functioning even in the presence of 
neuropathological changes are discussed in relation to pharmacological and non-




improved MCI screening procedures. Finally, the direction and aims of the present thesis are 
discussed in further detail. 
Chapter 2 describes the general method for the research, including the 
conceptualisation and the methodology followed for recruitment and data collection. 
Following this are five chapters which present the empirical results. These chapters cover the 
utility and reliability of using postal screening tools within a multi-stage screening approach 
for detecting likely cases of MCI within a community-dwelling population of older adults. In 
particular, the utility of this approach at Time 1 is initially analysed, followed by the 
reliability of the measures used over time and the relationship between self-report and 
informant-report measures and MCI. The overall effectiveness of this multi-stage screening 
methodology over time is then assessed, along with the reliability of MCI diagnosis within 
the sample group. Cognitively, physically, and socially stimulating activities, and the 
potentially beneficial impact of these on reducing cognitive decline is explored. Finally, MCI 
subgroups are compared and contrasted using latent class analysis to cluster participants and 
compare these to diagnostic groups. Following these empirical chapters, a general discussion 
(Chapter 8) summates the current findings and the implications of the present research. 
Limitations to the present results are also discussed further, as are some possible directions 
for expanding on the current findings. 
1.3 Background of Early Decline 
 Dementia as a concept has existed for a long time, yet the progression into dementia 
and early stages of the disease process have not had the same attention. Since the 1990s a 
number of attempts have been made to describe and operationally define the period of 
abnormal cognition preceding dementia that is discernible from normal aging (Bruscoli & 




Forgetfulness (BSF) as a memory difficulty that progresses slowly and is characterised by 
forgetting unimportant information, but is distinct from both normal cognition in the elderly, 
and from the malignant forgetfulness of dementia (Kral, 1962; Larrabee, Levin, & High, 
1986; Ritchie & Touchon, 2000). Following up individuals diagnosed with BSF revealed a 
higher than expected conversion rate to dementia, with a small but significant decline in 
cognition in the remaining sample (O'Brien et al., 1992); however, no psychiatric or organic 
cause was attributed to the disorder, and no suggestion of the neurodegenerative processes 
occurring was included in the conceptualisation of BSF (Bamford & Caine, 1988). Early 
declines have also been described as Mild Dementia in a number of early epidemiological 
studies (Henderson & Huppert, 1984; Jorm, Korten, & Henderson, 1987). However, Mild 
Dementia appeared to be used to describe the prodromal stage of several neuropathologically 
distinct disorders, and was only vaguely defined. Age-Associated Memory Impairment 
(AAMI) first described by Crook et al. addressed some of these problems by quantifying the 
difficulties required for diagnosis, and acknowledging the progression of cases into dementia 
(Crook et al., 1986; Reisberg, Ferris, Franssen, Kluger, & Borenstein, 1986). The difficulty 
with AAMI was in the reliance on memory as the only possible area of decline, and 
comparisons in performance made with younger individuals in the diagnosis (Petersen & 
Negash, 2008); this meant AAMI was unable to identify those most at risk of continuing on 
to pathological conditions as opposed to normal aging processes (Busse, Bischkopf, Riedel-
Heller, & Angermeyer, 2003; Hänninen & Soininen, 1997). Another term that generated 
support was Cognitive Impairment-No Dementia (CIND), which unlike those above had a 
stronger evidence base and describes an intermediary stage of cognitive decline, whereby 
individuals demonstrate marked difficulties, but less than would be required for a diagnosis 
of dementia (Fisk, Merry, & Rockwood, 2003). Subcategories of CIND include delirium, 




individuals meeting diagnostic cut-offs than those currently showing signs of prodromal 
dementia (Graham et al., 1997; Ritchie & Touchon, 2000). The wide range of presentations 
included from the varied subcategories, and the environmental basis for some of these raises 
potential problems using this diagnostic criterion in research on age-related cognitive decline 
(Petersen & Negash, 2008).  
 The diagnostic label that has generated the most research and academic support is 
mild cognitive impairment (MCI), a neurodegenerative disorder theorised to represent 
prodromal dementia, and characterised by cognitive deficits beyond those expected of normal 
aging (Petersen et al., 1997). Unlike BSF and AAMI, MCI is based on a pathological 
conceptualisation of cognitive change, indicating that individuals with MCI are undergoing 
neuroanatomical changes and declines, more akin to dementia than to normal aging (Ritchie 
& Touchon, 2000). Petersen’s MCI criteria include: subjective memory complaints; objective 
memory deficits as measured on a standardised neuropsychological measure; relatively intact 
Activities of Daily Living (ADL); otherwise intact cognition; and not meeting diagnostic 
criteria for dementia. These criteria were reconceptualised in 2011 by the National Institute 
on Aging (NIA) to account for the difficulties in self-reports, to include informant-reports or 
clinician judgement to fulfil the criteria of subjective memory complaints (Albert et al., 
2011). While the common usage of these criteria lends an advantage in shared terminology, 
there are still disagreements between studies about how to define and diagnose MCI (Busse et 
al., 2003; Matthews, Stephan, McKeith, Bond, & Brayne, 2008). The most controversial issue 
is what to include in the concept of cognitive decline, with MCI initially describing discrete 
memory complaints with otherwise unimpaired cognition (Petersen et al., 1997). One 
problem is that older adults experiencing cognitive decline and memory difficulties often 
report difficulties in a range of cognitive aspects, including orientation (H. Wolf et al., 1998) 




Reisberg, 1997). Executive functions (e.g., abstraction (Binetti et al., 1996), divided and 
sustained attention (Crowell, Luis, Vanderploeg, Schinka, & Mullan, 2002)) are also 
commonly affected in the dementia disease process, and these can often be identified by 
informants (Rabin et al., 2006). However, memory complaints remain the most common 
early cognitive deficit, and individuals with amnestic decline are more likely than those with 
any other early complaints to develop dementia (Busse, Hensel, Gühne, Angermeyer, & 
Riedel-Heller, 2006). Functional changes represented by ADL are also difficult to assess, and 
have led to disagreements between researchers as to the extent that impairment is expected in 
MCI (Burton, Strauss, Bunce, Hunter, & Hultsch, 2009). Furthermore, this leads to 
differences in operationally defining impairment in ADLs in the attempt to represent a stage 
between no impairment, and causing some interference with independence, which represents 
the diagnostic threshold for dementia (American Psychiatric Association, 2013). Functional 
impairment is typically conceptualised as a continuum, as the perceived difficulty of tasks 
increases and the ease of completion decreases (Farias et al., 2005). The diagnostic difficulty 
is therefore how much impairment is necessary for the diagnosis of MCI, and what degree of 
progression needs to occur before this represents dementia. Moreover, the measurement of 
functional difficulty is further obscured by the significant impact of comorbidities, such as 
physical complaints, on older adults’ ability to complete such ADLs (Di Carlo et al., 2016). 
Overall, the result of this diagnostic difficulty is variation in how individual studies 
operationalise this impairment, and variation in resultant attempts to quantify ADL 
impairment and track it over time. Another significant disagreement is whether to use 1.0 
(Busse et al., 2006; Ritchie, Artero, & Touchon, 2001) or 1.5 (Geslani, Tierney, Herrmann, & 
Szalai, 2005; Petersen et al., 1997; Petersen et al., 1999) standard deviations below age-
adjusted norms to define objective cognitive impairment, which results in different estimates 




normal cognition, as discussed below. There are also no uniform guidelines for 
neuropsychological tests or batteries to use, so despite the same umbrella diagnostic criteria, 
different operational definitions for MCI have effectively been used in each study considering 
cognitive decline. 
1.4 Progression to Dementia 
 Despite the common nomenclature for describing the early stage of age-related 
cognitive decline, there remain problems with the conceptualisation and diagnosis of MCI. 
These problems largely arise from the difficulties inherent in imposing a diagnostic 
classification upon what is a gradual and continuous disorder (Stewart, 2012). Even with the 
relative consensus on broad diagnostic features, each diagnostic criterion can be measured in 
various ways, and this has led to some confusion in the field. The problem with the current 
theory of MCI is demonstrated in the vast range in estimated prevalence rates, and the 
reported rates of conversion to dementia (Bruscoli & Lovestone, 2004). The expected 
incidence of dementia in older adults (65 years and older) is 1-2% per year (Petersen et al., 
1999), and so any reliable estimate higher than this lends support to the theory that those with 
MCI are at greater risk of developing dementia than cognitively healthy older adults. 
Estimates of the MCI to AD conversion rate vary between 5.6% (Ritchie et al., 2001) and 
41% (Geslani et al., 2005) per annum depending on study methodology and the sample used. 
However, from comparing rates across studies through meta-analyses the rate appears to be 
approximately 9.6-10.2% (Bruscoli & Lovestone, 2004; Mitchell & Shiri‐Feshki, 2009); such 
analyses also identified that the rate of decline in clinical samples was twice that of volunteer 
studies. It appears that more inclusive criteria have the benefit of identifying individuals most 
at risk of subsequent decline, even if this inflates the false positive rate (Busse et al., 2003). 
The prevalence rate also varies between epidemiological studies depending on the 




particular, by varying test cut-offs and neuropsychological tests used for screening and 
diagnosis, the reported prevalence rates vary between 5.3% (Hänninen, Hallikainen, 
Tuomainen, Vanhanen, & Soininen, 2002) and 53.8% (Koivisto et al., 1995). However, it 
appears that the prevalence of MCI among community dwelling older adults aged 65 and 
over is closer to 19%, although this rate typically increases with age to approximately 29% of 
individuals 85 years and older (Lopez et al., 2003). 
 As mentioned above, disagreement exists as to what criteria should be used to 
diagnose MCI, and in particular whether discrete memory difficulties are required for 
diagnosis, or whether cognitive decline more generally is indicative of prodromal dementia. 
This has led to an extended conceptualisation of MCI, including three major MCI subtypes: 
amnestic-MCI, non-amnestic MCI, and multiple-domain MCI (Busse et al., 2006). These 
subtypes involve the same diagnostic outline, but differ on the specific neuropsychological 
deficit observed on standardised testing (Petersen et al., 2001). These groups are then 
theorised to be prodromal stages of Alzheimer’s Disease (AD), Fronto-Temporal Dementia 
(FTD), and Vascular Dementia (VaD) respectively (Rasquin, Lodder, Visser, Lousberg, & 
Verhey, 2005); each of these are briefly discussed below. However, it is currently unclear 
whether these subtypes are useful for making predictions about ongoing decline, particularly 
as subsequent dementia diagnoses are not limited to the purported prodromal MCI subtype 
(Busse et al., 2006; Fischer et al., 2007).  
1.5 Dementias 
1.5.1 Alzheimer’s Disease 
 AD represents the most common dementing disorder, with prevalence estimates 
between 66% (Kukull et al., 2002) and 80% (Mesulam, 2000) of all dementia cases involving 
AD neuropathology. It is characterised by increasing impairment and neurological decline 




development of amyloid plaques and neurofibrillary tangles in the brain, which cause 
neuronal loss (Hardy & Selkoe, 2002). These changes begin in the temporal lobe and spread 
to the parietal and prefrontal areas as the disease progresses, accounting for the increasing 
range of cognitive aspects impacted (Schoenberg & Scott, 2011). Diagnosis of AD occurs 
when objective cognitive decline is assessed in at least two areas, one of which must be 
memory, along with impairment in social or occupational functioning (American Psychiatric 
Association, 2013). As previously noted, memory decline is the primary complaint in early 
AD, and this occurs on both measures of free and cued recall, indicating deficits in both 
consolidation and recall of new information (Schoenberg & Scott, 2011). 
1.5.2 Vascular Dementia 
 VaD represents the second most common dementing disorder, estimated to account 
for approximately 10% of cases, and a further 15% of mixed aetiology dementia showing 
signs of VaD (Schoenberg & Scott, 2011). VaD has also been termed multi-infarct dementia 
due to the pattern of cerebrovascular disease causing impairment. Neuronal loss occurs after 
infarction in small- and medium-sized arteries in the brain and the resulting penumbra, which 
results in an inconsistent pattern of decline across cases of VaD (Sadock & Sadock, 2011). 
The nature of such ischemic events results in a stepwise progression, unlike the continuous 
progression of decline in other forms of dementia, and can lead to plateaus during which 
cognitive declines are halted (Schoenberg & Scott, 2011). VaD can be divided into cortical 
and subcortical presentations based on where infarcts occur, with overlap in cases of multiple 
ongoing vascular events. The most common declines seen in cortical VaD include recall 
memory deficits, along with lapses in attention and concentration, and psychomotor slowing, 
while unlike AD, recognition memory tends to be preserved (Chui, 2007; Fein et al., 2000). 
Declines progress as more infarcts occur, resulting in an exacerbation of symptoms and a 




cortical VaD can often present in a similar manner to AD, and neuropsychological tests that 
differentiate healthy older adults from those with AD are also likely to detect VaD (Sadock & 
Sadock, 2011). Subcortical VaD tends to display a pattern more similar to FTD, with changes 
observed in personality and executive functioning as well as psychomotor slowing (J. A. 
Levy & Chelune, 2007; Lezak, 2004). 
1.5.3 Fronto-Temporal Dementia 
 FTD is used to describe a variety of clinical syndromes that all involve frontal lobe 
degeneration, and are neuropathologically distinct conditions (Schoenberg & Scott, 2011). 
While the particular pattern of decline differs between conditions such as behavioural variant 
FTD, Semantic Dementia, and Primary Progressive Aphasia, some cognitive deficits 
observed tend to overlap, and there is little evidence as to differentiation of these subtypes at 
a prodromal stage (Hallam, Silverberg, LaMarre, Mackenzie, & Feldman, 2008). Cognitive 
deficits begin with changes to personality and social interactions, along with deficits in 
executive functioning and flattened affect, followed by language and speech deficits (Sadock 
& Sadock, 2011; Schoenberg & Scott, 2011; Stopford, Thompson, Neary, Richardson, & 
Snowden, 2012). Executive dysfunction can be assessed through measures such as attentional 
switching, and fluency tests requiring a degree of abstraction, as increased concrete thinking 
is indicative of executive functioning deficits (Schoenberg & Scott, 2011). As FTD 
progresses it becomes harder to distinguish from advanced AD because the deficits overlap, 
and the neuropathology of each begins to look similar as a larger range of brain regions are 
impacted (Lezak, 2004; Raj, Kuceyeski, & Weiner, 2012). 
1.5.4 Dementia with Lewy-Bodies 
 Lewy-bodies are abnormal protein deposits that form in neural cells, which cause cell 




bodies (DLB) are the same as form in Parkinson’s Disease, and it is theorised that both of 
these disorders are related, as they tend to co-occur as they progress (Lippa et al., 2007). This 
shared aetiology is seen in the similar damage to the substantia nigra, leading to a dopamine 
deficit and extrapyramidal symptoms similar to the physical symptoms of early Parkinson’s 
(Sadock & Sadock, 2011). The cognitive profile of DLB is similar to AD, but there is more 
likely to be the presence of hallucinations, and deterioration tends to be much more rapid 
(Schoenberg & Scott, 2011). Prodromal cases are difficult to detect without the use of 
biomarkers or neuroimaging, and can present as any of the other subcategories of MCI 
(Donaghy, O'Brien, & Thomas, 2015). However, there is some evidence that memory 
remains intact early in the disease process, and attentional and executive function deficits are 
affected first (Schoenberg & Scott, 2011). 
 Differentiating between dementias is a difficult task, particularly early in the disease 
process when there is significant overlap in symptoms, and differential diagnosis usually 
requires neuroimaging or biopsy to confirm the presence of particular pathology (Koeppe et 
al., 2005). Moreover, an estimated 15% of dementia cases may be of mixed AD/VaD 
aetiology showing the individual neuropathological characteristics of both, further 
complicating the process of differentiating between the diagnoses (Schoenberg & Scott, 
2011; Zekry, Hauw, & Gold, 2002). 
1.6 MCI Diagnostic Issues and Reverters 
 As previously discussed, there remain complications in the diagnosis and 
conceptualisation of MCI, along with practical difficulties for research and primary health 
care. A major issue with the conceptualisation of MCI is in the apparent lack of reliability of 
diagnosis, with many individuals appearing to revert to normal cognition over time despite 
initially appearing impaired. If MCI does represent a neurodegenerative disorder then large 




significantly improve on neuropsychological tests over time. This group are often referred to 
as reverters and despite the theoretical problems with older adults demonstrating 
improvements to cognition over time these individuals tend to be ubiquitous in research on 
age-related cognitive decline (Larrieu et al., 2002). Rates of participants appearing to revert 
to normal cognition vary, with studies placing them between 4.5% (Nordlund et al., 2010) 
and 53% of individuals diagnosed with MCI (Ganguli et al., 2011) along with one study 
reporting that 92% of participants reverted or changed MCI subtype over time (Ritchie et al., 
2001). Individuals who revert from impaired to intact cognition appear to be a heterogeneous 
group, and are similar to impaired groups in age, sex, and neuropsychological performance at 
diagnosis (Palmer, Wang, Bäckman, Winblad, & Fratiglioni, 2002). 
 A range of possibilities have been offered to explain reverters, including initial 
misdiagnosis, psychometric test limitations, and other cognitive confounding variables 
(Sachdev et al., 2013). Confounding factors can include depression appearing as pseudo-
dementia (Kumar, Jorm, Parslow, & Sachdev, 2006; Zandi, 2004) or anxiety about the testing 
(Sachdev et al., 2013). Such psychiatric conditions can be transient, which accounts for 
changes between testing sessions, and are not necessarily related to age-related cognitive 
declines. Moreover, there is significant variation in the way MCI is diagnosed across studies, 
and the use of liberal criteria such as 1.0 instead of 1.5 standard deviations below age-
adjusted norms may account for some cognitively intact individuals incorrectly being 
identified as MCI (Ganguli et al., 2011). The reliability of diagnosis is even smaller when 
subtypes of MCI are considered, with many individuals appearing to move between these 
groups at follow up, as well as some reverting to normal cognition (Kochan et al., 2010). 
Collectively these issues lend support to one suggestion that individuals are better classified 
as normal or impaired rather than attempting to identify subcategories of MCI (Ganguli et al., 




tests used to quantify objective deficits and inform the MCI diagnosis. This particularly arises 
when scores on the Mini-Mental Status Exam (MMSE) are solely used as a criterion of 
decline, because it demonstrably does not differentiate with accuracy between healthy older 
adults and those suffering early cognitive declines (Ahmed, de Jager, & Wilcock, 2012). 
Specific issues with screening and testing for declines are discussed later. 
 Several factors appear to increase the reliability of diagnoses and make reversion less 
likely, and in particular adding an informant-report to the subjective memory complaints 
increases the reliability of the diagnosis (Sachdev et al., 2013). Informants are likely to notice 
more significant complaints, and while relatively minor cognitive issues may subjectively 
bother individuals it is less likely that these come to the attention of their friends and family 
until they reflect something more pathological (Mackinnon & Mulligan, 2014). Reverters 
also appear to have larger hippocampal volume than individuals who progress to AD over the 
same period, and so while not an efficient screening option it may be that neurological 
changes are able to differentiate progressive cognitive declines from transient declines, 
regardless of the aetiology of the temporary difficulty (Sachdev et al., 2013). Finally, those 
who revert are less likely to show functional declines, and so assessing any change in 
participants’ ADLs such as driving and handling finances may differentiate those likely to 
progress from those who may revert to normal cognition over time (Li, Jia, & Jia, 2012). 
1.7 Screening Tools 
 Due to the relatively recent theoretical development of MCI as a stage of decline 
between normal aging and dementia, there are a lack of screening tests currently available 
(Ahmed et al., 2012). One of the difficulties in developing sensitive tools has been the 
shifting state of diagnostic considerations that constitute MCI, along with disagreements 
about the type and degree of impairments needed to meet such criteria. The research used as 




no suggestion as to how these deficits should be measured (Petersen et al., 1997), nor did the 
international working group tasked with integrating perspectives on MCI (Winblad et al., 
2004).  
1.7.1 Limitations of Commonly Used Measures 
 A large number of tests have been trialled to screen for cognitive declines, but few 
have been validated in the populations for which they are intended, or they have 
demonstrated poor accuracy (Cullen, O'Neill, Evans, Coen, & Lawlor, 2007). A robust 
screening test should succinctly and accurately provide evidence on the important aspects of 
cognition likely to be affected by age-related cognitive declines, and to indicate those most 
likely to need more extensive neuropsychological testing to make an accurate diagnosis. A 
large amount of diagnostic disagreement arises based on the tests administered, and there is 
no agreed upon neuropsychological measure that represents the gold standard for making a 
diagnosis of MCI. Furthermore, screening tools such as the MMSE and measures of 
impairment like the Clinical Dementia Rating scale (CDR) are often used in place of more 
valid and reliable neuropsychological tests (Diniz, Yassuda, Nunes, Radanovic, & Forlenza, 
2007), despite this not being the function they were developed for.  
 The most commonly administered screening measure is the MMSE, which has widely 
been used by primary care professionals given its brevity and ease of administration (Cullen 
et al., 2007; Roalf et al., 2013; Shulman et al., 2006). However, there are significant 
shortcomings with the MMSE and other similar screening tools developed to screen for 
advanced cognitive decline. In particular, they are not sensitive enough to detect early signs 
of impairment, or to differentiate those with MCI from cognitively intact older adults (Ahmed 
et al., 2012; Hoops et al., 2009). This inability to rely on traditionally useful screening tools 
has led to a rapid rise in the development of brief cognitive screening measures, and this 




problems with validation trials, and methodological issues with participant selection limiting 
generalisation of results (Cullen et al., 2007). This has particularly occurred when sample 
groups have been collected from clinical populations, rest homes, or memory clinics but the 
screening tool is then generalised for community settings, where different outcomes are 
typically seen (Farias, Mungas, Reed, Harvey, & DeCarli, 2009). When sample recruitment is 
heavily restricted and extensive exclusion criteria applied, the applicability of the measure to 
the older adult target population needs to be questioned, particularly given the high rate of 
comorbidity amongst these individuals. 
1.7.2 Informant Reports 
 Currently there are no universally accepted screening tests indicated for the screening 
of MCI, but some have been used more frequently than others. In particular, for large scale 
screening, the Informant Questionnaire On Cognitive Decline in the Elderly (IQCODE, (Jorm 
& Jacomb, 1989)) has been used extensively (Cullen et al., 2007). The short-form version of 
the IQCODE reportedly demonstrates the same degree of reliability and validity as the longer 
version, and so given the abbreviated administration time for the 16 item short-form versus 
the 26 item original, it tends to be used exclusively in cognitive screening (Jorm, 2004). The 
IQCODE assesses changes in memory and ADL over a 10-year period, and is completed by 
an informant close to the individual who knows them well enough to comment on change 
over time. As the most widely used informant questionnaire assessing decline, versions of the 
IQCODE have been produced in a range of languages, including: Dutch, Finnish, Chinese, 
Polish, Korean, German, Japanese, Italian, Canadian French, Thai, and Spanish (Jorm, 2004). 
It has also been used with shorter duration of change (Barba et al., 2000), and retrospectively 
at post-mortem (Rockwood et al., 1998). Meta-analytic comparisons between the IQCODE 
and MMSE indicate the IQCODE has a significantly greater predictive validity, although 




advantage of the IQCODE is its negligible association with intelligence and education (Isella 
et al., 2006), as both of these are important to consider when assessing cognition and decline. 
The range of such correlations has been reported from r =  -0.20 to 0.07, demonstrating that 
increasing levels of education or intellectual ability are not reflected in higher or lower 
scores, and that the IQCODE can be administered as a first-line screening tool without pre-
emptively collecting these other variables (Christensen & Jorm, 1992; Fuh et al., 1995). The 
focus on ADLs also increases the reliability of the measure for predicting MCI, as older 
adults having trouble with everyday functioning are more likely to experience further decline, 
and are much less likely to revert to normal cognitive functioning over time (Peres et al., 
2006; Purser, Fillenbaum, Pieper, & Wallace, 2005). Therefore, measuring any early impact 
in functional capacity is likely to have strong prognostic value for subsequent declines and 
for differentiating individuals with MCI who are likely to revert or remain stable from those 
likely to experience progressive and rapid decline (Li et al., 2012). Functional impairment is 
present across the varied subtypes of MCI, and so while the IQCODE has a focus on memory 
impairment it still provides some screening utility for disparate presentations of prodromal 
dementia (Li et al., 2012). 
 The goal of screening tests is to indicate those likely to experience further declines, 
and there is encouraging evidence that IQCODE scores can differentiate cognitively intact 
older adults from those likely to progress to dementia within two years (Louis, Harwood, 
Hope, & Jacoby, 1999), showing its utility as a screening tool. While it was not explicitly 
tested, these individuals were highly likely to represent those suffering MCI. Further research 
using a cut-off score of 3.19 on the IQCODE has reported sensitivity of .82 and specificity of 
.71 for detecting cases of MCI, indicating that this allows insight into those potentially 
suffering early declines in an efficient format (Isella et al., 2006; Li et al., 2012). There is 




institutionalisation, although mortality was not significantly predicted in the same study 
(Jorm & Jacomb, 1989). 
1.7.3 Comprehensive Screening Tools 
 More comprehensive screening tools have also been explored for detecting MCI, and 
in particular the Montreal Cognitive Assessment (MoCA) and the Addenbrooke’s Cognitive 
Examination-Revised (ACE-R) both have high reported sensitivity at between 84% and 90% 
(Mioshi, Dawson, Mitchell, Arnold, & Hodges, 2006; Nasreddine et al., 2005). The 
advantage of these tests lies in assessing a range of cognitive aspects, including those most 
likely to show early signs of decline, and are therefore not limited to detecting amnestic 
decline (Lonie, Tierney, & Ebmeier, 2009). The ACE-R incorporates the MMSE, and so 
utilises useful elements of this measure, including assessing orientation. By extending the 
MMSE the deficiencies in the original measure are compensated for, and cases of MCI can be 
differentiated from healthy controls. More recently the ACE-R was updated to the ACE-III in 
order to remove copyrighted elements of the MMSE, while maintaining the components 
shown to be useful in screening for MCI (Hsieh, Schubert, Hoon, Mioshi, & Hodges, 2013; 
Noone, 2015). The ACE-III offers a more comprehensive measure of memory than the 
MoCA, and requires approximately five minutes longer to administer. Both measures assess 
attention, executive functions, and complex language abilities (Ahmed et al., 2012). This 
range of cognition assessed is important in detecting early declines, because while memory is 
the most reliable predictor of subsequent AD (Welsh, Butters, Hughes, Mohs, & Heyman, 
1992) and conversion from MCI to AD (Isella et al., 2006; Morris et al., 2001; Petersen et al., 
1999), there is evidence that the predictive validity of screening is improved by including 
varied cognitive processes. In particular, it appears that the range of screening elements 
offered by the ACE-III can be used as prognostic indicators for continuing declines (Ahmed, 




limited evidence for differentiating between progressive declines and non-progressive 
psychiatric disorders that can present in a similar way (Lonie et al., 2009). They also have not 
been trialled outside of memory clinics and so it is unclear how relevant they are for 
screening community samples (Jubb & Evans, 2015; Lonie et al., 2009). The elements of 
screening tools are important to consider for maximising the detection of early cognitive 
declines, and combining ADLs and a variety of aspects of cognition appear to provide the 
best diagnostic screening validity. 
1.8 Multi-Stage Screening 
 Given the aforementioned difficulties in identifying cases of MCI and cognitive 
decline, one possible option to improve screening is to adopt a multi-stage approach. Face-to-
face screening and neuropsychological examination are both costly and time consuming, and 
put significant pressure on primary care physicians who typically see the first presentation of 
early decline (S. E. Cook, Marsiske, & McCoy, 2009; Crooks, Clark, Petitti, Chui, & Chiu, 
2005). In contrast, telephone and postal screening approaches require less time investment 
and are cheaper to administer widely, which would present an ideal first-line screening 
approach for detecting cognitive decline, provided that these demonstrate adequate reliability 
and validity (Jansen et al., 2008; Welsh, Breitner, & Magruder-Habib, 1993). In particular, 
postal screening offers an opportunity to identify those most at risk and in need of further 
assessment, and to briefly enquire about a range of issues without requiring presentation to a 
health professional at the point of first contact (Alessi et al., 2003). By adopting the universal 
approach to screening that is achievable through postal questionnaires it is also more likely 
that individuals who would not present to primary care physicians may be identified (Hábert, 
Bravo, Korner-Bitensky, & Voyer, 1996). In particular, males are more likely to be identified 
through both telephone and postal screening for cognitive decline than through memory clinic 




 Few tests have been trialled or developed for alternate screening approaches in this 
way, although the Telephone Interview for Cognitive Status (TICS) has been trialled with 
mixed success (S. E. Cook et al., 2009; van Uffelen, Chin, Klein, van Mechelen, & Hopman-
Rock, 2007). Research using multi-stage screening methodology has the added advantage of 
allowing efficient community screening; a significant limitation across many studies of MCI 
and AD has been recruitment approaches through memory clinics and institutions, which has 
limited the generalisability of results (Andersen et al., 2010). Often postal screening as a first-
line approach has been unsophisticated, and contained little more than asking outright “Do 
you have memory complaints” (e.g., (Alessi et al., 2003; Hábert et al., 1996; van Uffelen et 
al., 2007; van Uffelen, Hopman-Rock, Chin, & van Mechelen, 2005)). There is also limited 
but encouraging evidence that informant-report questionnaires and brief self-report cognitive 
screening tools are able to discriminate between cognitively intact individuals and those with 
MCI, when utilised through postal screening (Cullen et al., 2007; Jansen et al., 2008). The 
obvious limitation with postal and telephone screening lies in the amount of information 
gathered, as individuals are unlikely to complete overly time-consuming questionnaires. 
However, by focusing on well known risk factors, this brief screening can inform more 
detailed testing, and risk factors such as psychiatric history, physical comorbidities, and 
current cognitive concerns, can all be addressed in a brief format. Overall, while current 
evidence is limited, there are a number of potential advantages to adopting multi-stage 
screening for early cognitive declines, and utilising efficient tools such as validated postal or 
telephone screening measures would allow more targeted neuropsychological assessment for 
those most likely to be suffering decline. 
1.9 Psychometric Testing 
 Neuropsychological measures used in the diagnosis of dementia need to reliably 




individuals. Unlike screening tools these do not tend to be brief, and have the advantage of 
using more time to test cognitive domains robustly. Such neuropsychological measures also 
often have age-adjusted norms, which allows comparison of scores between individuals of 
different ages, without normal age-related changes having a significant impact on such 
comparisons. However, a criticism of current screening and detection efforts is the overly 
extensive use of psychometrics, which creates a burden on study volunteers, and individuals 
presenting to memory clinics (Potter & Attix, 2006). In order to determine valid diagnostic 
groups with any reliability the aspects of cognition that tend to decline must be assessed, and 
differential diagnoses limited as much as possible; in particular verbal and visual memory, 
attention and orientation, along with processing speed and general executive functioning 
collectively represent the target areas for determining the presence of varied dementias 
(Bäckman, Jones, Berger, Laukka, & Small, 2004; Stopford et al., 2012). Therefore, a trade-
off is necessary between brevity and range, along with the ideal of double dissociations to 
ensure deficits are in the area assumed, for example ensuring that observed memory deficits 
are not being caused by a deficit in another area such as processing speed. 
1.9.1 Assessing Verbal Memory and Learning 
 Verbal learning measures are useful predictors of memory decline due to the medial 
temporal atrophy seen in MCI and AD causing difficulties in verbal memory performance, 
through progressive reduction in hippocampal volume (Du et al., 2001; Jack et al., 2000). 
One such test that utilises learning trials and delayed conditions to test declines in memory 
and learning is the Rey Auditory Verbal Learning Test (RAVLT: (Rey, 1964), also referred 
to as the Auditory Verbal Learning Test, AVLT). The RAVLT has been used extensively to 
assess verbal memory deficits in a range of neurological conditions, including varied 
dementias (Estévez‐González, Kulisevsky, Boltes, Otermín, & García‐Sánchez, 2003). The 




examiner, followed by a distractor condition featuring 15 different words. Immediate recall is 
then measured without prompts, and delayed memory assessed 20 minutes later, followed by 
a recognition trial. Participants are encouraged to repeat as many words as they can 
remember, and are given as long as required to do so. One advantage offered by the RAVLT 
over other similar tests is the allowances included in the standardised instructions so that 
older adult participants can be encouraged, and the difficulty of the task explained (Lezak, 
2004); such instructions help to offset test anxiety and promote representative performance 
on psychometric tests. Between-groups differences have been shown on the delayed trial for 
cognitively intact, MCI, and AD groups, indicating the ability of this measure to detect early 
declines (Estévez‐González et al., 2003; Tierney et al., 1996). The RAVLT has demonstrated 
reasonable psychometric properties, and in particular test-retest reliability of .51 to .72 for 
delayed and recognition trials. Furthermore, the RAVLT has been normed on a number of 
populations, including older adults (Delaney, Prevey, Cramer, & Mattson, 1992; Strauss, 
Sherman, & Spreen, 2006). 
 There are a number of verbal memory measures similar to the RAVLT, such as the 
California Verbal Learning Test (CVLT: (Delis, Kramer, Kaplan, & Thompkins, 1987)), 
which is one of the most commonly administered memory tests (Lezak, 2004). The largest 
difference from the RAVLT is that the CVLT contains 16 words divided into 4 categories, so 
the words are able to be easily grouped (Stallings, Boake, & Sherer, 1995). This creates a 
possible confounding effect when considering the impact of learning on such memory tests, 
as remembering the categories removes one of the primary challenges in word list recall, 
which is developing a strategy to remember seemingly unrelated words (Lezak, 2004). A 
further option for assessing memory is the Consortium to Establish a Registry for Alzheimer 
Disease (CERAD) Word List Memory test (Rosen, Mohs, & Davis, 1984), which was 




declines, but is shorter than similar measures and so is less aversive for individuals struggling 
to recall any words (Greene, Baddeley, & Hodges, 1996; Lezak, 2004). A range of other 
verbal memory tests exist, and many have been trialled to detect early cognitive declines 
without evidence of success, or currently lack robust psychometric properties and normative 
data (Lezak, 2004). 
1.9.2 Assessing Visual Memory and Learning 
 Along with verbal learning and memory it is also important to assess visual memory, 
with some indication that deficits in visual memory performance can precede AD (Baddeley, 
Bressi, Della Sala, Logie, & Spinnler, 1991); one study identified signs of such decline up to 
15 years before subsequent AD diagnoses (Kawas et al., 2003). Like verbal recall, visual 
memory is theorised to decline in the presence of hippocampal atrophy, so this occurs early in 
the pathological process of AD, while tests with additional visuospatial components also 
show decline when there are attentional difficulties (Alescio-Lautier et al., 2007; Du et al., 
2001; Goldstein et al., 2009). The Brief Visuospatial Memory Test – Revised (BVMT-R: 
(Benedict, 1997)) was developed in order to provide a measure of visual delayed memory 
with six equivalent forms to minimise the likelihood of practice effects (Benedict, Schretlen, 
Groninger, Dobraski, & Shpritz, 1996). Although practice effects tend to disappear in 
advanced cognitive decline, this is not the case for individuals diagnosed with MCI, and on 
delayed memory tests scores can improve by repeated administration to the degree that 
individuals no longer appear impaired (Duff et al., 2008). The BVMT-R contains three 
learning trials followed by delayed and recognition conditions after 30 minutes. For each trial 
participants have 10 seconds to view 6 geometric shapes and then to replicate these in form 
and position on a response sheet. One of the largest advantages of a measure such as the 
BVMT-R is scoring criteria taking into account the motor ability of each individual through a 




alongside a measure of delayed verbal memory offers a further advantage given that 
individual patterns of strengths and weaknesses are less likely to confound the detection of 
early declines when verbal and visual components of memory are both measured. 
 The Rey-Osterreith Complex Figure Test (ROCF: (Osterrieth, 1944; Rey, 1941)) is 
one the most widely used and researched visual reproduction and memory measures, and has 
led to several alternate forms being developed (e.g., Taylor Figure (Taylor, 1979), Medical 
College of Georgia Figures (Ingram, Soukup, & Ingram, 1997), Emory Figures (Freides, 
Engen, Miller, & Londa, 1996), which allows multiple administrations of the test over time 
(Lezak, 2004). However, normative studies have consistently shown that these alternate 
forms are not all equivalent, and that scores tend to be higher on particular versions of the 
complex figure (Tombaugh & Hubley, 1991). There are also a range of scoring systems and 
normative datasets available, but even administration instructions vary between studies on 
complex figures (Lezak, 2004). Differences in scoring systems limit the generalisability of 
the norms developed, given that with such disparate scoring and administration instructions 
there is no clear consensus about which version and norms to use (Shin, Park, Park, Seol, & 
Kwon, 2006). Despite these methodological inconsistencies, there is some evidence that the 
ROCF can be used to differentiate cases of MCI from healthy controls, although research on 
using complex figures for this purpose is ongoing (Kasai et al., 2006). A possible problem of 
using this test with older adults struggling with cognitive declines lies in the difficulty of the 
task, and the potentially aversive experience that can occur on a task deemed too difficult or 
that elicits negative self-stereotypes (Hess, Auman, Colcombe, & Rahhal, 2003). Other visual 
learning and memory measures such as the Visual Spatial Learning Test (VSLT: (Malec, 
Ivnik, & Hinkeldey, 1991)) and the Ruff-Light Trail Learning Test (RULIT: (Ruff, Light, & 
Parker, 1996)) offer variations on the previously mentioned measures, where the novel 




Overall, there is a current lack of well researched and validated measures of visual memory, 
and many have not specifically looked at assessing early signs of cognitive decline, despite 
the inherent value in using such measures for this purpose. 
1.9.3 Assessing Verbal Fluency 
 Measuring verbal fluency and semantic ability is another important facet of 
identifying early cognitive declines. Many tests of verbal fluency also allow higher order 
executive functions to be assessed, so deficits in either basic semantic ability or attentional 
switching can be identified (Lezak, 2004). A large number of fluency tests have been 
developed based on Thurstone’s Word Fluency Test (Thurstone & Thurstone, 1962), with 
increasing complexity as they have been developed and used for more sophisticated 
diagnoses. The Controlled Oral Word Association Test (COWAT: (Benton, Hamsher, & 
Sivan, 1994)) is one of the most commonly used verbal fluency measures and includes three 
letter fluency trials using F, A, and S (Lezak, 2004). Letter fluency requires individuals to 
generate lists of words beginning with the letter in question in one minute. As such it relies 
on strategies to generate lists and to access varied vocabulary which requires executive 
functioning. The need to develop a strategy makes this difficult for individuals struggling 
with cognitive slowing, as well as individuals with poor lexical knowledge. A large range of 
norms are available for commonly used tests of letter fluency, and such tests have been 
trialled across various age groups and ethnicities (Lezak, 2004). Letter fluency forms a core 
component of many cognitive screening tests and is a reliable and brief way of assessing 
semantic ability and strategy development (Tallberg, Ivachova, Jones Tinghag, & Östberg, 
2008). 
 Category fluency trials are typically easier than letter fluency for older adults, given 
that strategies for developing lists are easier to identify than they are for letters, and so 




Razani, & DElia, 2005). However, category fluency tends to be impacted in disorders 
affecting the temporal lobe, and so significant deficits can be observed on measures of 
category fluency in older adults with AD (Clark et al., 2009). Category Fluency (e.g., from 
the Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency subtest) assesses 
participants’ ability to list words from a particular category, with the most common being 
animals. While strategies are still necessary to do well on this task, participants tend to find it 
easier to develop these for categories than for letter fluency (Monsch et al., 1994). A further 
step has been included in the D-KEFS test protocol, with a switching condition adding further 
complexity by assessing individuals’ ability to switch between categories and keep complex 
rules in mind while completing the task. Using two completely distinct categories (e.g., fruit 
and furniture, or vegetables and musical instruments (Delis, Kaplan, & Kramer, 2001)) 
participants are forced to continuously switch the cognitive set they need, and to efficiently 
do so while giving unique examples. Cognitive inflexibility is an early sign of frontal lobe 
damage, and so difficulty on switching or deviations from instructions may indicate such 
declines (Troyer, Moscovitch, Winocur, Alexander, & Stuss, 1998). These switching 
conditions have demonstrated some effectiveness at differentiating individuals with MCI 
from cognitively intact older adults (Nutter-Upham et al., 2008). One variation on verbal 
fluency that has previously been trialled involved writing words down, which encourages a 
more broad range of strategies for developing word lists (Lezak, 2004); however, such 
measures have not demonstrated the ability to differentiate accurately between impaired and 
non-impaired individuals (Cohen & Stanczak, 2000). 
1.9.4 Assessing Non-Verbal Fluency and Construction 
 Non-verbal fluency offers a useful comparison to verbal fluency measures, and allows 
double dissociation of pathology by limiting the overall impact of individuals’ innate verbal 




Five Point Test (Regard, 1982) which involves creating unique designs by drawing lines 
between any number of the five dots presented in a page of 40 identical squares was the first 
widely used non-verbal fluency measure. This concept was expanded upon for the D-KEFS 
Design Fluency (Delis et al., 2001) which includes an inhibition condition and a switching 
task, as well as the original design task. 
Furthermore, several measures involving visuospatial construction are commonly used to 
detect cognitive declines. In particular, clock-drawing is able to predict declines amongst 
dementing individuals despite its simplicity (Shulman, Pushkar Gold, Cohen, & Zucchero, 
1993). Moreover, there is some indication that simple constructional tasks like clock-drawing 
can be used to screen for likely cases of MCI (Yamamoto et al., 2004), although mixed 
results using clock-drawing as a basis for diagnosis means caution is required in basing 
estimations of decline purely on this measure (Ehreke, Luppa, König, & Riedel-Heller, 
2010). 
1.9.5 Assessing Executive Functioning 
 Executive functions incorporating planning and decision making are an integral part 
of higher order cognitive functioning, and are necessary to adapt to novel situations and 
contribute to social, emotional, and cognitively demanding situations (Lezak, 2004). The 
frontal lobes are primarily involved in executive functioning, and so atrophy of cortical tissue 
across this area has a profound effect on individuals’ higher order functions, integration of 
information, and planning (Schoenberg & Scott, 2011). Damage to the frontal lobes can also 
lead to significant personality changes and social inhibition; for example loss of social 
proprieties and tactlessness (Sadock & Sadock, 2011; Snowden et al., 2003). However, 
because executive functions rely on inputs from a range of brain regions, cortical and 
subcortical damage in other areas can affect this functioning; although not severely impacted 




disease progresses. Therefore, it is possible that small deficits in executive functioning, and in 
particular decreased inhibition and cognitive flexibility, may be observed in cases of 
amnestic-MCI. Executive function deficits appear much earlier in the pathological process of 
FTD and sometimes VaD, and so it is likely that that prodromal non-amnestic MCI may be 
detected by such deficits.  
 Along with Switching Fluency, a commonly used measure of executive functioning is 
the Trail Making Test (TMT: (Reitan, 1958)) as this allows a brief assessment of executive 
functions, processing speed, and visual scanning. First used for Army recruitment from 1944 
this test is now commonly administered as part of neuropsychological batteries, and has 
alternate forms for retesting (Franzen, Paul, & Iverson, 1996). Trails B is a switching 
condition, meaning participants need to switch between letters and numbers, and keep track 
of both lists. This switching requires cognitive flexibility, and so scores 1.5 standard 
deviations below age-adjusted norms are indicative of impaired cognitive flexibility (Kortte, 
Horner, & Windham, 2002). 
1.10 Subjective Memory Complaints 
 One of the Petersen criteria for MCI is Subjective Memory Complaints (SMC), 
indicating that it is necessary that individuals be able to self-identify some degree of deficit 
for a diagnosis of MCI. The 2011 update to MCI criteria expanded this criterion to include 
reports from informants who know the individual well, or from the observations of a skilled 
clinician (Albert et al., 2011). This change represents the realisation that a large number of 
individuals experiencing cognitive decline do not endorse SMC, or do not perceive such 
changes as problematic and are therefore unable to self-report subjective changes (Iliffe & 
Pealing, 2010). Also referred to as subjective memory impairment, SMCs often lead to 
individuals presenting to primary health professionals, and this is the most common manner 




Schmand, 1999). SMCs tend to be highly prevalent among older adults, with estimates 
around 50% of older adults reporting some self-identified memory difficulties (Jonker, 
Geerlings, & Schmand, 2000). This value varies somewhat based on the operational 
definition and the methodology of assessing these subjective complaints, with studies ranging 
from a single question through to structured questionnaires with graded responses. 
Controversy regarding the utility and assessment of SMC as a predictor of cognitive declines 
is similar to issues with subjective assessment in general, whereby many researchers dismiss 
such reports as unreliable and too susceptible to confounds to use this as a measure or 
predictor of decline (Abdulrab & Heun, 2008; Lenehan, Klekociuk, & Summers, 2012). 
Interestingly there is some evidence that simplistic measures of SMC (e.g., simply asking 
older adults if they struggle with their memory) are able to divulge clinically significant 
information about memory functioning and decline (Mattos et al., 2003).  
1.10.1 Limitations of Using Subjective Memory Complaints 
 A glaring issue with using SMC as an indicator of decline is the lack of strong 
associations between these and objective measures of memory across a number of cross-
sectional studies (Hänninen et al., 1994; Jonker, Launer, Hooijer, & Lindeboom, 1996). 
Disparate conclusions about the utility of SMC have been reached on the basis of such 
outcomes, with some finding no relationship between SMC and quantifiable memory deficits 
(Jungwirth et al., 2004). If such research is accurate and representative it calls into question 
the appropriateness of subjective memory complaints as a diagnostic criterion for MCI. The 
functional use of a diagnostic category like MCI is for intervening and slowing or halting 
subsequent cognitive and functional declines, and so if the commonly used criteria are unable 
to identify those most at risk then this needs refinement. It is possible that the lack of 
significant findings reflects an issue with testing, whereby individuals suffering from early 




below age-adjusted norms (Abdulrab & Heun, 2008); this would strengthen the argument for 
taking SMC into account in diagnosing early decline. There are also studies that have shown 
a significant link between SMC and cognitive declines, including an awareness of a deficit 
preceding and existing through until mild dementia (Schmand, Jonker, Hooijer, & 
Lindeboom, 1996; Schofield et al., 1997). A meta-analysis of studies with longitudinal 
designs provided further evidence that subjective complaints may be a significant and reliable 
indicator of cognitive decline over time (Jonker et al., 2000). Furthermore, a review of this 
literature concluded that methodological limitations call into question the validity of many 
studies that found no association, and in particular raised questions about the appropriateness 
of drawing conclusions from cross-sectional studies instead of longitudinal research (Jonker 
et al., 1996). In contrast, a number of studies dispute the usefulness of SMC as a diagnostic 
criterion for MCI, citing the difficulties in measurement and inconsistencies in the observed 
relationship between SMC and progressive cognitive impairment (Yates, Clare, & Woods, 
2015). In particular, one possible confounding factor of SMC are psychopathological mood 
and anxiety manifesting with difficulties in memory (McDougall, Becker, & Arheart, 2006), 
with an established relationship seen between depression and anxiety with SMC among older 
adults (e.g., (Minett, Da Silva, Ortiz, & Bertolucci, 2008; Zandi, 2004)). 
 Older adults experiencing SMC have been shown to have smaller hippocampal 
volume (van der Flier et al., 2004), were more likely to show white matter lesions on MRI 
(Purser, Fillenbaum, & Wallace, 2006), and are significantly more likely to display the 
Apolipoprotein E4 allele (ApoE4, (Small et al., 1999)). Reduced hippocampal volume, 
ApoE4, and white matter lesions have all been linked to increased likelihood of AD, meaning 
that if these are related to the expression of SMC, then it may be a good predictor of 
subsequent decline. Whereas both allele expression and neuroimaging have shown utility in 




be administered widely to at risk older adults. If these risk factors were related to a 
behavioural presentation that could be identified efficiently this would be a useful tool in 
assessing cognitive declines (Lonie et al., 2009).  Although such evidence is currently 
lacking, there is ongoing research in order to elucidate this relationship further and 
demonstrate the strength of links between SMC and neuropathological changes (Petersen et 
al., 2010). Overall, given the inconsistency of research findings to date, and vast range of 
sampling on SMC, more research is required to identify the best way of measuring SMC in 
order to inform MCI diagnosis and make predictions about disease progression. 
1.10.2 Subjective Non-Memory Complaints 
 The concept of self-reporting cognitive difficulties in the context of non-amnestic 
declines is more problematic than for amnestic declines. Cognitive changes likely to present 
with non-amnestic and multiple-domain MCI, theorised to represent prodromal FTD and 
VaD, include changes in personality and deficits in executive functioning (Isella et al., 2006; 
Rahman, Sahakian, Hodges, Rogers, & Robbins, 1999). Although individuals tend to 
understand the concept of memory and what a memory deficit may entail, it is unlikely that 
they are able to notice or verbalise changes to executive functions, which creates problems 
for criteria of decline based on self-report. Furthermore, individuals with poor insight into 
their functioning are also likely to be unable to self-report memory or other cognitive deficits. 
This has led to many researchers and the NIA working group expanding the operational 
definition of “subjective” complaints to include either self-reports, informant-reports, or 
clinician judgement of cognitive decline (Albert et al., 2011; Lenehan et al., 2012).  
 A final issue with the convoluted phenomenon of SMC arose through research linking 
SMC more strongly to personality characteristics than to memory deficits, arguing that such 
individuals’ anxiety about memory difficulties was more likely to cause presentation of 




worry about possible memory declines and its ramifications become self-fulfilling, which has 
been termed stereotype threat. 
1.11 Stereotype Threat 
 Negative stereotypical beliefs about a group can have a significant effect on the 
performance of that group, with stronger belief in the stereotype increasing the impact 
(Spencer, Logel, & Davies, 2016). In particular there is some evidence that older adults who 
believe themselves to be declining, and believe that older adults in general perform poorly, 
will conform to this stereotype on neuropsychological testing (Hess et al., 2003). When 
individuals have such concerns these can increase cognitive load, and reduce the processing 
capacity for test taking (Cavanaugh, 1996; Chasteen, Bhattacharyya, Horhota, Tam, & 
Hasher, 2005). Even subtle or unconscious priming appears to decrease older adults’ 
performance on memory measures, indicating the strength and cognitive accessibility of 
stereotypes of decreased memory and competence in old age (Barber & Mather, 2013; B. 
Levy, 1996; Stein, Blanchard-Fields, & Hertzog, 2002). In particular, working memory 
appears to be negatively affected by stereotype threat (Schmader & Johns, 2003); because 
working memory is often a construct used in diagnosing age-related cognitive decline, this 
may result in false positives through lowered neuropsychological scores. The existence of 
stereotype threat has important implications for research on age-related cognitive declines, so 
it is important to reduce the cognitive load associated with these worries as much as possible, 
as well as removing stereotype primes from the research procedure. 
 Stereotype activation can initiate a physiological stress cascade and increase 
cardiovascular effort, which can have a further negative impact on test performance (B. Levy, 
Hausdorff, Hencke, & Wei, 2000). The opposite does not appear to be true, as priming 
positive older adult stereotypes does not confer a protective effect, or reduce cardiovascular 




relationship between elevated anxiety and decreased performance on neuropsychological 
tests (e.g., (Hickey, 1980; L. F. Wolf & Smith, 1995)), and one possibility is that stereotype 
threat may have a flow-on effect of causing anxiety, further affecting cognitive functioning of 
older adults. As mentioned previously, anxiety also has a potential impact on the SMC 
individuals report, and so it is possible that stereotype threat increases the presentation of 
MCI through elevating SMC in otherwise cognitively intact individuals. 
 The concept of stereotype threat is not without issues however, and in particular the 
impact of stereotypes appears to be moderated by the perceived importance of memory, 
where individuals attributing great importance to memory were significantly more affected 
by stereotype activation (J. Aronson et al., 1999; Hess et al., 2003). There are also potentially 
significant limitations in many of the studies in the area, including no direct measurement of 
stereotype activation, or generalisation being limited by the use of overly strong 
manipulations (e.g., explicitly stating that aging damages memory) (Chasteen et al., 2005; 
Hess et al., 2003). The outcome memory measures have also been questioned, again relating 
to the difficulties arising from a lack of standard neuropsychological batteries or approaches 
for measuring memory decline in older adults, as discussed above. Overall, the current 
evidence indicates that there is an impact of negative age-related self-stereotypes on 
neuropsychological performance, but that this is moderated by other factors. From a practical 
research view this means that stereotype activation needs to be limited, with efforts made 
through neuropsychological test administration to utilise non-specific encouragement and 
allow older adults to perform to their potential. This can be achieved subtly by deemphasising 
the memory component of tests, or more overtly by giving older adults positive information 
about aging (Hess et al., 2003).  
1.12 Treatment and Prevention of MCI 




many attempts have been made to treat or prevent such declines, however with mixed 
success. There is also an increasing body of research work being undertaken to try and slow 
or prevent future decline, along with understanding the processes and risk factors involved in 
dementing disorders. Pharmacological and behavioural interventions are both being trialled, 
and novel treatment approaches are regularly being developed. 
1.12.1 Neural Reserve Hypothesis 
 Theories of preventing cognitive decline are largely based around concepts such as 
the neural reserve hypothesis, which refers to the capacity for the brain to cope with age-
related changes and disease pathology (Fratiglioni & Wang, 2007). This hypothesis is based 
on findings at autopsy, where many older adults did not demonstrate the level of impairment 
that the pathological changes in their brains would have predicted (Boyle et al., 2013; Riley, 
Snowdon, & Markesbery, 2002; Satz, 1993). It has then been theorised that maintenance of a 
healthy brain may offer protection from cognitive declines, or mean that a greater degree of 
pathological change is required before it has an observable impact (Kempermann, 2008). It is 
likely that susceptibility to dementia is comprised of a range of genetic, environmental, and 
biological factors, along with the impact and interaction of these across the life-span 
(Fratiglioni & Wang, 2007). If so, then through positive lifestyle factors and engaging in 
activities that positively impact neural health it is possible that the onset of dementia could be 
delayed or prevented (Scarmeas & Stern, 2003; Wang, Karp, Winblad, & Fratiglioni, 2002).  
1.12.2 Life-Span Activities 
 The idea of cognitive activity and engagement over the lifespan having an impact on 
late-life cognitive health has been a growing area of research, based on the neural reserve 
concept. This has led to evidence that higher frequency of cognitive activity during formative 




in cognitively stimulating work and leisure activities appear to contribute to neural reserve, 
with ongoing activity leading to increasing reserve in late life (Fritsch et al., 2007; Karp et al., 
2006; Wilson et al., 2013). Conversely, the colloquial phrase, use it or lose it, appears to refer 
to the opposite side of developing neural reserve across the lifespan, whereby a deficit of 
neurologically stimulating activity can decrease individuals’ capacity to cope with 
pathological neural changes in old age (Salthouse, 1991).  
 Research has demonstrated that being involved in leisure activities with cognitive, 
physical, and social components during mid-life and adulthood can improve memory 
functioning (Christensen & Mackinnon, 1993). An example of this is seen in research linking 
increased cardiovascular risk factors at mid-life (age approximately 40) to a 24% to 46% 
increased risk of dementia in old age (Whitmer, Sidney, Selby, Johnston, & Yaffe, 2005). 
This has been specifically looked at in terms of ongoing physical activity promoting physical 
health and decreased cognitive impairment from mid-life through to old age (Singh-Manoux, 
Hillsdon, Brunner, & Marmot, 2005). Although there are few Randomised Controlled Trials 
(RCT) to test the impact of more frequent participation in these areas and the corresponding 
effect on neural reserve, longitudinal and correlational studies provide reasonable evidence in 
support, given that the trends are consistently observed (Karp et al., 2006). Overall, this 
indicates that neural reserve is a dynamic process and that lifestyle changes can have an 
impact at any stage of life, and even during old age there are protective benefits from 
maintaining a varied and active lifestyle (Wilson et al., 2013; Wilson et al., 2002b). Even 
small contributions of physical, cognitive, and social enrichment appear to have a significant 
impact on reducing the incidence of cognitive declines and dementia, with more engagement 
resulting in a lower likelihood of cognitive decline (Karp et al., 2006). 
1.12.3 Participation in Cognitive Activity  




between cognitively demanding occupations and decreased likelihood of developing 
dementia are prevalent in literature on age-related declines (Karp et al., 2006; Sachdev et al., 
2013). On a related note, education appears to have a similar protective effect, whereby those 
with a higher level of education have a lower likelihood of dementia in old age (Callahan et 
al., 1996; Wilson et al., 2013). This trend remains even when confounding effects such as 
cardiovascular health and age are controlled for (Ott et al., 1995). The interrelationship 
between education and occupation is important however, as neural reserve appears to be 
encouraged throughout the lifespan by cognitive load (Stern et al., 1994), and less time spent 
in schooling does not prevent individuals from working in cognitively stimulating 
occupations. These trends are further demonstrated by research from developing nations 
indicating the increased impact of a lack of education and demanding work for women 
resulting in higher prevalence rates of MCI for women (Ho, Woo, Sham, Chan, & Ashley, 
2001; Zhang et al., 1990). These results contrast with those from prevalence studies 
conducted in Western countries with a longer history of opportunities for women, as the 
gender distribution of cognitive decline tends to be similar, particularly after controlling for 
age (M. K. Aronson et al., 1991). 
 Cognitive activity in old age remains important, with strong relationships observed 
between the frequency of cognitive engagement and cognitive health. This pattern appears to 
remain valid even when controlling for important factors such as age, education, and sex 
(Wilson et al., 2002a). One longitudinal study provided strong evidence for this trend and 
established that maintaining cognitive activity is a protective factor, where those reporting 
more frequent baseline cognitive activity were 47% less likely to be diagnosed with AD by 
the end of the 4.5 year trial (Wilson et al., 2002b). Observational studies have resulted in 
similar outcomes, with cognitive activity in old age consistently demonstrating benefits in 




2002a). It is theorised that frequent cognitive activity promotes working memory and 
processing speed, which helps to overcome early deficits via providing a compensatory 
mechanism (Reuter-Lorenz et al., 2000; Stern, 2003). Overall, a pattern is seen in older adults 
engaged in frequent cognitively stimulating leisure activities, where age-related cognitive 
declines are slowed and normal cognition is maintained for longer (Ball et al., 2002; Sattler, 
Toro, Schönknecht, & Schröder, 2012; Spector et al., 2003; Verghese et al., 2006). 
1.12.4 Participation in Physical Activity 
 Maintaining physical activity in old age has long been encouraged for physical health, 
but longitudinal studies provide evidence that cognitive declines can also be prevented or 
delayed by adequate physical exercise (Heyn, Abreu, & Ottenbacher, 2004; Lautenschlager et 
al., 2008). One such study following 5,925 women over an 8 year period demonstrated that 
those in the highest quartile for physical activity were 37% less likely to experience cognitive 
declines than those in the lowest quartile (Barnes, Whitmer, & Yaffe, 2007). This is not an 
isolated finding, as other longitudinal research has demonstrated protective benefits of 
between 30% and 50% reductions in cognitive decline and dementia (Abbott et al., 2004; 
Karp et al., 2006; Laurin, Verreault, Lindsay, MacPherson, & Rockwood, 2001; Wilson et al., 
2002b). While the majority of these studies looked at dementia, it is expected that the 
protective effect of physical activity on cognitive decline would also occur early on in the 
process of decline, given the range of evidence as to the benefits of ongoing physical activity. 
For example, continued exercise in late-life also reduces the likelihood of obesity and 
vascular events, including cerebrovascular damage (Heyn et al., 2004; United States 
Department of Health & Services, 1996). Moreover, based on animal models it is currently 
thought that physical activity directly contributes to neurogenesis and synaptogenesis, as well 
as elevated levels of neurotrophic factors, all of which contribute to neural health and the 




Cotman & Berchtold, 2002; Kronenberg et al., 2006). There is also emerging evidence for 
these processes outside of animal models, and a number of advantages to continuing to be 
physically active after retirement have been demonstrated, including: prevention of 
significant declines in cerebral perfusion (Lucas et al., 2012; R. Rogers, Meyer, & Mortel, 
1990); increased production of neurotrophic factors (Dishman et al., 2006), and maintenance 
of  higher neural tissue density even after adjusting for age (Colcombe et al., 2003). 
 Short-term physical interventions with older adults have demonstrated a statistically 
significant improvement in cognitive performance, and in particular executive functioning 
and processing speed appear to improve with cardiorespiratory fitness (Barnes et al., 2007; 
Colcombe & Kramer, 2003). This trend also appears with older adults already experiencing 
cognitive decline, further demonstrating the dynamic protection and restorative effect that 
lifestyle choices can have on cognitive health (Colcombe & Kramer, 2003; Diesfeldt & 
Diesfeldt-Groenendjik, 1977; Heyn et al., 2004). However, many of the studies on the 
positive benefit from exercise have suffered from methodological shortcomings, in particular 
small sample sizes or exclusion criteria removing older adults with cognitive disorders (Heyn 
et al., 2004; Keysor & Jette, 2001). Therefore, there is a possibility that protective effects 
may not be as large as reported for older adults in general, and correlational studies of this 
type need to be interpreted with caution. 
 The impact of physical activity on preventing early cognitive declines is less clear, 
with some research indicating that between-group physical activity levels were not related to 
MCI (Broe et al., 1998; Middleton, Kirkland, & Rockwood, 2008; Sumic, Michael, Carlson, 
Howieson, & Kaye, 2007; Wang et al., 2002), whereas other studies have demonstrated a 
significant risk reduction of developing MCI with higher frequencies of physical activity 
(Etgen et al., 2010; Geda et al., 2010; Lytle, Vander Bilt, Pandav, Dodge, & Ganguli, 2004). 




intervention in MCI found significant cognitive improvements in the treatment group, but this 
trend was much stronger for women than men (Baker et al., 2010). Although the majority of 
studies support the view that lower frequency of physical activity has a significant effect on 
the likelihood of developing dementia, one possibility for contrary findings for MCI may 
arise from the heterogeneity of older adults, and the vast range of presentations amongst 
those at risk of early decline. The effect of exercise on the biological mechanisms 
hypothesised to offer protection from cognitive declines may become more apparent as the 
disease progresses, and therefore some cases of MCI may represent prevented AD, whereby 
individuals demonstrate the neuropathology of AD but not the behavioural presentation of the 
disease (Middleton et al., 2008). A meta-analysis looking at physical activity across 15 
studies and 33,816 participants indicated a 38% decreased likelihood of cognitive decline 
amongst highly physically active older adults, and a 35% difference for those engaging in 
low to moderate physical activity (Sofi et al., 2011).  
1.12.5 Participation in Social Activity 
 As with physical and cognitive considerations there is now extensive evidence that 
social integration and an active social support network have beneficial effects on health 
outcomes (Fratiglioni, Wang, Ericsson, Maytan, & Winblad, 2000; House, Landis, & 
Umberson, 1988; Kawachi et al., 1996; Saczynski et al., 2006). There are strong links 
between social support and quality of life (Becker et al., 1998), mortality (Welin, Larsson, 
Svärdsudd, Tibblin, & Tibblin, 1992), and psychiatric disorders (Litwin, 1998). Health 
outcomes and the progression of age-related cognitive declines also tend to be worse for 
single older adults, and those without close family support (Cervilla & Prince, 1997; 
Fratiglioni et al., 2000; Nicholson, 2012). Given the impact of a socially-integrated lifestyle 
on a range of physical and psychological outcomes, it has been theorised that social activity 




stimulation, and other physical health benefits (Ho et al., 2001; Saczynski et al., 2006; 
Steptoe, Shankar, Demakakos, & Wardle, 2013; Wang et al., 2002); it is possible with 
adequate social support that individuals would be better placed to cope with MCI or other 
minor age-related difficulties (Fratiglioni et al., 2000). Through such meaningful social 
interactions the environment of older adults is enriched, and this in turn promotes cognitive 
health and neuroplasticity (Nithianantharajah & Hannan, 2006; Rosenzweig & Bennett, 1996; 
Wang et al., 2002). Another possible mechanism for this protective effect comes from 
findings that social activity in old age can affect the immune system, specifically by reducing 
inflammatory markers in the brain, which are hypothesised to decrease the neuropathological 
processes of dementia (Fratiglioni et al., 2000; Karp et al., 2006; Seeman, 1996). Engaging in 
pleasurable social activities regularly appears to offer protection from subsequent cognitive 
declines, and research shows a consistent pattern of lower incidence rates of dementia and 
age-related cognitive decline amongst individuals that remain socially engaged in older 
adulthood (Karp et al., 2006; Saczynski et al., 2006; Wang et al., 2002). The degree of social 
integration necessary for an effect to be seen appears to be minor, suggesting that there is a 
dose response effect with decreasing incidence rates correlated with higher social integration 
(Verghese et al., 2006; Wang et al., 2002). For individuals with little or no social support the 
risk of dementia is up to 60% greater than those with close family or friends (Fratiglioni et 
al., 2000; Verghese et al., 2006); it also appears that for individuals who experience social 
disengagement as they age there is a far greater likelihood of developing dementia (Saczynski 
et al., 2006; Wang et al., 2002). 
1.12.6 Pharmacological Treatment 
 Pharmacological therapies for dementia have attracted a large amount of research 
attention, and multiple attempts have been made to reduce the neuropathology associated 




such as donepezil are readily prescribed for individuals with AD to increase the acetylcholine 
available for neurotransmission, which reduces the impact of AD pathology (Doody et al., 
2001; Fillit et al., 2002; S. Rogers, Doody, Mohs, & Friedhoff, 1998). While the impact of 
such medications is small, any reduction in impairment is worthwhile, and so the use of 
cholinesterase inhibitors is common. Another potential treatment is Vitamin E, with some 
evidence that this can have a small impact on slowing the rate of subsequent decline (Giraldo, 
Lloret, Fuchsberger, & Vina, 2014; Sano et al., 1997), although there have been few 
controlled studies supporting this (Farina, Isaac, Clark, Rusted, & Tabet, 2012). The 
ubiquitous nature of pharmacological treatment approaches have led to trials being conducted 
looking at adapting medications used to treat AD for treating MCI, attempting to halt the 
declines before they reach the level of AD (Petersen et al., 2005). There have been mixed 
results from such trials, with no impact from Vitamin E, but a possible slowing from 
cholinesterase inhibitors seen in one study (Feldman & Jacova, 2005). Other pharmaceutical 
options have been considered based on animal models, such as muscarinic agonists (Avery, 
Baker, & Asthana, 1997) and glutamate modulators (Winblad & Poritis, 1999) but so far no 
pharmacological treatment has been shown to be an effective and efficacious treatment for 
MCI (Farina et al., 2012; Fillit et al., 2002; Gauthier, 2004; Ströhle et al., 2015). Overall, 
findings to-date have been statistically significant but lacking practical clinical benefits. 
However, research into novel pharmacotherapeutic treatment of MCI is likely to continue, 
with ongoing studies experimenting with medications targeting neuropathological substrates 
of cognitive decline (Karakaya, Fußer, Schroder, & Pantel, 2013; Raina et al., 2008). In 
particular the focus appears to be on developing symptomatic pharmacotherapy to slow or 
halt decline, and to demonstrate clinically significant effects, beyond what has been shown to 




1.12.7 Non-pharmacological Treatment 
 Due to the evidence that maintaining cognitively enriching and stimulating leisure 
activities can prevent or delay the onset of MCI, a number of interventions have been trialled 
for increasing this protective effect (Acevedo & Loewenstein, 2007). Non-pharmacological 
therapies have been advanced, in part due to the lack of success with trials of 
pharmacological treatments. Cognitive and physical interventions have been trialled, with the 
intention of demonstrating an improvement in episodic memory and executive functioning, 
given that these cognitive aspects are often the first impaired in the process of cognitive 
decline (Teixeira et al., 2012). Experimental cognitive interventions have typically either 
been one of two therapy modalities, cognitive training or cognitive rehabilitation. Cognitive 
training has a focus on training a specific memory deficit, such as episodic memory, through 
the use of mnemonics and semantic elaboration techniques (Belleville, 2008; Clare & Woods, 
2004; Rapp, Brenes, & Marsh, 2002). Cognitive rehabilitation focuses on supporting 
cognitive functions that are still preserved by utilising occupational and behavioural therapy 
(Cipriani, Bianchetti, & Trabucchi, 2006; Kurz, Pohl, Ramsenthaler, & Sorg, 2009; Talassi et 
al., 2007). Despite the strong theoretical basis for such interventions the results have been 
mixed, with some studies indicating only small or non-significant effects (Rapp et al., 2002; 
Talassi et al., 2007), while others suggest significant cognitive improvements even for 
individuals already suffering MCI (Ball et al., 2002; Belleville, 2008). The trend of results is 
encouraging but far from unanimous, and better quality trials for determining what types of 
cognitive enrichment and rehabilitation are successful are required (Acevedo & Loewenstein, 
2007; Clare & Woods, 2004). 
 Physical interventions have the benefit of increasing cardiovascular fitness, with the 
associated positive outcomes mentioned previously, such as improved cerebral perfusion and 




that physical interventions appears to have the greatest impact on is executive functions 
(Colcombe & Kramer, 2003); this is theorised to be directly due to the improvement in 
cerebral perfusion allowing increased frontal lobe metabolism (Scherder et al., 2005; Teixeira 
et al., 2012). Individuals in treatment groups for physical activity interventions have 
demonstrated cognitive stability at 12 months follow-up, significantly higher than treatment-
as-usual groups (Olazaran et al., 2004). A modest improvement in cognition was 
demonstrated after an 18 month follow-up in a RCT of a 24-week in-home exercise program  
for participants with self-reported memory difficulties (Lautenschlager et al., 2008). The 
exercise in question was relatively small, with only 150 minutes per week recommended, 
involving participants being encouraged to walk for 50 minutes at a time, on three occasions 
per week; importantly this only equated to an average of 20 minutes per day more than the 
treatment as normal condition. This demonstrates that even modest changes to physical 
activity are likely to have an impact, which is a conclusion often not shown in observational 
research comparing very physically active individuals against sedentary individuals (Barnes 
et al., 2007; Weuve et al., 2004). As an RCT this provides stronger evidence as to the causal 
relationship between physical activity and cognition; previous observational and correlational 
studies are unable to conclusively determine whether decreases in physical activity 
precipitate, or are a result of cognitive decline (James, Wilson, Barnes, & Bennett, 2011; 
Wilson et al., 2002b). Although there are few RCTs establishing the causality of 
cardiovascular fitness and decreased likelihood of developing age-related cognitive declines, 
the weight of evidence, and the presence of plausible biological mechanisms, suggests that 
maintaining physical fitness has a protective effect in old age. However, there remains a need 
for more physical intervention trials for preventing cognitive decline, as few RCTs have been 
conducted, and the evidence on prevention of dementia as opposed to short-term 




 Social interventions have not been researched extensively, but the inclusion of a 
social component in physical interventions for AD appears to encourage treatment 
compliance (Tappen, Roach, Applegate, & Stowell, 2000). Other behavioural and social 
interventions have been poorly controlled and evaluated, which severely limits the 
conclusions that can be drawn from these (Zarit & Leitsch, 2001). Based on the impact of 
social supports and networks for maintaining cognitive and physical health in the presence of 
age-related cognitive decline, it is likely that interventions aimed at boosting social contact 
would be beneficial. However, it remains to be seen whether this is a viable treatment 
approach and whether the necessary controls can be implemented for valid conclusions to 
arise from such trials (Voigt-Radloff et al., 2011; Zarit & Leitsch, 2001). 
1.13 Direction of the current study 
1.13.1 Interim Summary 
 From the review above it can be seen that research on MCI is complex and with little 
agreement between studies as to the prevalence, diagnostic criteria, and screening methods to 
be used. It is also clear that persevering with attempts to detect older adults most at risk of 
developing dementia is financially and socially important, and will become an increasingly 
important health focus over the next 40 years. It is currently estimated that with increasing 
lifespans and the resulting increased prevalence of age-related cognitive decline that 115.4 
million individuals worldwide will have dementia by 2050 (Prince et al., 2013). Current 
treatment approaches to dementia have demonstrated only limited success, and only 
temporarily slow the progression of decline. Novel treatment approaches including 
pharmaceutical and cognitive therapies are currently being trialled, but due to diagnostic 
difficulties individuals are not identified early enough in the disease process for such 
treatment to be effective. The most promising intervention target to halt cognitive declines 




beyond those expected as part of normal aging, but falling short of the diagnostic severity 
required for a dementia diagnosis. Individuals with MCI progress to dementia at a 
significantly higher rate than older adults in general, leading to hypotheses that MCI 
represents a prodromal stage of dementia. 
 There is no single agreed upon approach to detecting MCI, although the most 
common criteria were proposed by Petersen, and include subjective and objective memory 
deficits along with relatively intact activities of daily living and general cognition. More 
recently it has been theorised that non-AD dementias are associated with diverse 
presentations of MCI, and so it has been suggested that these criteria be expanded to include 
non-amnestic deficits. The particular tests used to measure early cognitive deficits are also 
debated, but the common approach is to measure a range of cognitive facets including 
memory, orientation, attention, and executive functioning. The major limitation in such 
detection has been in finding individuals early in the disease process, and this has led to a 
proliferation of short screening measures being developed. At present, many of these lack 
adequate evidence as to their reliability, validity, and screening utility. Moreover, traditional 
pen-and-paper tests are not necessarily efficient enough to utilise clinicians’ time whilst 
identifying all those at risk. One possible solution to this is through a more global screening 
approach, and utilising more efficient techniques such as postal or telephone measures as a 
first-line screening methodology.  At present the evidence in support of these alternative 
screening approaches is limited, due to methodological problems and issues with sampling; in 
particular, a reliance on inpatient groups hampers the generalisability of findings.  
1.13.2 Objectives and Hypotheses of the Current Research 
 The principal aim of the present research was to explore the utility of a postal 
screening approach as a first-line screening methodology to detect cases of MCI amongst a 




informant-report, and cognitive screening measures in order to gather a diverse range of 
information pertinent to predicting cognitive decline. Frequency of participation in 
cognitively, physically, and socially stimulating activities was also collected as part of the 
screening approach, to research what impact such engagement has on MCI. 
 A neuropsychological battery was administered to all participants to validate the 
screening measures, and to indicate how accurate the screening tools were for predicting 
likely cases of MCI. Given the measures chosen to be used in the postal screening it was 
hypothesised that the postal measures would detect cases of MCI significantly better than 
chance, and that this approach could be shown to be a valid multi-stage screening 
methodology. In particular, SMCs as measured through self- or informant-reports have been 
linked with subsequent cognitive declines, and generally older adults are able to accurately 
identify the early signs of amnestic impairment. Furthermore, due to the importance of SMCs 
in the diagnosis of cognitive declines it was hypothesised that a self-report measure would 
increase the diagnostic utility of a postal screening tool. 
 One issue across the field of research on MCI and the prediction of further cognitive 
declines has been reliability of diagnoses, with individuals appearing to revert to normal 
cognition from an impaired state. It has previously been theorised that informant-reports may 
be unaffected by the transient declines seen in this group, and thus it was hypothesised that 
the combination of a self-report and informant-report would help to differentiate cases of 
transient cognitive decline from progressive neuropathological conditions. 
 The second stage of the present research aimed to test the reliability of the screening 
tools used by reassessing the participant group after 12 months. Whilst one year is a relatively 
short retesting period, between 5.3% and 41% of individuals with MCI are predicted to 




should be long enough to detect further declines amongst some participants, while seeing a 
reliable pattern of scores amongst cognitively intact older adults. Thus, it was hypothesised 
that the screening tools trialled in the current study would demonstrate high reliability at a 
12-month follow-up. Moreover, a further possibility was that the self-reports and informant-
reports of decline could be predictive of further declines, so that Time 1 postal measures may 
have predictive validity for subsequent cognitive deterioration. 
 Reliability of diagnoses have been inconsistent across previous research into MCI, 
particularly when subtypes of MCI are considered. Therefore, the present research aimed to 
assess the reliability and consistency of MCI diagnoses amongst a community sample. It was 
of interest whether MCI diagnoses based on the Petersen criteria demonstrated reliability over 
time, given that this is the most common diagnostic schedule in use. A further aim was to 
explore the reliability of an expanded Petersen criteria to include MCI subtypes including 
amnestic, non-amnestic, and multiple-domain MCI. Finally, the disparate nature of these 
theoretical subgroups can be explored through using multivariate statistical methods such as 
cluster analysis, by determining whether the resulting groups correspond to the predicted 
subtypes and whether they are able to be independently detected from neuropsychological 
data. The current sample size was limited, so these analyses are considered exploratory, but if 
MCI subtypes represent orthogonal groups then such statistical clustering may demonstrate 
this. 
 A final aim was to collect information about current and historical engagement in 
stimulating activities to test the relationship between such involvement and cognitive declines 
over time. Based on the neural reserve hypothesis it was predicted that older adults with more 
frequent involvement in cognitively, physically, and socially stimulating activities would 
show less incident decline, represented by less change between Time 1 and Time 2. Similar 




age, and such information was also collected to test this alongside the impact of current 
activities on cognitive health. 
1.13.3 Summary 
 The current research aimed to explore cognitive screening with a more generalisable 
community sample than previous work, along with demonstrating the utility of first-line 
postal screening through a meaningful comparison with standardised neuropsychological 
measures. The practical benefit of such community screening is in reducing the burden on 
health practitioners, and allowing in-depth psychometric administration to be used only 
where necessary. A further aim was to assess the presence of varied MCI subtype 
presentations amongst a representative community group, and to investigate the reliability of 




2. General Methods 
2.1 Participants and Procedure 
 Participants were recruited from Canterbury, NZ, from a range of sources. 
Community groups (e.g., Rotary, Probus) were initially contacted, and they passed project 
information on to interested members. An advertisement was also placed in Age Concern, a 
free local newsletter with an older adult target population. The remainder of the sample were 
recruited from the New Zealand Brain Research Institute (NZBRI) volunteer database, 
containing names and contact information from 1,300 older adults who were healthy at the 
last point of contact. Before beginning to recruit from this database the order of individuals 
was randomised so that participants were not more likely to be contacted based on particular 
demographic variables. Contact was made with a total of 145 individuals who expressed 
interest in the present research. Contact was attempted with approximately even proportions 
of male and female volunteers from the NZBRI database, but more female individuals were 
able to be contacted, and therefore offered participation. The sample size was maximised 
given the resource and time constraints of the project, where N=110 participants were needed 
for an estimated power of 90% to detect a significant correlation of r  = .3 with  = .05 (two 
tailed). It was also thought that participant drop-out of 20-30% was possible, so recruitment 
continued beyond the N=110 calculated. 
 Postal screening measures were sent to all interested individuals, and after a two-week 
period all were contacted again, and a neuropsychological testing session was organised. At 
the same time participants were reminded to bring corrective lenses and hearing aids as 
required for the neuropsychological testing. In total 114 participants (70 Female, 44 Male) 
completed the postal screening and neuropsychological testing at Time 1. Participants 
provided verbal consent upon initial contact, and written consent at the testing session. All 




Ethical approval for the project was obtained from the University of Canterbury Human 
Ethics Committee (Appendix A). 
 After 12 months all individuals who completed participation at Time 1 were contacted 
again and were invited to take part in the second stage of the research, looking at any changes 
over time. In total 78 participants took part in both stages of the research (68.4%), including 
49 females and 29 males.  
2.2 Instruments 
 The postal screening questionnaires used included self-report and informant-report 
versions of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE; 
Appendix B and Appendix C), the Self-Administered Gerocognitive Examination (SAGE; 
Appendix D), and the General Activities Questionnaire (GAQ; Appendix E). 
 The IQCODE is a measure of change over time, and is comprised of 16 questions 
regarding memory and instrumental activities of daily living, such as handling finances 
(Jorm, 1994). Each item is scored on a five-point Likert scale, from Much Improved to Much 
Worse based on informants’ ratings of change over the preceding 10 years, with the average 
of these used as a measure of memory and functioning change over time. The IQCODE has 
been used as a screening tool for a number of disorders and sources of cognitive decline 
including AD and VaD (Cherbuin & Jorm, 2011, 2013). It has also been used to assess post-
stroke damage (Cullen et al., 2007; Jorm & Jacomb, 1989), and there is limited but 
encouraging evidence for using the IQCODE to detect MCI (Isella et al., 2006; Li et al., 
2012). For the present research two versions of the IQCODE were completed by each 
participant, an informant-report, and a self-report. Each participant gave the informant copy 
to somebody who had known them for at least 10 years, and collected this back before 




data were collected regarding them. Each participant was able to identify an appropriate 
informant. 
 The SAGE was developed to screen for MCI amongst older adults and involves 
assessing a range of aspects of cognition including orientation, memory, visuospatial abilities, 
and executive functioning (Scharre et al., 2010). The SAGE has 11 items which are scored 
out of 22 and summed to give a total score which has encouraging evidence for 
differentiating MCI and healthy older adults. The current study used an updated version of 
the SAGE with New Zealand demographic options, and modified currency terminology. 
 The GAQ was adapted from a semi-structured interview used by Robert Wilson in 
research on the effect of life-course and late-life involvement in stimulating activities on 
cognitive decline in older age (e.g., (Wilson et al., 2005; Wilson et al., 2013; Wilson et al., 
2002b)). Questions assess involvement in cognitively stimulating activity during childhood, 
teenage, young adulthood, and middle age, as well as cognitively, physically, and socially 
stimulating activity at present. Each item was scored on a four-point frequency scale, from 
Every day or almost every day to Several times a year/Rarely with the scores averaged for 
each time point as an estimate of cognitive activity participation. As this questionnaire was 
adapted for the present research the psychometric properties are not known, but as a semi-
structured interview the questions have demonstrated reasonable reliability and validity 
(Wilson et al., 2013). 
 Neuropsychological measures used in the objective cognitive testing were the Rey 
Auditory Verbal Learning Test (RAVLT), Brief Visuospatial Memory Test - Revised 
(BVMT-R), Trail Making Test (TMT), Verbal Fluency (including Letter Fluency, Category 
Fluency, Switching Fluency, and Switching Accuracy), and the Addenbrooke’s Cognitive 
Examination – 3
rd




alternate forms used in retesting at Time 2 where these were available, to reduce any practice 
effects. Further information along with reliability and validity for these measures are 
provided below. 
2.3 MCI Screening 
 Following completion of both postal and neuropsychological stages of the research, 
individuals were classified based on MCI criteria suggested by Petersen and the NIA (Albert 
et al., 2011; Petersen et al., 1997), including: a score of at least 1.5 standard deviations below 
age-adjusted scores on a standardised neuropsychological memory measure; generally intact 
cognitive functioning; SMC by self-report or informant-report; relatively intact ADLs; and 
not meeting diagnostic criteria for dementia. Current ADL difficulty was assessed through 
postal measures and by interview when participants came in for the neuropsychological 
testing session. 
2.4 Empirical Results 
 The results from the present research are presented in five empirical chapters 
exploring different facets of the collected information. The number of participants varies 
between each of these chapters based on the analyses being conducted, and the number of 
available responses for these. Each chapter was prepared as a manuscript to be submitted for 
publication, and therefore some necessary repetition of introductory and methods material is 
included, although attempts have been made to minimize the redundancy.  
Initially postal screening is looked at in the sample collected, with a focus on the 
utility of using postal screening tools as a first-line screening approach among a community 
sample of older adults (Chapter 3). The reliability over time of self-report and informant-
reports is then explored, with a particular focus on how each of these relate to cognitive 




effectiveness of screening approaches over time is then analysed, with a focus on including 
cognitive screening, self-report, and informant-report in such screening approaches (Chapter 
5). Following this, the relationship between life-course and late-life engagement in 
stimulating activities is explored in the context of subsequent cognitive declines, and the 
theoretical potential of such activity participation offering a protective effect for older adults 
(Chapter 6). Finally, subtypes of MCI are examined using cluster analysis, with a particular 
focus on the reliability of these distinct groups, and the practical usefulness of separating 
MCI diagnoses into subtypes early in the process of decline. All statistics were calculated 
using SPSS version 23 (IBM Corp, 2013), except for cluster analyses which were calculated 
using the Mclust package (Fraley & Raftery, 1999) in R (R Core Team, 2013). 
2.5 Outcomes and Results 
 Participants were all offered a summary of results to be sent to them at the conclusion 
of the research. Given the potential impact of a diagnosis of MCI each participant was also 
offered a brief summary of their results if they so choose, including the recommendation that 
they speak to their GP if they had one or more low scores and were concerned about this. 
Given the potential impact of a false positive, care was taken during testing and in providing 
feedback so as to not cause alarm, as well as not overstating the accuracy of the results for 
any particular individual. However, it is also important that participants were given the 




3. Postal Screening Effectiveness 
3.1 Introduction 
Age is the strongest risk factor for dementing disorders, such as Alzheimer’s Disease 
(AD),  which represent a growing concern in the developed world as medical interventions 
have prolonged the average lifespan (Anderson & Hussey, 2000). Although preventing 
dementia is increasingly a research focus, practical difficulties inhibit progress in developing 
interventions. One of these challenges is the early identification of those most at risk of 
dementia, and in particular older adults meeting criteria for mild cognitive impairment (MCI). 
MCI is theorised to represent prodromal dementia in an intermediate stage of cognitive 
decline, beyond that expected with normal ageing but without meeting full dementia criteria 
(Fischer et al., 2007). There is an increasing awareness that current screening methods are not 
sensitive enough to detect the majority of individuals with MCI, and typically deficits are 
only noticed once they progress in severity and meet the full criteria for AD (Ahmed et al., 
2012). An efficient and reliable screening process for MCI is crucial for progress in 
developing interventions to reduce the impact of AD (Petersen & Negash, 2008). If MCI can 
be detected, then early treatments developed to slow or halt declines are more likely to have a 
clinically significant effect on cognitive and adaptive functioning of older adults.  
  Currently the identification of MCI is limited by the tools available to primary care 
physicians when screening for cognitive difficulties (Cullen et al., 2007; Kazui et al., 2005; 
Lindeboom & Weinstein, 2004). MCI assessments by physicians tend to be brief and easy to 
administer, but are relatively insensitive in the detection of the subtle decline associated with 
MCI (Scharre et al., 2010). This means at present the accurate diagnosis of MCI is reliant on 
lengthy and costly neuropsychological assessment (Petersen et al., 1999), and there remains a 




A large number of brief screening tools for AD have been developed and have 
extensive research support, and several of these have been trialled for detecting MCI, with 
varying degrees of success (Ahmed et al., 2012). Screening tools such as the Mini-Mental 
Status Examination (MMSE) and the Clinical Dementia Rating scale (CDR) have 
demonstrated only limited success for use in detecting MCI, despite being extensively used 
and relied on for the detection of dementia (Ahmed et al., 2012; Petersen, 2003). In contrast, 
there is growing evidence that the Informant Questionnaire Of Cognitive Decline in the 
Elderly-Short Form (IQCODE) (Jorm & Jacomb, 1989) may be an effective screen for MCI 
(Ehrensperger, Berres, Taylor, & Monsch, 2010; Isella et al., 2006; Li et al., 2012). 
Additionally, an increasing number of novel tests such as the Self-Administered 
Gerocognitive Examination (SAGE) and the Computer Administered Neuropsychological 
Screen (CANS) have been developed specifically for use in detecting cases of MCI, all with 
the goal of increasing diagnostic utility without being costly and difficult to administer 
(Cullen et al., 2007; Scharre et al., 2010; Tornatore, Hill, Laboff, & McGann, 2005). 
However, a significant limitation of all these screening tools is the necessity of face-to-face 
administration, meaning that even the few screening tests with adequate psychometric 
properties are still time consuming and are not cost effective. 
A number of studies exploring multi-stage screening for MCI have been conducted, 
with the majority of these using telephone interviews to increase participant convenience and 
decrease clinician administration time (Jansen et al., 2008; Welsh et al., 1993). The drawback 
with telephone interview screening is that it still requires appropriately trained individuals to 
administer the test, and therefore does not completely remove the problems with traditional 
face-to-face screening approaches. Using postal questionnaires as a first-line screening 
approach would circumvent this time investment further and allow a more global approach to 




present to primary care physicians, and to detect declines before they advance to the point 
that individuals seek medical help (Andersen et al., 2010; Hábert et al., 1996). Once such 
first-line screening has been administered the individuals most likely to be experiencing early 
cognitive impairment can then be assessed further, thereby reducing the extent of testing to 
only those most likely to meet MCI criteria. 
However, limitations of scope and design have largely restricted how useful such 
postal and telephone screening attempts have been in the past (Cullen et al., 2007; Jansen et 
al., 2008).  Some problems have included testing of self-report measures without having a 
criterion for comparison  (Jansen et al., 2008); only examining memory deficits and 
neglecting other possible cognitive declines early in the AD process (Beversdorf et al., 2007; 
Cullen et al., 2007); and screening tools only being compared to the MMSE, which has 
consistently been shown to be a poor predictor of MCI (Ahmed et al., 2012; Lonie et al., 
2009; Petersen, 2003). A further limitation with some trials of postal or telephone screens is 
that neuropsychological tests have only been administered on those identified as MCI by the 
screening measure, therefore providing no way to assess the specificity of the measures (van 
Uffelen et al., 2007).  
The present study attempted to address these limitations by testing the utility of postal 
screening measures and following all participants up with neuropsychological testing, which 
allowed MCI to be diagnosed. Specifically, our goals were 1) To validate a postal screening 
approach to identifying individuals in the community with MCI; and 2) To compare the 
effectiveness of the IQCODE and SAGE as postal screening tools. This was explored by 
administering cognitive screening via postal questionnaires and following this up with a brief 







 Community groups in Christchurch, NZ, (e.g., Rotary and the Alzheimer’s society) 
were contacted, and an advertisement was also placed in Age Concern, a free newsletter with 
an older adult target population. Further participants were recruited from the NZBRI 
volunteer database, containing names and contact information from 1,300 older adults who 
were healthy at the last point of contact.  In total 145 individuals were contacted for the 
present study, of whom 114 completed both the postal and neuropsychological stages of the 
study. The only inclusion criteria were that participants were at least 65 years old. The only 
exclusion criterion was that participants had not received a diagnosis of dementia. 
All interested participants were mailed the screening questionnaires, and after a two-
week period were again contacted to organise face-to-face neuropsychological testing. At this 
time they were reminded to bring corrective lenses and hearing aids as needed to the testing 
session. 114 participants took part through to the completion of the neuropsychological 
examination.  
All participants gave informed consent at the testing session, and were fully informed 
about the nature and purpose of the study. Ethical approval for the project was obtained from 
the University of Canterbury Human Ethics Committee (Appendix A). 
3.2.2 Instruments 
 To maximise the effectiveness of the brief screening it is important to get a range of 
information, namely a change from previous levels of functioning along with early signs of 




Fischer et al., 2007). Several postal screening measures were used to efficiently gather 
information in these areas. 
3.2.2.1 Postal screening measures 
The Self-Administered Gerocognitive Examination (SAGE; Appendix D) is a recently 
developed screening measure for detecting early AD and MCI, and examines a range of 
facets of cognition including, memory, executive functions, orientation, and visuospatial 
manipulation (Scharre et al., 2010). It is comprised of 11 questions scored out of 22, and 
together these items are summed to give a total score, which has previously demonstrated 
effectiveness for differentiating individuals with MCI from both healthy individuals and 
those with dementia (Scharre, Chang, Nagaraja, Yager-Schweller, & Murden, 2014). We 
used an adapted version of the SAGE, with demographic questions that were appropriate for 
NZ, and modifications between USA and NZ terminology for money calculation questions.  
The IQCODE includes 16 items asking about changes in memory over time, as well 
as difficulties in instrumental ADLs (Jorm, 1994). It has been used as a screening tool for a 
number of disorders including AD, VaD, MCI, and to assess post-stroke damage (Cullen et 
al., 2007; Jorm, 1994; Jorm & Jacomb, 1989). Each item is scored on a five-point scale from 
Much Improved to Much Worse, and the average score is taken from the 16 items (Jorm, 
2004).  The IQCODE items assess memory functioning, as well as instrumental ADLs such 
as handling finances or using familiar household products (e.g., Microwave oven). 
Participants were asked to complete two versions of this measure, an informant-report 
(IQCODE (IR); Appendix B), to be completed by someone who had known them for at least 
10 years, and a self-report (IQCODE (SR); Appendix C). Reviews of the use of the IQCODE 
in assessing cognitive decline indicate limited evidence for a cut-off on this measure 




3.19 represented the optimal sensitivity and specificity for differentiating MCI and healthy 
older adults (Isella et al., 2006; Li et al., 2012). 
3.2.2.2 Neuropsychological measures 
The Brief Visuospatial Memory Test Revised (BVMT-R; (Benedict et al., 1996)) is a 
measure of visual learning and memory including delayed recall and recognition. It involves 
participants remembering the shape and location of six geometric objects, and reproducing 
these immediately for three learning trials, and then reproducing these objects after a 30 
minute delay. The BVMT-R was developed to address a lack of memory assessment 
instruments appropriate for repeated administrations, including multiple forms to reduce 
practice effects. Test-retest reliability is reported at .63 to .92 for delayed recall and total 
recall conditions, with an inter-rater reliability of .97 (Benedict, 1997). Moreover the BVMT-
R appears to have good construct validity, with correlations of .62 to .77 with other memory 
and visuospatial construction measures (e.g., the Hopkins Verbal Learning Test and the 
ROCF), and .25 to .30 with tests of language ability (e.g., Boston Naming Test and Verbal 
Fluency) (Benedict et al., 1996). 
 The Rey Auditory Verbal Learning Test (RAVLT; (Rey, 1964)) assesses short- and 
long-term verbal memory, as well as recognition memory. Participants are presented with a 
list of 15 words read out 1-per-second and at the conclusion of the list have to repeat as many 
as they can remember for five learning trials, then after a 20 minute delay they are asked 
again to verbally list as many words as they can remember. The RAVLT has high test-retest 
reliability of .61 to .86 for the trials, and .51 to .72 for delayed and recognition conditions 
(Delaney et al., 1992). It also appears to have good content validity, correlating highly (.33 to 
.47) with other verbal learning and memory tasks, such as the CVLT (Macartney-Filgate & 




Trails A and B from the Trail Making Test (TMT; (Reitan, 1958)) give information 
about executive functions, processing speed, visual scanning, and have also shown some 
utility in previous research for detecting MCI (Ashendorf et al., 2008). Participants are 
required to draw connections between items in ascending order as quickly and accurately as 
they are able. The TMT correlates fairly highly with other visual searching tasks (e.g., Digit 
Symbol Coding from the WAIS-III at .63), and in general tends to have high reliability 
coefficients reported at .65 and above (Lezak, 2004). Trails B is also correlated with 
measures of mental flexibility such as the Wisconsin Card Sorting Test (.59) (Kortte et al., 
2002). 
Verbal Fluency from the D-KEFS (Delis et al., 2001), including Letter Fluency, 
Category Fluency, Switching Fluency, and Switching Accuracy, gives a further measurement 
of executive functioning including inhibition control and cognitive flexibility, as well as 
divided attention (Gomez & White, 2006). Participants are required to generate a list of as 
many words as possible that fit the Letter Fluency condition within one minute. In older 
adults test-retest reliability is .70 or greater for Letter Fluency, which is considered more 
difficult than Category Fluency (Snow, Tierney, Zorzitto, Fisher, & Reid, 1988). Verbal 
Fluency is also only modestly correlated with memory measures (e.g., Wechsler Memory 
Scale short stories =.22, Selective Reminding Test =.17), meaning measurement on this task 
should not be particularly impacted by memory deficits (Ruff, Light, Parker, & Levin, 1997). 
Finally, the ACE-III is a brief tool used to detect likely cases of MCI through an 
assessment of orientation, memory, visuospatial ability, and verbal fluency (Mioshi et al., 
2006). The ACE-III subscales are correlated well with convergent neuropsychological 
measures, and it appears the ACE-III is a valid measure of these. Additionally the ACE-III 
correlated very highly with the ACE-R (.99) giving evidence that the many uses and 




2013). Collectively these neuropsychological tests briefly measure the most common early 
deficits seen in cognitive decline, and have been shown to be sensitive at detecting MCI and 
early deficits in AD (Aggarwal, Wilson, Beck, Bienias, & Bennett, 2005; Busse et al., 2006). 
3.2.3 Procedure 
Screening measures were mailed to all consenting participants. Three screening tools, 
the IQCODE (both versions) and the SAGE were mailed out together to screen cognitive 
functioning. Implied consent was obtained by telephone, and this was followed with written 
consent when participants attended the testing session. Participants all underwent the same 
battery of tests administered in the same order by a clinical psychology PhD student who had 
been specifically trained, and the testing took between 50-80 minutes.  
3.2.4 MCI Screening   
All psychometric tests were administered by a single clinician trained in their use, and 
this individual subsequently scored and interpreted the results which led to MCI 
classification. Individuals were classified as MCI based on the commonly used Petersen 
criteria (Petersen et al., 1997), including: a score at least 1.5 standard deviations below age 
adjusted norms on at least one memory test, along with subjective memory complaints; 
relatively intact ADLs; generally intact cognitive functioning; and not meeting diagnostic 
criteria for dementia. As per Petersen’s criteria and NIA recommendations objective 
cognitive deficits were judged to be present if any one score was below the 1.5 standard 
deviation cut-off.  
3.2.5 Data Analysis 
 Descriptive statistics were used to characterise overall responding. Following these 




the postal measures used, and Receiver Operating Characteristic (ROC) curves calculated for 
each of the postal questionnaires assessing how well each predicted MCI. Odds Ratios (OR) 
were then calculated using logistic regression for each significant ROC analysis. Internal 
consistency of the Postal measures was calculated using Cronbach’s alpha followed by an 
item analysis, and subsequent attempts at improving the predictive accuracy of the postal 
measures as assessed by ROC area. 
3.3 Results 
3.3.1 Participants  
Participants were aged between 65 and 93 years at the time of testing (M = 75.04, SD 
= 5.88).  In total 70 females and 44 males took part in the present study. Their ethnicity was 
similar to the expected distribution in Canterbury based on District Health Board (DHB) data 
from the 2013 census (Statistics New Zealand, 2013), with 95.7% of the sample NZ 
European/Pakeha, 1.8% British, 1.8% Asian, 0.9% Maori, and 0.9% other. Demographic 





Participant Demographic Data 
 Male Female Overall 
 N N  
Sex Total 44 (38.6%) 70 (61.4%) 114 
Age    
- 65-69 8 (29.6%) 19 (70.4%) 27 
- 70-74 10 (33.3%) 20 (66.7%) 30 
- 75-79 14 (46.7%) 16 (53.3%) 30 
- 80-84 10 (47.6%) 11 (52.4%) 21 
- 85+ 2 (33.3%) 4 (66.7%) 6 
Ethnicity    
- NZ European/Pakeha 42 (38.9%) 66 (61.1%) 108 
- Maori 1 (100%) 0 (0%) 1 
- British 0 (0%) 2 (100%) 2 
- Asian 1 (50%) 1 (50%) 2 
- Other 0 (0%) 1 (100%) 1 
Highest Level of Education    
- High School 27 (46.6%) 31 (53.4%) 58 
- Post-school Training 3 (60%) 2 (4%) 5 
- Undergraduate 
Qualification 
8 (19.0%) 34 (80.9%) 42 
- Postgraduate 
Qualification 
6 (66.7%) 3 (33.3%) 9 
 
Participants were categorised as either MCI or non-MCI based on the commonly used 
Petersen criteria (Petersen et al., 1997). Of the 114 participants, 34 were classified as MCI 
based on their reports of subjective complaints, normal ADLs, and neuropsychological test 
results. There was no significant difference in gender between participants in the two groups, 
with 20 females (28.6%) and 14 males (31.8%) meeting MCI criteria, χ
2
 (2, 114)=.136, 




vs. M=73.95, SD=5.82 years, d=.662). The age range was similar for both groups (69-85 for 
MCI and 65-93 for non-MCI).  
3.3.2 Postal Measures Descriptive Statistics and Comparisons 
 Descriptive statistics for postal and neuropsychological tests are presented in Table 2 
and the numbers of participants below cut-off values are also shown. For postal measures 
these are given at previously established cut-offs (Cherbuin & Jorm, 2011; Isella et al., 2006; 
Li et al., 2012; Scharre et al., 2010), and for the neuropsychological measures this is given by 
1.5 standard deviations below age-adjusted norms.  
Table 2 
Descriptive Statistics for Postal and Neuropsychological Measures 
















IQCODE (IR) 3.14 .37 3.27 .39 3.09 .35 62 
IQCODE (SR) 3.16 .35 3.20 .45 3.14 .29 68 
SAGE 19.28 2.73 18.24 3.96 19.73 1.86 10 
BVMT-R        
- Delayed Recall 6.89 3.2 3.35 2.59 8.39 2.13 26 
- Total Recall 17.26 7.07 9.91 5.97 20.39 4.85 25 
RAVLT        
- Delayed Recall 9.11 3.4 6.38 3.60 10.28 2.61 8 
- Total Recall 47.21 9.75 40.32 9.90 50.14 8.11 2 
Verbal Fluency        
- Letter 40.64 12.21 37.41 12.57 42.01 11.88 12 
- Category 37.82 8.64 35.00 7.82 39.01 8.74 11 
- Switching Total 12.59 2.61 11.59 2.64 13.01 2.50 13 
- Switching 
Accuracy 
11.28 3.08 10.50 3.18 11.61 2.99 13 
Trail Making Test        
- Trails A 36.58 13.15 41.62 16.30 34.44 10.99 3 
- Trails B 97.54 59.82 133.09 85.16 82.44 36.25 12 





 Scores on the neuropsychological measures were converted to age-adjusted 
standardised scores based on established norms. Overall the present sample were significantly 
different from established age-adjusted norms and this was tested using single sample t-tests 
with 100 for standard scores, and 10 for scaled scores as the comparison. The only test that 
was not significantly different from previous norms was Trails B (t(113)=1.75, p=.083, 
M=103.84, SD=23.42). However, differences existed in both directions, for example on 
RAVLT Delayed Recall and Total Recall the sample scored significantly higher than 
expected t(113)=5.38, p<.001, d=.50 and t(113)=9.86, p<.001, d=.92 respectively. In contrast, 
both BVMT-R measures were lower than expected based on norms, Delayed Recall t(113)=-
2.64, p<.001, d=.23 and Total Recall t(113)=-5.03, p<.001, d=.47. 
There was significant variation in participants’ scores across the three postal 
measures, as well as a ceiling effect observed on the SAGE where 14 participants reported 
the maximum score. Boxplots of these tests are shown on Figure 1, where z-scores were used 
for comparison between the different measures. A number of outliers were observed in the 
present result, indicating that while most participants were grouped closely together a number 
reported more extreme positive and negative cognitive changes, these outliers are shown by 





















Figure 1. Boxplots of Postal Measures z-scores. 
On two of the postal measures scores differed significantly between groups. 
Participants with MCI scored significantly below non-MCI individuals on the SAGE, 
t(39.3)=2.74, p=.043, d=.48 (M=18.24, SD=3.96 vs. M=19.725, SD=1.856). Moreover, on the 
IQCODE (IR) scores were significantly higher for those with MCI, indicating a higher level 
of memory difficulty t(99)=-2.35, p=.021, d=.51 (M=3.27, SD=0.39 vs. M=3.08, SD=0.36). 
However, for the IQCODE (SR) there was no significant difference between mean scores for 
the MCI and non-MCI groups, t(104)=-.841, p=.125, d=.16 (M=3.20, SD=0.45 vs. M=3.14, 
SD=0.29). Despite not being part of the postal screening, a planned comparison showed that 
the two groups differed on the ACE-III, with the MCI group scoring significantly lower 




3.3.3 Predicting MCI 
ROC curves were calculated for each of the three postal measures (SAGE and both 
versions of the IQCODE). Each cut-off was also compared to cut-offs previously reported in 
the literature. The IQCODE (IR) had an optimal cut-off at 3.22, which gave a sensitivity of 
57% and specificity of 70%. The Area Under the Curve (AUC) of the ROC curve for this 
analysis was 0.685 (p=0.004), and represented the highest predictive value of the three postal 
measures used. A follow up logistic regression gave an OR = 4.62, 95% CI (1.152, 18.56). 
The IQCODE (SR) had an AUC of 0.578 (p>.05), and the optimal cut-off was 3.20 with 46% 
sensitivity and 69% specificity. Two previous studies identified an estimated optimal cut-off 
at 3.19 using the IQCODE (Isella et al., 2006; Li et al., 2012) and using this value made no 
appreciable improvement to sensitivity or specificity of the current sample for either self-
report or informant-report conditions. For the SAGE, the AUC was 0.624 (p=0.036), and the 
best cut-off was at 20.5, much higher than the previously reported 16 (Scharre et al., 2010). 
At a cut-off of 20.5 the SAGE had sensitivity of 77% and specificity of 46%. Using the 
established cut-off of 16 gave 14.7% sensitivity and 95.6% specificity in the present sample. 
The Odds Ratio for the SAGE was OR = 1.24, 95% CI (1.04, 1.49). Table 3 shows the 
correlations between the three postal measures and the neuropsychological measures 
collected. The SAGE was moderately significantly correlated with all neuropsychological 
measures used, while the IQCODE (SR) was only significantly correlated with both 
switching measures from Verbal Fluency, and the IQCODE (IR) was significantly correlated 









Correlations between Postal Measures and Neuropsychological Tests 
  SAGE IQCODE (IR) IQCODE (SR) 
Verbal Fluency     
- Letter Total  .342*** -.059 -.080 
- Category Total  .252** -.021 -.077 
- Switching Total  .390*** -.094 -.202* 
- Switching 
Accuracy 
 .393*** -.111 -.195* 
Trail Making Test     
- Trails A  -.259** .024 -.012 
- Trails B  -.420*** .059 .083 
BVMT-R     
- Delayed Recall  .311*** -.180* -.095 
- Total Recall  .323*** -.221* -.089 
RAVLT     
- Delayed Recall  .246** -.047 -.114 
- Total Recall  .329*** -.055 -.129 
ACE-III Total Recall  .591*** -.236** -.142 
SAGE   -.096 -.175 
IQCODE (IR)    .323** 
* p<.05,  ** p<.01,  *** p<.001 
3.3.4 Internal Consistency 
Cronbach’s alpha was calculated to measure the internal consistency of the items used 
in postal screening, and the IQCODE had high internal consistency (α=.915 informant-report, 
and α=.872 self-report). Internal consistency of the SAGE was lower than the IQCODE 
(α=.591), although assessing this item by item showed only a marginal improvement by 
removing one question (α=.605).  
Despite strong internal consistency of items, an item analysis looking at the 
correlation of each postal question with MCI indicated that some questions were not 
contributing to the predictive power of the measure. Items from the three measures with 
correlations less than ±0.07 (p>.50) were removed and ROC analyses recalculated. Three 




from the SAGE. Two of these recalculations resulted in modest improvements to the AUC, 
with IQCODE (IR) remaining the same, although the significance increased slightly 
(p=0.003). The improved AUCs were IQCODE (SR) AUC=.620 (p=.049), and SAGE 
AUC=.645 (p=.014). The degree of AUC change was measured using Hanley and McNeil’s 
methodology (Hanley & McNeil, 1983), which showed that both z-scores were below the 
1.96 cut-off, meaning the increase in AUC was not large enough to be statistically significant 
(.61 and 1.39 for IQCODE (SR) and SAGE respectively). 
The items removed did not vary much between versions of the IQCODE, except that 
overall the item analysis indicated less relationship between individual items and MCI 
grouping with the IQCODE (SR). Items removed from the IQCODE (IR) included: Making 
decisions on everyday matters; Handling money for shopping; and Handling other everyday 
arithmetic problems (e.g., knowing how much food to buy, knowing how long between visits 
from family or friends). IQCODE (SR) items removed included: Learning new things in 
general; Following a story in a book or on T.V; Making decisions on everyday matters; 
Handling money for shopping; and remembering his/her address and phone number. SAGE 
items removed included: Today’s date; Item similarity; and 3-D figure construction. 
3.4 Discussion 
Difficulties in screening for early cognitive decline have stimulated the development 
of a large variety of brief cognitive screening measures. Despite this development, significant 
limitations with existing tests mean that there are a lack of sensitive and simple to administer, 
yet efficient, cognitive screening measures available for clinicians working with older adults. 
There are numerous advantages for patients if accurate early screening were possible, 
including decision making about the future, as well as the increasing possibility of 




The present study aimed to 1) Validate the use of a postal screening approach as a 
first line screening method for detecting cognitive decline and 2) Assess the effectiveness of 
three measures used as postal tools. The IQCODE was used in both self-report and 
informant-report forms, and the SAGE was a pen and paper task that could be filled in 
without clinician input. 
Participants were categorised as having MCI based on the commonly used Petersen 
criteria (Petersen et al., 1997), with a particular focus on subjective memory complaints and 
relatively unimpaired everyday functioning, backed by deficits on neuropsychological testing 
carried out during the current study. As a result of this 29.8% of the current sample were 
classified as having MCI; while this number appears high it is not outside of inclusive 
estimates from previous studies (Petersen et al., 2001). For the current study an inclusive 
definition of individuals scoring 1.5 standard deviations below age-matched norms on a 
delayed or total memory measure was used as the neuropsychological criterion for MCI. An 
inclusive measure of MCI should allow for the best assessment of whether postal screening 
appears an effective first choice screening procedure, and indicate those most at need of 
further testing to assess declines. 
The SAGE was designed to be a sensitive measure of cognitive decline, meaning that 
cognitively intact older adults are not expected to be particularly challenged by the items, 
resulting in a ceiling effect where a large number of participants got all items correct. Despite 
the resulting differences in the variance between groups there was still a significant 
difference in the observed mean score for individuals classified as MCI. Although group 
differences were observed on mean scores, there was less evidence of a clear cut-off on the 
SAGE that could be used to identify individuals with MCI given how high the calculated cut-




Sensitivity and specificity were also substantially lower than has been previously 
reported (Scharre et al., 2010), although this could be for a number of reasons. Firstly, the 
SAGE assesses a range of cognitive functions and this could account for why it did not 
appear to be particularly sensitive to MCI as measured by ROC curve analyses. In particular 
if older adults are experiencing difficulties in areas consistent with fronto-temporal decline 
this may not be detected in early stages using a criterion of decline based primarily on 
memory. Another potential complication resulted from problems scoring whether participants 
had been able to recall the date. This makes up 4 of the 22 points on the SAGE, and by the 
admission of several participants they had checked the date before writing it down (despite 
instructions to the contrary). Recalling the date is a good measure of orientation and memory 
that by itself can give some indication into memory decline (O'Keeffe, Mukhtar, & T 
O'Keeffe, 2011), and so without this being reliably completed the measure loses some utility. 
Therefore, it was not surprising that remembering the date had such a weak correlation with 
MCI from the item analysis, and that the removal of this improved the predictive accuracy of 
the SAGE. 
IQCODE (IR) responses represented an area of significant difference between MCI 
and cognitively intact groups, indicating that informants close to older adults are sensitive to 
detecting early declines, and are able to report this effectively on a questionnaire. This 
finding is consistent with previous studies looking at informant-reports and early stage 
cognitive decline (Cullen et al., 2007; Jorm, 1994; Jorm & Jacomb, 1989), and represents 
some evidence that this trend is maintained through a postal screening format. The IQCODE 
(IR) showed the best predictive validity in the current study, with an AUC of .685 and an 
optimal cut-off at an average score of 3.22. This cut-off is very close to previously reported 
cut-offs for the detection of MCI, and appears to show that this tool has measured individuals 




In contrast, there was no significant difference in mean scores on the IQCODE (SR) 
for MCI and non-MCI groups in the present study. Self-report and subjective declines are an 
important part of identifying MCI, but tailoring self-report questions to areas of memory and 
daily functioning that increase diagnostic accuracy could cut down on false positives from 
screening measures such as those in the present study. This was demonstrated by the 
improvement in the AUC for IQCODE (SR) of .578 to .620 when items that appeared 
unrelated to cognitive status were removed. These items included those assessing ADLs 
(such as everyday decision making and handling finances), which may be expected to remain 
intact until cognitive decline had progressed beyond mild impairment (Petersen & Negash, 
2008).  
Prior to removing the poorly correlated items, the predictions of the IQCODE (SR) 
were no better than chance. Individuals’ ability to estimate their current cognitive functioning 
may be increasingly impaired as they develop MCI or other age-related cognitive declines, 
meaning they are less likely to rate themselves highly on measures such as the IQCODE. In 
contrast, cognitively intact older adults may be very sensitive to information consistent with 
potential declines, given how worrisome this possibility is for many people, and the impact 
that such declines would have for them (Chasteen et al., 2005; Hess et al., 2003). Future work 
looking at this anxiety, or difficulty in self-assessment of memory and ADLs would be useful 
to explore further. 
Collectively, these findings do indicate that using postal measures as a first-line 
screening modality has merit. In particular each of the three measures, with minor 
modifications, were better than chance at identifying individuals with MCI. Although further 
work is needed to modify and improve such measures, the current results are encouraging. 
The observed results are also in line with previous work looking at postal screening, despite 




Of the three postal measures trialled the SAGE was the most highly correlated with 
the neuropsychological test battery, with the magnitude of correlations ranging from .246 to 
.591, and all correlations being significant at the p<.01 level. Of particular interest was the 
relationship between the SAGE and measures of memory and executive functioning from the 
neuropsychological tests. The two switching conditions on Verbal Fluency are used as 
measures of executive functioning and divided attention, and correlations of .390 and .392 
represent a moderately strong relationship between these tests, and may indicate that the 
SAGE is measuring executive functioning. This conclusion is further supported from the 
correlation (-.42) with Trails B from the Trail Making Test, which also assesses executive 
functioning and cognitive switching. The correlations with measures of memory were 
expected, given the nature of the SAGE and what it was attempting to assess. The strongest 
observed relationship was between the SAGE and the ACE-III, a longer measure of cognitive 
decline with some evidence for detecting MCI (Ahmed et al., 2012). This lends further 
support for the validity of the SAGE in terms of detecting difficulties in memory, executive 
functions, visuospatial abilities, and verbal fluency. 
The IQCODE (IR) was significantly correlated with the BVMT-R, thus providing 
some evidence that it is measuring a similar construct to this memory test, as well as with the 
ACE-III. This may indicate that there is utility for using the IQCODE (IR) for detecting 
cognitive decline more generally. The IQCODE (SR) was only significantly correlated with 
the two Verbal Fluency switching measures, and it is unclear from the present research why 
self-reporting on cognitive decline would be related to executive functioning or fluency 
ability, but not to memory; this relationship would be worthwhile exploring further in future 
research. 
Several limitations may have had some impact on the observed results. Firstly, 




consulting a calendar to check that the date was correct) likely led to an underestimation of 
memory difficulties. There were also several participants who mentioned having multiple 
attempts answering items on this test, and any deviation from instructions could have had an 
impact on the representativeness of subsequent responses. There were also a number of 
missing responses on the IQCODE, due to participants sometimes failing to return both self- 
and informant-responses at the initial screening. In particular, five individuals with MCI were 
missing one of their IQCODE responses, and it is possible that this added data could have 
had an impact on the observed trends.  
Overall, the present results are an encouraging step towards developing cost effective 
and easy to administer screening for age-related cognitive declines. Although the ROC 
analyses did not demonstrate ideally high levels of sensitivity and specificity, the postal 
screening measures had significant predictive validity for MCI.  Future work should focus on 
tailoring tests and test instructions so there is more clarity about how to respond, and 
changing items as needed so that they can be appropriately scored. In particular, removing the 
date question on the SAGE in favour of a more appropriate measure of memory would 
improve the likelihood of accurately identifying MCI cases. Examples of such questions used 
in other measures include who is the current prime minister, or who is the current president of 
the USA. MCI remains a difficult condition to identify even with extensive psychometric 
testing, and any screening procedure that would reduce the demand on clinician time and 




4. Self-Report versus Informant-Report 
4.1 Introduction 
 Industrialised nations are increasingly struggling with aging populations. There are 
particular challenges for healthcare and medical practitioners, including extensive 
comorbidity and age-related declines associated with an increase in older patients. Of these 
cognitive declines, dementia and Alzheimer’s Disease (AD) have enormous financial and 
social costs for the individuals affected and for their families (Anderson & Hussey, 2000; M. 
K. Aronson et al., 1991). The insidious and progressive course of dementing conditions 
means that the pain and cost suffered by older adults with these diseases can last for extended 
periods of time. Due to the severity and impact of age-related cognitive pathologies the 
development of interventions for improving or consolidating aspects of cognition associated 
with declines have generated significant research interest. While theoretically sound and 
building on the concept of neural reserve and enrichment interventions, this research has 
encountered significant difficulties (Acevedo & Loewenstein, 2007; Grundman, Dibernardo, 
Raghavan, Krams, & Yuen, 2013). 
 One major challenge with developing effective interventions is the difficulty with 
early identification, which results from the progressive nature of dementing conditions. The 
diagnosis of individuals most at risk, or during prodromal stages, remains problematic due to 
the lack of clarity of stages of degeneration, and large heterogeneity within and between these 
disorders (Fischer et al., 2007). MCI refers to a stage between normal ageing and dementing 
conditions, where deficits are greater than would be expected based on age, yet are not 
substantial enough to impair the ADLs or to meet criteria for dementias such as AD (Petersen 
& Negash, 2008). The criteria of MCI have varied since it was initially proposed, but the 




2011; Petersen et al., 1997), including subjective memory complaints, relatively intact ADLs, 
with quantified deficits on standardised neuropsychological measures.  
Although there is increasing support for the hypothesis that MCI represents a 
prodromal phase of decline (Aggarwal et al., 2005; Bruscoli & Lovestone, 2004; Fischer et 
al., 2007), there are still problems with this view. In particular, a number of studies have 
identified individuals appearing to revert from MCI back to normal cognitive function 
(Ganguli et al., 2011; Gauthier et al., 2006; Kumar et al., 2006; Sachdev et al., 2013), 
whereas others have reported vastly different rates of further decline among individuals 
categorised as MCI (Busse et al., 2006; Fischer et al., 2007). Overall, the emerging evidence 
indicates that older adults experiencing early cognitive decline are a heterogeneous group, 
and that identifying early deficits should take this into consideration. 
 Early detection of cognitive decline would potentially lead to a number of benefits, 
including making decisions about end-life care, as well as the possibility of interventions to 
decrease, halt, or partially compensate for cognitive declines (Li et al., 2012). A number of 
tests have been used to screen and diagnose AD, the most common of which is the MMSE; 
(Ahmed et al., 2012). Such tests work because of the large differences in cognition between 
healthy and dementing older adults, but such discrepancy does not necessarily present during 
early stages of decline. Consequently, tests such as the MMSE or the CDR have not 
consistently shown utility for detecting more subtle prodromal changes (Ahmed et al., 2012; 
Petersen, 2003). By necessity, MCI diagnosis is based on neuropsychological testing, which 
can be very resource intensive in terms of time and financial costs (Petersen et al., 1999). 
This has led to an increasing body of work looking for cost-effective screening measures in 
order to reduce the burden on medical practitioners of identifying age-related cognitive 




for their effectiveness, but at present MCI screening remains a time consuming and expensive 
endeavour.  
The IQCODE (Jorm & Jacomb, 1989) has been used to assess changes in cognition 
associated with AD, VaD, and post-stroke damage (Cullen et al., 2007; Jorm, 1994; Jorm & 
Jacomb, 1989). This is an informant-report questionnaire that measures changes in memory 
and functional ADLs over a 10-year period, and as such appears to assess areas of interest in 
MCI. Although there are few examples of the IQCODE being used to screen for MCI (Li et 
al., 2012), if a measure like this were shown to have predictive validity for MCI it would 
resolve some of the difficulties in terms of time and cost for front-line screening.  
 One of the Petersen criteria are subjective memory complaints, meaning that for an 
MCI diagnosis individuals, or informants who know them well, need to be able to detect and 
comment on changes in memory. Therefore, self-reports are an important consideration in 
identifying cases of MCI, despite potential problems with the accuracy of self-reports in the 
midst of cognitive declines; for example, lack of awareness of difficulties, or being unable to 
access their own cognitive processes (Hess et al., 2003; Nisbett & Wilson, 1977; Rabbitt & 
Abson, 1990). The IQCODE has previously been trialled as a self-report measure in order to 
test a predictive relationship with cognitive decline (Jansen et al., 2008), but this was only a 
feasibility study and the comparison measures used were limited. It is possible that 
individuals are able to notice early difficulties that they are struggling with before this 
cognitive decline becomes apparent to those close to them. However, if early difficulties can 
be readily compensated for then these may not be noticed by anybody else until they progress 
further (Buckner, 2004). Consequently, it is important to look at both self and informant-
reports to compare and contrast the information that each provide about cognitive decline. 
Informants have long been considered a more reliable resource in assessing declines, but 




combination of self- and informant-reports may improve the screening accuracy beyond the 
use of either alone in identifying likely cases of MCI. 
 The IQCODE has high reported test-retest reliability at .75 (Jorm, 2004), an 
impressive reliability coefficient given the older adult target population. With good test-retest 
reliability, and assuming reasonable content validity, it is expected that scores on this 
measure should remain stable over time; the exception being if individuals are showing 
declines subsequent to initial testing.  Thus, we predicted that any substantial declines over 
time in IQCODE scores would indicate increasing cognitive impairment and likely MCI.  
 The goals of the present study were: 1) To explore the relationship between self-
report and informant-report versions of the IQCODE, with a particular focus on how each of 
them relate to MCI; and 2) To evaluate any change in scores of self- and informant-reports 
over a 12-month period, along with the reliability of each measure. If changes in scores on 
these measures align with objective neuropsychological evidence of deficits then this lends 
support for the use of the IQCODE as an MCI screening tool. It is also important to establish 




 Participants were initially recruited through contacting local community groups with 
older adult members, such as Rotary and Probus clubs. An advertisement was also placed in 
Age Concern, a free newsletter with an older adult target population. The remainder of 
participants were recruited through the NZBRI volunteer database, which contained the 




individuals completed the first stage of the research, with 92 (80.7%) individuals providing 
both IQCODE responses at Time 1.  
 After 12 months all 114 participants were contacted again through phone calls or by 
sending a written invitation to participate in the second stage of the study. Of this group 78 
participants took part in both stages of testing. For the remainder of analyses only those with 
full responses are included. In the present analyses 77 participants returned at least one pair 
of IQCODE responses, although only 68 individuals returned all four IQCODEs. All 77 
participants who participated in both stages and sent back at least one pair of IQCODES were 
included in the current analyses as appropriate. 
The only exclusionary criterion applied during recruitment was that participants not 
be suffering dementia at the initial presentation, so that the sample would be as representative 
of the population as possible. The only inclusion criteria was that participants be 65 years or 
older before the first testing session. All participants provided both verbal and written 
consent, and ethical approval for the project was given by the University of Canterbury 
Human Ethics Committee.  
4.2.2 Instruments 
4.2.2.1 Postal Screening Measures 
 In order to obtain both self- and informant-reported changes to memory and daily 
functioning, two versions of the IQCODE; (Jorm, 1994; Jorm & Jacomb, 1989) were sent to 
participants; the self-report measure included the same questions as the original measure, but 
with modified instructions. The IQCODE is comprised of 16 items assessing changes in 
memory and associated ADLs such as handling finances or learning to use a new gadget 
around the house. Each of these items were scored on a five-point Likert scale, from Much 




and higher scores indicating increasingly significant impairment. The IQCODE has been used 
to screen for a number of disorders (e.g., AD, delirium, and post-stroke damage (Jorm, 
2004)), in a number of settings (e.g., inpatient, outpatient, and community samples (Cullen et 
al., 2007; Jansen et al., 2008)), and with disparate geographical populations (e.g., Chinese, 
Dutch, French, and Norwegian population groups (Jorm, 2004; Li et al., 2012)). 
4.2.2.2 Neuropsychological Measures 
 Neuropsychological measures were used to give a criterion measure of decline in 
order to validate how well the self- and informant-reports assessed cognitive difficulties. The 
neuropsychological tests used for this included: 1) the Brief Visuospatial Memory Test – 
Revised (BVMT-R; (Benedict et al., 1996)), which measures visual working and delayed 
memory as well as spatial orientation. 2) The Rey Auditory Verbal Learning Test (RAVLT; 
(Rey, 1964)) measures verbal working and delayed memory, as well as assessing recall and 
recognition abilities. Together these two memory measures have been shown to differentiate 
individuals with amnestic MCI from non-impaired older adults (Luis et al., 2011; Small, La 
Rue, Komo, Kaplan, & Mandelkern, 1995), and collectively assess verbal and visual delayed 
memory, which together are the most common areas of early deficits in amnestic cognitive 
decline (Small et al., 1995). 3) The Trail Making Test (TMT; (Reitan, 1958)) offers an 
evaluation of executive functioning, along with processing speed and visual scanning. It is 
less reliant than other measures on working memory, and so offers a measure that is 
somewhat resistant to memory deficits (Kortte et al., 2002). 4) Verbal Fluency from the       
D-KEFS (including Letter Fluency, Category Fluency, Switching Fluency, and Switching 
Accuracy conditions) (Delis et al., 2001) offers a further measure of executive functions, 
along with divided attention and semantic ability (Gomez & White, 2006). This has been 
shown to be a reliable measure over time (Snow et al., 1988), and is only modestly correlated 




amnestic declines (Ruff et al., 1997). 5) Finally, the Addenbrooke’s Cognitive Assessment – 
III (ACE-III; (Hsieh et al., 2013; Mioshi et al., 2006)) was administered as a comparison test. 
This was developed as a standalone screening tool of cognitive functioning, and provides a 
brief measure of memory, orientation, visuospatial ability, and verbal fluency (Hsieh et al., 
2013). Collectively these areas are those most likely to be affected throughout early stages of 
cognitive decline, and so this test offers some utility to screen for MCI (Aggarwal et al., 
2005; Busse et al., 2006). 
4.2.3 Procedure 
 The two versions of the IQCODE were mailed out along with information and 
consent forms to all participants who had indicated they wanted to take part in the present 
research. Following this postal questionnaire all participants underwent a brief 
neuropsychological examination to identify likely cases of MCI, taking approximately one 
hour. Implied consent was initially given over the phone, with written consent then collected 
at the beginning of the neuropsychological testing. Administration of these tests was in the 
same order for all participants and tests were conducted by a clinical psychology student 
trained in their administration. 
After 12 months participants were contacted again, and were invited to participate in 
the second stage of the research, looking for any changes over time, and the test-retest 
reliability of the postal measures used. The testing procedure was then repeated, with 
different forms administered where possible. Test administration was by the same researcher, 
and again all individuals consented to participating in the research. 
4.2.4 MCI Screening   
Individuals were classified as MCI based on the commonly used Petersen criteria 




below age adjusted norms on at least one memory test, along with self-reported or informant-
reported subjective memory complaints; relatively intact activities of daily living; generally 
intact cognitive functioning; and not meeting diagnostic criteria for dementia.  
4.2.5 Data Analysis 
 Differences between scores on the two versions of the IQCODE were initially 
explored using t-tests. Regression analyses were used to explore the relationship between 
each version of the IQCODE at each point in time. Test consistency over time and internal 
consistency coefficients were calculated, including an item analysis, followed by intraclass 
correlations for both versions of the IQCODE. Finally, convergent validity was explored 
through correlations with neuropsychological measures. 
4.3 Results 
4.3.1 Demographic Data and Descriptive Statistics 
 Participants were aged between 65 and 86 (M=74.90, SD=5.42), and included 48 
females and 29 males. Participants’ ethnicity was similar to expected proportions of older 
adults based on Canterbury District Health Board data from the 2013 census (Statistics New 
Zealand, 2013), with 94.9% NZ European/pakeha, 1.3% Māori, and 3.8% other. Participant 










Participant Demographic Data at Time 1 and Time 2 
 Time 1  Time 2  
 Male Female Male Female 
 N (%) N (%) N (%) N (%) 
Sex Total 44 (38.6) 70 (61.4) 29 48 
Age     
- 65-69 8 (29.6) 19 (70.4) 5 (29.4) 12 (70.6) 
- 70-74 10 (33.3) 20 (66.7) 7 (31.8) 15 (68.2) 
- 75-79 14 (46.7) 16 (53.3) 10 (45.5) 12 (54.5) 
- 80-84 10 (47.6) 11 (52.4) 7 (50) 7 (50) 
- 85+ 2 (33.3) 4 (66.7) 0 (0) 2 (100) 
Ethnicity     
- NZ European/Pakeha 42 (38.9) 66 (61.1) 28 (38.4) 45 (61.6) 
- Maori 1 (100) 0 (0) 1 (100) 0 (0) 
- British 0 (0) 2 (100) 0 (0) 2 (100) 
- Asian 1 (50) 1 (50) 0 0 
- Other 0 (0) 1 (100) 0 (0) 1 (100) 
Highest Level of Education     
- High School 27 (46.6) 31 (53.4) 19 (46.3) 22 (53.7) 
- Post-school Training 3 (60) 2 (4) 2 (11.8) 15 (88.2) 
- Undergraduate 
Qualification 
8 (19.0) 34 (80.9) 2 (18.2) 9 (81.8) 
- Postgraduate 
Qualification 
6 (66.7) 3 (33.3) 6 (75) 2 (25) 
 
In total 10 participants were classified as MCI at both Time 1 and Time 2, with a 
further 24 meeting this criteria at one time or the other. Overall, this means 43.6% of the 
present sample met the criteria for MCI. However, nine participants that met criteria for MCI 
at Time 1, did not continue to meet these criteria at Time 2; this group appeared to revert 




memory measures indicated that they were at least 1.5 standard deviations below age-
adjusted norms at Time 1, but they were not below this cut-off at Time 2. 
 Means and standard deviations for each of the four IQCODE collections were initially 
calculated and are presented in Table 5. These show that similar means and standard 
deviations were observed on both tests at Time 1 and Time 2. 
Table 5 
Descriptive Statistics for Time 1 and Time 2 Postal Measures 
 Time 1 Time 2 
 M SD M SD 
IQCODE (SR) 3.150 .344 3.206 .282 
IQCODE (IR) 3.142 .329 3.129 .373 
 
Self- and informant-reports were compared using t-tests of dependent means for Time 
1 and then for Time 2. At Time 1 this difference between the two forms was not significant 
t(62)=-.89, p=.377, d=.39. However, there was a significant difference between self- and 
informant-reports seen at Time 2, with self-report ratings indicating a higher degree of 
impairment t(76)=-2.31, p=.024, d=.90 (M=3.206, SD=.282, and M=3.129, SD=.373 for self- 
and informant-report respectively). 
At Time 1 there was a positive linear relationship between self- and informant-report 












































Figure 2. Scatterplot of self-report and informant-report IQCODE scores at Time 1. The grey 
line represents equality (x=y) and trend line of y=.6385x+1.1139, R
2
=.415. 
Figure 3 shows a similar scatterplot for Time 2 scores. As with the scores at Time 1, 
Figure 3 shows the strong linear relationship between both versions of the questionnaire at 
Time 2 (r(77)=.633, p<.001), with few points deviating from the tight grouping of data, 









































Figure 3. Scatterplot of self-report and informant-report IQCODE scores at Time 2. The grey 
line represents equality (x=y) and trend line of y=.836x+.4489, R
2
=.400. 
Regression analyses were then conducted to test for differences in the two IQCODEs, 
in particular to see if there was evidence that deficits were under-reported on the self-report 
IQCODE. To this end a regression analysis for Time 1 with the IQCODE (SR) as the 
dependent variable was calculated which gave a significant result, Ŷ=.650Χ+1.13, t(61)=6.58, 
p<.001. At Time 2 a similar pattern was observed Ŷ=.479Χ+1.71, t(75)=7.08, p<.001, this 
indicates that while linearly related, scores on these two measures did not increase at the 
same rate, with a slope less than 1. Due to the intercepts at 1.13 and 1.71 for Time 1 and 
Time 2 respectively it may also indicate that under-reporting was occurring at the lower end 
of responses on the self-report IQCODE.  
4.3.2 Test-Retest Reliability 
 The coefficient of reliability was calculated for both versions of the IQCODE and 


























IQCODE (IR) Time 1 
The scatterplots of these relationships are shown on Figure 4 and Figure 5 for Time 1 and 
Time 2 respectively. Both figures show that the majority of responses are closely clustered, 
although more deviation from the group can be seen in the IQCODE (IR) over time, 










Figure 4. Scatterplot of Time 1 and Time 2 IQCODE informant-report scores. The grey line 













































Figure 5. Scatterplot of Time 1 and Time 2 IQCODE self-report scores. The grey line 
represents equality (x=y) and trend line of y=.5239x+1.555, R
2
=.393. 
Repeated measures t-tests were calculated for both versions of the IQCODE to look 
for differences in mean scores across the 12 months, and these demonstrated no significant 
differences for either version: IQCODE (SR) t=(78)=-1.686, p=.096,  (MDif=.051, 
SDDif=.269); and IQCODE (IR) t(71)=.176, p=.861 (MDif=.0067, SDDif=.319). This indicates 
that the questionnaires demonstrated high stability over time, and that across the sample these 
scores stayed constant. 
Correlations between scores over time were then calculated again for the four groups 
of participants; those that did not meet criteria for MCI (non-MCI); participants that met 
criteria at Time 2 (MCI-single); participants that met MCI criteria at Time 1 but not at Time 2 
(Reverters); and participants that met criteria at both Time 1 and Time 2 (MCI-both). 




IQCODE (SR) had significant consistency over time for all groups except Reverters, whereas 
the IQCODE (IR) only had significant test-retest reliability for Reverter and non-MCI 
groups. 
Table 6 
Test-Retest Correlations for each MCI Category  
       IQCODE (SR)         IQCODE (IR) 
 r N r N 
MCI-both .719* 10 .038 9 
MCI-single .709** 13 .339 13 
Reverters .088 9 .744* 8 
Non-MCI .673*** 42 .746*** 37 
* p<.05,  ** p<.01,  *** p<.001 
Paired samples t-tests were then run on these four groups to look for differences in 
mean scores across a 12-month period. Results of these analyses are shown in Table 7. The 
only statistically significant observed difference across the 12-month period was for the MCI-
single group on the IQCODE (SR).  
Table 7 
Repeated Measures t-tests for each MCI Category 
 IQCODE (SR) IQCODE (IR) 
 MDiff t df d MDiff t df d 
MCI-both -.305 -2.07 9 .54 -.079 -.364 8 0.12 
MCI-single .096 2.26* 12 .53 -.103 -1.21 12 .33 
Reverters -.102 -.732 7 .25 -.047 -.778 7 .26 
Non-MCI -.034 -1.23 41 .18 .069 1.83 36 .29 
* p<.05 
4.3.3 Internal Consistency 
 Cronbach’s alpha was calculated for both versions of the IQCODE at each time point 
to measure internal consistency of the items when used in postal screening. All four of these 
alpha calculations showed high internal consistency (IQCODE SR: Time 1 α=.879, Time 2 




indicated that these values of Cronbach’s alpha would not be improved by removing any of 
the items. 
The consistency of items across time was also measured to assess whether any of 
these were changing over a 12-month period. This was done by calculating repeated measures 
t-tests for each IQCODE item at both time points. For the IQCODE (IR) the means of one 
item were significantly different between Time 1 and Time 2: “Remembering where to find 
things which have been put in a different place from usual”, t(71)=2.04, p=.045, d=.24. Three 
items on the IQCODE (SR) showed significant differences over time: “Following a story in a 
book or on T.V”, t(78)=-2.35, p=.021, d=.26; “Handling money for shopping”, t(78)=-2.00, 
p=.049, d=.23; and “Handling other everyday arithmetic problems, e.g., knowing how much 
food to buy”, t(78)=-2.109, p=.038, d=.24. All other pairwise comparisons showed non-
significant changes over time, but not all were significantly correlated with each other. On the 
IQCODE (IR) “Remembering what day and month it is”, and “Using his/her intelligence to 
understand what’s going on and to reason things through” had correlations of r=.191 (p=.108) 
and r=.185 (p=.128) respectively. Similarly, four items on the IQCODE (SR) were not 
significantly correlated over time: “Remembering things that happened recently” r=.200 
(p=.079); “Making decisions on everyday matters” r=.098 (p=.394); “Handling money for 
shopping” r=-.100 (p=.380); and “Handling other everyday arithmetic problems” r=.215 
(p=.057). 
Intraclass correlations were calculated for the means of both versions of the IQCODE, 
with Time 1 and Time 2 as two items being assessed. A high degree of reliability was found 
between the two measurements of the IQCODE (SR), ICC=.759 F(72,72)=4.22, p<.001, 
η
2
=.80. The IQCODE (IR) also had a high degree of reliability across the two measurement 
points, ICC=.744 F(66,66)=3.86, p<.001, η
2
=.79. This process was again repeated after 




are presented in Table 8. These demonstrated that statistically significant ICCs were observed 
for each group except Reverters on the IQCODE (SR), but only for Reverter and non-MCI 
groups on the IQCODE (IR). 
Table 8 
Intraclass Correlations for each MCI Category 
 IQCODE (SR) IQCODE (IR) 
 ICC F-value ICC F-value 
MCI-both .768 5.384* .072 1.070 
MCI-Single .787 5.873** .468 1.909 
Reverters .088 1.091 .851 6.43* 
Non-MCI .780 4.585*** .843 6.713*** 
* p<.05,  ** p<.01,  *** p<.001 
4.3.4 Convergent and Divergent Validity 
 Validity of the IQCODE as used in postal screening was further tested through 
comparisons with neuropsychological measures of memory, and the ACE-III which measures 
a range of cognitive areas, in order to explore convergent and discriminant validity. These 


















Correlations Between Postal Questionnaires and Neuropsychological Tests at Time 1 
 IQCODE (SR)  IQCODE (IR)  
 r= r= 
BVMT   
- Total Recall -.094 -.283* 
- Delayed Recall -.056 -.326** 
RAVLT   
- Total Recall -.191 -1.75 
- Delayed Recall -.223 -.174 
ACE-III   
- Attention -.023 -.103 
- Memory .137 -.044 
- Fluency .288* .293* 
- Language .177 .038 
- Visuospatial .221 -.079 
- Total .236* .027 
Trail Making Test   
- Trails A .006 -.113 
- Trails B .000 -.075 
Verbal Fluency   
- Letter .054 -.130 
- Category .011 -.005 
- Switching -.139 -.199 
- Switching Accuracy -.130 -.208 
IQCODE (IR) .644***  





Correlations Between Postal Questionnaires and Neuropsychological Tests at Time 2 
 IQCODE (SR)  IQCODE (IR)  
 r= r= 
BVMT   
- Total Recall -.300** -.328** 
- Delayed Recall -.407*** -.455*** 
RAVLT   
- Total Recall -.445*** -.346** 
- Delayed Recall -.475*** -.349** 
ACE-III   
- Attention -.148 -.346* 
- Memory .036 -.217 
- Fluency -.017 -.201 
- Language -.003 -.050 
- Visuospatial -.266 -.169 
- Total -.069 -.300* 
Trail Making Test   
- Trails A -.464*** -.225* 
- Trails B -.266* -.085 
Verbal Fluency   
- Letter -.087 -.113 
- Category -.226* -.067 
- Switching -.311** -.211 
- Switching Accuracy -.264* -.141 
IQCODE (IR) .633***  
* p<.05,  ** p<.01,  *** p<.001 
 Few significant correlations were observed at Time 1, with the IQCODE (SR) only 
correlating with the ACE-III, and the IQCODE (IR) correlating with the BVMT-R measures 
and an ACE-III subscale. The two versions of the IQCODE were also significantly 
correlated. Overall, this demonstrated that the IQCODE demonstrated some convergent 
validity with a general measure of cognitive decline (the ACE-III), while not strongly 
correlating with more specific neuropsychological measures. This pattern changed at Time 2, 
with more significant correlations observed. At Time 2 both IQCODEs were correlated with 
all four memory measures, with the IQCODE (SR) also correlated with both TMT conditions 




again highly correlated with each other. The IQCODE (IR) was correlated with Trails A and 
the ACE-III. This pattern of convergent validity with the neuropsychological memory 
measures was more in line with expectations, given the strong memory focus of the 
IQCODE. 
4.4 Discussion 
 The current study aimed to explore the relationship between self- and informant-
report versions of the IQCODE, with a particular focus on assessing the reliability of these 
measures over a 12-month period. The IQCODE has been used to look for changes in 
cognition in older adult populations, and there is emerging evidence that it may have 
screening utility for detecting MCI (Li et al., 2012). The early detection of cognitive decline 
is an area where there currently exists a dearth of efficient and reliable screening tools, which 
has created considerable demand for such procedures to be developed (Ahmed et al., 2012; 
Cullen et al., 2007). One possible avenue involves collecting self-reports, given that 
subjective complaints of decline are an explicit diagnostic criterion of MCI (as per the 
original Peterson criteria). Previous work has looked at using the IQCODE as a self-report 
measure, but no informant report was collected for comparison, and it has been unclear 
whether the same or different information can be collected using these as complementary 
tools (Jansen et al., 2008).  
 Participants in the current study were categorised as MCI based on the Petersen 
criteria (Albert et al., 2011; Petersen et al., 1997), including subjective memory complaints 
along with objective neuropsychological deficits on a standardised memory measure. There 
were four categories resulting from this: individuals who met criteria for MCI at both Time 1 
and Time 2 (MCI-both); those meeting MCI criteria at Time 2 (MCI-single); participants who 




(reverters); and participants that did not meet criteria for MCI (non-MCI). This resulted in 
42.9% of the present sample meeting the criteria for MCI at one or both times of testing. This 
proportion is higher than expected, and outside of most population estimates from previous 
studies (Hänninen et al., 2002; Lopez et al., 2003; Petersen et al., 2001), but still within some 
MCI prevalence estimates which have been reported as high as 53.8% amongst adults 65 
years and older (Koivisto et al., 1995). However, for the present research looking at the utility 
of screening measures, inclusive MCI criteria were used in order to maximise the chance of 
demonstrating the use of self- and informant-report measures to detect declines. 
 The IQCODE has been used in a number of settings (Jorm & Jacomb, 1989) and with 
a number of populations to detect cognitive declines (Ehrensperger et al., 2010), including 
MCI (Li et al., 2012). There is also emerging evidence about the utility of the IQCODE as a 
self-report measure (Jansen et al., 2008). In the present study differences between scores at 
Time 1 and Time 2 were initially looked for, and repeated measures t-tests of both self- and 
informant-reports indicated no significant differences between mean scores over time. The 
lack of significant differences overall supports the idea that both forms of the IQCODE are 
reliable measures over time. However, despite consistency over time there would be expected 
differences in scores if declines were occurring, so repeated measures t-tests were again 
conducted after separating the participants based on MCI categorisation. Scores on the 
IQCODE (SR) were significantly different for those in the MCI-single group, showing that 
on this measure differences were observed over a 12-month period. However, the direction of 
this change was not in the expected direction, as the average self-report scores decreased 
from Time 1 to Time 2, indicating cognitive improvement. It is unclear why this self-reported 





The most interesting trend from the t-tests was in the MCI-both group, where a fairly 
large difference between means at Time 1 and Time 2 on the IQCODE (SR) was observed, 
and it is possible that this would have reached significance had the group been larger. It is 
likely that this is reflecting ongoing decline in the group who were consistently meeting 
criteria for MCI over time. Previous research has estimated that the conversion rate of MCI to 
AD and other dementias is between 5.6% and 41% per year (Geslani et al., 2005; Petersen et 
al., 1999; Ritchie et al., 2001), and so while none of the participants in the present research 
met criteria for AD these individuals are likely to be experiencing accelerating cognitive 
declines. 
 The group that reverted from MCI to normal cognition appeared to have no difference 
between Time 1 and Time 2 on the paired t-tests. This is unsurprising if something other than 
cognitive decline led to the initial MCI categorisation, as in this case whatever has affected 
neuropsychological measures may not have had the same impact on ADLs. It would be 
unexpected to see a significant improvement in ADLs over time, but objectively this group 
has improved on the neuropsychological memory measures over a 12-month period. Previous 
research has identified a number of possible reasons for individuals appearing to revert from 
MCI including: misdiagnosis using overly liberal criteria (Ganguli et al., 2011); transient 
cognitive decline due to depression or other psychiatric conditions (Kumar et al., 2006); or 
poor neuropsychological test performance arising from ill-health or a lack of motivation 
(Sachdev et al., 2013). It is not clear whether these factors or other uncollected variables 
contributed to the individuals reverting to normal cognition during the present study. 
  The coefficient of reliability was high for both versions of the IQCODE, supporting 
previous evidence of good test-retest reliability on the informant-report measure (Jorm, 
2004). However, what has not been demonstrated previously is the test-retest consistency of 




to informant-reports. This gives evidence to support the idea that self-reports on cognitive 
decline are reliable over time. Coefficients of reliability showed a different pattern when 
participants were grouped by MCI status, and in particular informant-reports were not 
significantly correlated over time for MCI-both and MCI-single groups. There are a number 
of possible explanations, but the lack of relationship between Time 1 and Time 2 may be 
reflecting a range in degrees of decline between individuals in these MCI categories. More 
work looking specifically at individuals with MCI over time using this measure would be 
useful to explore, particularly by increasing the sample size, and therefore power, of the 
present study. IQCODE (SR) test-retest consistency for three groups appear to indicate strong 
relationships between scores on self-reports over time, with no linear relationship observed 
from Time 1 to Time 2 for reverters.  
 The significant intraclass correlations (ICC) supported the use of both measures over 
time, and indicated that the measurement of cognitive decline over time is reliable. This 
pattern was repeated when the ICC was recalculated between MCI categories, except for 
MCI-both on the IQCODE (IR); this had only a weak and nonsignificant ICC, which may 
indicate there was inconsistency in measurement for this particular group. As mentioned 
above, it is important to interpret this with caution given the low number in this analysis, with 
only eight degrees of freedom. Looking at the ICC when participants had been categorised by 
MCI status showed a slightly different pattern for self-report and informant-report measures. 
On the self-report measure all groups showed significant ICC values except for the reverters, 
indicating that those whose cognitive status appeared to improve over time may not have 
been reliably assessing their functioning. This fits with the idea of an external cause of their 
difficulty, such as stress or depression at Time 1. The informant-report measures had 
significant ICCs for the group of reverters, which may indicate that informant-reports are 




cognitive decline. Alternatively, with their objective change in cognitive status it may be that 
the self-reports were more accurate, and that the ICC should not be significant given the 
changes that have taken place. The current study was not designed to answer this, but it will 
be well worth exploring in future research and was both an interesting and unexpected 
finding. 
 Item consistency as measured by repeated measures t-tests gave some interesting 
results about consistency over time of individual items, and whether particular items may be 
sensitive to decline. There was a significant difference on “Remembering where to find 
things” on the IQCODE (IR), which could indicate a noticeable change in memory 
functioning. In contrast the self-report items that changed significantly over a one year period 
were more related to functional ADLs, such as “Handling finances and everyday arithmetic 
problems”. The differences here may reflect that informants noticed memory lapses, whereas 
participants were more sensitive to noticing practical difficulties in day-to-day life. Several 
items on each version were not correlated with each other between testing sessions, and again 
these largely followed the pattern seen in paired t-tests, with self-report items predominantly 
regarding ADLs, and informant-report items more related to difficulties in memory. One 
possibility for this is that the lack of correlation between these items was due to varying 
decline over the 12-month period, with particular ADLs being more affected than others. 
 There was good evidence for content validity as shown by the correlations between 
the two versions of the IQCODE and the neuropsychological measures administered. The 
IQCODE (SR) had an unexpected pattern of correlations at Time 1, where the only 
significant relationships found were with Verbal Fluency and total score on the ACE-III, with 
no significant correlations with memory measures. A more expected pattern was seen with 
the IQCODE (IR), which was strongly correlated with both BVMT-R measures, although the 




was a strong relationship with Verbal Fluency, and it appears that performance on the 
IQCODE was related to fluency ability for the current sample. At Time 2 both IQCODEs 
were strongly related to all four memory measures, with the IQCODE (IR) also significantly 
correlating with the total score on the ACE-III.  
 The correlation coefficients calculated with the other neuropsychological measures 
offer some evidence of discriminant validity. At Time 1 neither version of the IQCODE was 
significantly correlated with Trails A, or Letter or Category Fluency subscales, which was 
expected given that these measure constructs including visual scanning and verbal 
communication deficits (Ashendorf et al., 2008; Loonstra, Tarlow, & Sellers, 2001). These 
subscales are also not as sensitive to cognitive decline in general as the other subscales of the 
tests, and performance should remain intact on these even in early stages of MCI (Kortte et 
al., 2002), and so it was not expected that they would correlate strongly with measures 
estimating decline such as the IQCODE (Murphy, Rich, & Troyer, 2006). However, Trails B 
and Switching Fluency both measure divided attention and executive functions, and these are 
expected to be impacted to some degree by MCI, even if early declines are predominantly 
amnestic (Ashendorf et al., 2008; Nutter-Upham et al., 2008). The correlations between 
postal and neuropsychological measures at Time 2 showed more significant relationships; in 
particular the IQCODE (SR) was correlated with both Trails A and B, and with Category 
Fluency, Switching Fluency, and Switching Accuracy subscales. This may indicate that the 
IQCODE (SR) was assessing more executive functioning than the informant-report, and 
could be useful to make predictions about facets of cognitive decline beyond memory, 
including other aspects of cognition that can be impacted as a part of ongoing cognitive 
decline. 
 In the present study a relatively high proportion of individuals appeared to revert to 




present analyses were not set up to assess the cause of reverters, but the presence of such 
individuals may have had an impact on the observed results. In particular, measuring the 
consistency of tests presumes that domains being investigated are relatively consistent, and 
this may not have been the case for some individuals. It is also important to note that 32.5% 
of the initial sample did not return for the second stage of this research, and so were unable to 
be included in analyses. The effect of participant dropout is unclear, but it does reduce the 
power of the study for detecting a true effect. 
The aim of the current study was to assess the relationship between self- and 
informant-reports in older adults, with a particular focus on the psychometric properties of 
each version. From the present research both give valuable information about declines and 
used together are likely to offer greater screening utility than either by itself. In particular, 
changes in self-reported difficulties over time may relate more to instrumental ADLs, but 
self-reports are more likely to be influenced by transient difficulties. Informant-reported 
difficulties appear more likely to indicate changes in memory, but may not reflect the 
practical changes that cause distress to the individual. The consistency of both self-report and 
informant-reports was high over a 12-month period, with the only inconsistent results in 
groups where this would be expected, such as those experiencing increasing declines, and 
individuals found to have reverted from MCI to normal cognitive functioning. Overall, the 
present study demonstrated that self-reports demonstrate similar reliability to informant-
reports for older adults experiencing early cognitive declines, and that each may offer 




5. Effectiveness of Multi-Stage Screening Over Time 
5.1 Introduction 
 Age-related cognitive declines represent a growing financial and social cost as 
increasing life expectancy continues to affect the incidence of neurological declines (M. K. 
Aronson et al., 1991). The most prevalent of these is mild cognitive impairment (MCI), a 
progressive neurodegenerative disorder theorised to represent prodromal dementia (Bayer et 
al., 2014; Bruscoli & Lovestone, 2004). Individuals experiencing MCI often refrain from 
presenting to primary health clinicians, or underestimate early difficulties caused by 
neurodegeneration (Löppönen, Räihä, Isoaho, Vahlberg, & Kivelä, 2003). As a result, such 
individuals are not assessed until declines have progressed and cognitive impairment has a 
more significant impact on functioning. However, even when individuals present to 
physicians there are significant limitations in the detection of early cognitive declines in 
primary healthcare sectors (Cullen et al., 2007). The most common tool used in predicting 
declines is the MMSE, which is brief and can be administered by a general practitioner, but 
has shown only limited predictive validity for diagnosing cases of MCI and for identifying 
those likely to progress to AD (Aggarwal et al., 2005; Ahmed et al., 2012; Petersen, 2003). 
This has led to a number of brief screening tools being developed and trialled in an attempt to 
improve the detection of early cognitive impairment (Cullen et al., 2007). The aim of such 
measures is to offer a way of efficiently and effectively identifying at risk individuals without 
the necessity of extensive psychometric assessment as a first-line screening methodology 
(Scharre et al., 2010).  
 The rate of progression from MCI to dementia tends to be rapid, with conversion 
estimates between 5.6% (Ritchie et al., 2001) and 41% (Geslani et al., 2005) per annum, 




develop dementia over a period of 12 months (Petersen et al., 1999). Another complicating 
factor in assessing continuing declines are individuals who have been termed reverters. These 
individuals appear to revert to normal cognition over a period of time, having previously met 
criteria for MCI (Ganguli et al., 2011). A number of reasons have been suggested for why 
some individuals’ cognition appears to improve, including psychiatric disorders such as 
depression appearing as pseudo-dementia (Kumar et al., 2006), or test taking behaviours and 
anxiety impacting initial measurement (Sachdev et al., 2013). Despite a lack of clarity around 
why some individuals revert, such reports are ubiquitous in the literature, and rates of 
reverting are typically reported between 4.5% (Nordlund et al., 2010) and 53% (Ganguli et 
al., 2011), with one study reporting that 92% of participants reverted or changed diagnostic 
categories over time (Ritchie et al., 2001). Overall, inconsistencies in diagnosis and prognosis 
for cases of MCI have led to a situation where despite the knowledge that individuals with 
MCI represent those most at risk of progressive cognitive declines, it is difficult to briefly and 
accurately identify these individuals.  
 Collectively these challenges with the detection and diagnosis of MCI, along with the 
unreliability of the diagnostic category, limit the detection of cases, and the possible impact 
that early intervention may offer. One solution may lie in improving the detection of early 
declines, and determining whether particular characteristics indicate those most likely to 
revert to normal cognition instead of progressively declining. Several attempts at multi-stage 
screening for cognitive decline have been attempted, but have been restricted by 
methodological limitations. One possible way to improve the efficiency of cognitive 
screening involves using postal questionnaires as a first-line screening approach, and 
following this with neuropsychological testing where indicated. A multiple-stage screening, 
such as this would allow testing to be targeted at individuals most likely to meet criteria for 




experiencing early cognitive declines who would be unlikely to present to primary health 
physicians (Alessi et al., 2003).  
 Limitations in previous attempts at developing postal screening have included testing 
self-report measures without a meaningful comparison (Jansen et al., 2008), postal tools only 
being measured against the MMSE (Lonie et al., 2009), and only offering neuropsychological 
testing to those presenting as MCI on the postal screen (van Uffelen et al., 2007). These 
significantly limit the conclusions that can be drawn from the respective studies; as a multi-
stage MCI screening needs to demonstrate that those identified via screening as likely MCI 
are also likely to meet more stringent criteria on standardised gold-standard testing.  
 While self-reported memory difficulties are a key diagnostic consideration of the most 
commonly used MCI criteria (Petersen et al., 1997) there is limited but encouraging evidence 
that by also considering informant-report information the individuals who are likely to revert 
to normal cognition over time can be identified (Sachdev et al., 2013). The updated MCI 
criteria reflect the benefit of self- or informant-reported difficulties, allowing either to be 
considered for diagnosis (Albert et al., 2011). Postal screening offers a simple and 
straightforward means of collecting such self-report and informant-report data. Moreover, 
individuals who revert to normal cognition demonstrate less functional decline, so utilising 
well validated questionnaires measuring changes in ADLs through multi-stage screening may 
offer utility for differentiating individuals expected to cognitively decline from those likely to 
be experiencing transient cognitive difficulties (Li et al., 2012).  
 The present study aimed to explore the utility of a multi-stage screening approach to 
assess cognitive changes over time. Postal screening was used a first-line screening approach, 
and this included collecting self- and informant-reports in order to predict subsequent 




screening tools for identifying cases of MCI; 2) Explore changes in cognition over time to see 
how screening measures reflect objective cognitive changes; and 3) Assess whether self- and 
informant-reports add reliability to the diagnosis of MCI. This was accomplished by 
administering postal screening tools followed by a neuropsychological battery, and then 
repeating this process 12 months later. 
5.2 Method 
5.2.1 Participants 
 Participants were recruited through multiple means from the local community. 
Community groups with older adult members, such as Rotary and Probus Clubs, were 
contacted and in turn passed on project information to members. An advertisement was 
placed in Age Concern, a free local newsletter with an older adult target population. The 
remainder of the sample were recruited through the NZBRI’s volunteer database from a list 
of 1,300 older adults who were cognitively and physically healthy at the last point of contact. 
This list was randomised before recruitment began, with the only inclusion criteria being 65 
years or older at the point of first contact. From these approaches 114 individuals were 
recruited and participated in the initial postal screening, with 78 taking part in both stages of 
testing, meaning a retention rate of 68.4% across both of the postal and neuropsychological 
sessions. However, only 77 participants returned the necessary responses for the present 
analyses. 
 The only exclusionary criteria used were that participants were not to have a diagnosis 
of AD, so that the sample would reflect the community and be as representative as possible. 
All participants provided verbal followed by written consent, and ethical approval was 





5.2.2.1 Postal Screening Measures 
 Three questionnaires were used in postal screening in the present study. These were 
selected to gather a range of information, which is crucial for identifying likely cases of MCI. 
The SAGE examines a range of cognitive functions including, memory, executive functions, 
orientation, and visuospatial manipulation (Scharre et al., 2010). It is comprised of 11 
questions with a maximum score of 22, and the summed score is used to differentiate 
individuals with MCI from those with dementia, as well as cognitively intact older adults. For 
the present study an adapted version of the SAGE was used, with demographic and ethnicity 
questions appropriate for New Zealand, and modifications between USA and NZ terminology 
for money calculation items. 
 The IQCODE includes 16 items assessing change in memory and ADLs over the last 
ten years (e.g., handling finances or learning to use a new gadget around the house) (Jorm, 
1994). Each item is scored on a five-point Likert scale from Much Improved to Much Worse, 
with higher average scores indicating more impairment. The IQCODE has been extensively 
used as a screening tool to look for cognitive changes after a range of disorders including AD 
(Cullen et al., 2007), VaD (Jorm & Jacomb, 1989), and to assess post-stroke damage (Jorm, 
1994). Informants are often relied upon in the detection of early cognitive changes (Cullen et 
al., 2007) but self-reports of decline are of equal importance. SMCs are one of the Petersen 
criteria, so it stands to reason that self-reports and/or informant-reports should be collected in 
any MCI screening process, and there is emerging evidence that the IQCODE has good 
reliability and validity as a self-report measure as well as an informant-report measure (Refer 
to chapter 2 & 3; (Jansen et al., 2008)). For the present study two versions of the IQCODE 




5.2.2.2 Neuropsychological Measures  
 A battery of neuropsychological tests was administered to objectively measure aspects 
of cognition, and to give a criterion measure of decline in order to assess how well the 
screening tools were able to detect and predict cognitive deficits. The BVMT-R (Benedict, 
1997) measures visual memory and includes delayed and recall conditions to assess visual 
encoding and retrieval deficits. This test was developed to address a lack of visual memory 
measures appropriate for multiple administrations, and the six alternate forms allow retesting 
with reduced practice effects. Test-retest reliability is reported at .63 to .92 for total recall and 
delayed recall conditions, and inter-rater reliability is given at .97, indicating that this a 
reliable memory measure (Benedict et al., 1996). 
 The RAVLT (Rey, 1964) assesses verbal delayed memory, and also contains a 
recognition trial. Test-retest reliability is reported at .51 to .86 across all the trials, and 
content validity appears to be high with strong correlations between the RAVLT and other 
verbal memory tests such as the CVLT (Delaney et al., 1992). The most common early signs 
of cognitive decline are in the areas of visual and verbal delayed memory, and these two 
neuropsychological memory measures are able to detect these early changes (Luis et al., 
2011; Small et al., 1995). 
 The TMT (Reitan, 1958) was included in the neuropsychological battery as it offers a 
measure of executive functions, as well as divided attention and processing speed. The TMT 
is less reliant on working memory than many other tests, so it is somewhat resistant to 
amnestic cognitive declines, and performance should not be significantly impaired by discrete 
early memory difficulties (Kortte et al., 2002). The TMT correlates fairly highly with other 
visual searching tasks (e.g., Digit Symbol from the WAIS-III, .63; (Sanchez-Cubillo et al., 




 Verbal Fluency from the D-KEFS, including Letter Fluency, Category Fluency, 
Switching Fluency, and Switching Accuracy, gives another measure of executive functions 
and divided attention, as well as semantic ability (Delis et al., 2001). In older adults test-retest 
reliability is reported at .70 or greater for letter and category conditions, which are most 
resistant to decline (Snow et al., 1988). The Verbal Fluency conditions are also only modestly 
correlated with memory measures (.17 to .22 with Wechsler Memory Scales and the Selective 
Reminding Test), giving another test that should be relatively unaffected by amnestic decline 
(Ruff et al., 1997). 
 Finally, the ACE-III (Hsieh et al., 2013; Mioshi et al., 2006) was administered. This 
test was developed as a standalone screening tool of cognitive functioning, and provides a 
brief measure of memory, orientation, visuospatial ability, and verbal fluency (Hsieh et al., 
2013). Collectively these areas are those most likely to be affected throughout early stages of 
cognitive decline, and so this test offers some utility to screen for MCI (Aggarwal et al., 
2005; Busse et al., 2006). 
5.2.3 Procedure 
 The SAGE and both versions of the IQCODE were mailed out to all participants who 
had indicated interest in the study at the initial phone contact, along with project information 
and consent forms. Following these postal questionnaires all participants took part in a brief 
neuropsychological testing session assessing current cognitive functioning. Implied consent 
was initially given over the phone, with written consent obtained at the testing session. Test 
administration occurred in the same order for all participants, and they were administered by 
a clinical psychology PhD student trained in the use of these measures. 
 After 12 months all participants who completed the research at Time 1 were contacted 




over time. The testing procedure was repeated, with alternate forms administered where 
possible. Neuropsychological administration was by the same researcher, and all participants 
consented to their involvement at the second stage as well as the first. 
5.2.4 Data Analysis 
 Initially ANCOVA were used to look for differences over time on the measures used. 
Change scores were then calculated based on these differences and the correlations with 
postal and neuropsychological measures were computed. Analysis of Variance (ANOVA) 
and multiple regression analyses were used to explore between-group differences and the 
degree to which individual tests contributed to predicting cases of MCI. Finally, Receiver 
Operating Characteristics (ROC) curves were used to measure the predictive validity for MCI 
of the postal questionnaires and MCI status over time, and Odds Ratios (OR) calculated for 
each statistically significant ROC curve using logistic regression. Given the exploratory 
nature of the present analyses, and a lack of prior evidence as to cut-offs, single optimal cut-
offs are reported from ROC analyses for each measure. 
5.3 Results 
5.3.1 Participants  
During the initial recruitment and testing 70 females and 44 males completed the 
postal screening and neuropsychological testing, with an age range of 65-93 (M=75.04, 
SD=5.88). At Time 1 there were 34 individuals categorised as MCI based on Petersen’s 
criteria (Albert et al., 2011; Petersen et al., 1997), including subjective memory complaints 
and objective memory deficits observed on the neuropsychological measures. Included in this 
group were 20 females (28.6%) and 14 males (31.8%), and the individuals in this group were 
significantly older than the non-MCI participants (M=77.62, SD=5.26 vs. M=73.95, SD=5.82, 




 At Time 2 (12 months after initial testing), 78 participants agreed to take part in the 
second stage of the research, giving a total response rate of 68.4%. Of these 77 returned the 
necessary responses and so are included in the present analyses. This group was aged 
between 65 and 86 (M=74.90, SD=5.42); in total 48 females and 29 males participated in 
both stages of the research. Their ethnicity was not dissimilar to recent census data from the 
Canterbury DHB (Statistics New Zealand, 2013), with 94.9% NZ European/Pakeha, 1.3% 
Maori, and 3.8% other.  
5.3.1.1 Returners and Non-returners 
 ANCOVA were used to compare participants depending on whether they agreed to be 
tested at Time 2, based on their Time 1 responses, with age and gender considered as 
covariates. In total 36 participants did not take part at Time 2, and one did not provide postal 
responses. There was no significant difference between these groups on postal scores, 
although the SAGE was trending towards significance, F(1, 110)=3.03, p=.085 (Returners 
M=19.60, SD=1.98, Non-returners M=18.58, SD=3.84).  
Scores on the neuropsychological measures were converted to age-adjusted 
standardised scores based on established norms (Population M=100, SD=15). There were 
significant differences observed on both conditions of the RAVLT between those who 
returned and those who did not, with RAVLT Delayed Recall F(1, 110)=4.83, p=.030 
(Returners M=113.0, SD=18.54, Non-returners M=103.75, SD=21.71), and Total Recall 
F(1,110)=4.68, p=.033 (Returners M=119.89, SD=17.25, Non-returners M=111.52, 
SD=20.58) showing that those who did not return had lower age-adjusted standard scores on 
average at Time 1 for measures of verbal memory. There was also a difference observed on 
the ACE-III raw scores indicating a possible difference in current cognitive functioning, F(1, 
110)=14.36, p<.001 (Returners M=90.03, SD=5.46, Non-returners M=84.94, SD=8.59). Of 




participants elected not to return, 44.1% of those identified as experiencing cognitive declines 
at Time 1 chose not to return. The difference in MCI proportion between those who returned 
and those who did not approached significance, χ
2
=3.53, p=.06, φ=-.176. Subsequent 
analyses are based on participants who completed both phases of data collection (n=77). 
5.3.2 MCI Categorisation 
 Twenty-four individuals met MCI criteria at Time 2 (13 females (27.1%) and 11 
males (37.9%)). Overall this meant 42.9% of the present sample were classified as MCI at 
one or both testing points. Participants were categorised into four groups based on MCI 
status: individuals who met MCI criteria at both Time 1 and Time 2 (MCI-both); individuals 
meeting MCI criteria at only Time 2 (MCI-single); individuals who did not meet criteria for 
MCI (non-MCI); and participants who appeared to revert from MCI to normal cognition 
between Time 1 and Time 2 (Reverters). In total 10 participants were classified as MCI-both, 
14 MCI-single, 44 non-MCI, and 9 reverters. The participants that appeared to revert to 
normal cognition all scored at least 1.5 standard deviations below age-adjusted norms on 
neuropsychological memory measures at Time 1, but did not score below this cut-off at Time 
2. There were no significant differences between the ages of individuals in the four MCI 




 Paired t-tests were initially used to look for differences over time on postal measures. 
Neither version of the IQCODE differed significantly over the 12 months, t(72)=-1.70, 
p=.094 for the IQCODE (SR) and t(66)=.049, p=.961 for IQCODE (IR). In contrast, there 
was a significant difference observed on the SAGE, with decreased average scores indicating 
more difficulty on this measure over time, t(76)=2.86, p=.006, d=.15 (Time 1 M=19.58, 
SD=1.99, Time 2 M=18.86, SD=2.38). Paired t-tests were then used to look for differences 




on MCI category, and these are shown in Table 11. The SAGE and IQCODE (SR) showed 
significant differences over time for MCI-single participants, with both representing a larger 
degree of cognitive decline. There were no significant differences observed for the other MCI 
groups over time, including for reverters. 
Table 11 
Paired t-tests for Postal Measures from Time 1 to Time 2 for each MCI Group 
 IQCODE(SR) IQCODE (IR) SAGE 
 MDiff t d MDiff t d MDiff t d 
MCI-both -.305 -2.07 .654 -.079 -.36 .121 1.40 1.58 .500 
MCI-single .096 2.26* .628 -.103 -1.21 .334 1.43 2.22* .593 
Reverter -.102 -.732 .269 -.047 -.78 .275 1.00 1.25 .417 
Non-MCI -.034 -1.23 .190 .069 1.83 .300 .295 .994 .015 
* p<.05 
 Changes on the neuropsychological measures for the overall sample were assessed 
using paired t-tests. The only tests showing significant differences between Time 1 and Time 
2 were Switching Fluency and Switching Accuracy on the Verbal Fluency test, with both 
scores increasing over time, t(76)=-2.83, p=.006, d=.080 (Time 1 M=11.30, SD=2.92, Time 2 
M=12.60, SD=4.13) and t(76)=-5.37, p<.001, d=.174 (Time 1 M=10.97, SD=2.95, Time 2 
M=13.13, SD=3.30) respectively. Differences on neuropsychological measures for each MCI 
group were then explored in the same way, with memory test comparisons shown on Table 
12, and the remaining neuropsychological measures on Table 13. MCI-single participants 
showed a large and significant decrease in average Total Recall BVMT-R scores, while 
reverters significantly improved on this measure over time. All groups except reverters also 





Paired t-tests of Neuropsychological Memory Measures for each MCI group 
 BVMT-R Delayed BVMT-R Total RAVLT Delayed RAVLT Total ACE-III 
 MDiff t d MDiff t d MDiff t d MDiff t d MDiff t d 
MCI-both 1.95 -.47 .01 5.70 -1.88 .06 7.50 1.05 .02 6.80 1.41 .03 1.20 .66 .04 
MCI-single 23.36 6.12*** .11 19.93 6.76*** .16 5.27 1.90 .05 2.86 .89 .02 -.93 -.84 .06 
Reverters -14.83 -2.48* .05 -21.47 -2.77* .04 -6.97 -.78 .01 -2.50 -.62 .02 1.56 .95 .06 
Non-MCI 2.07 1.13 .01 -1.28 -.75 .01 2.30 -1.35 .02 -1.60 -.87 .01 -.21 -.39 .02 
* p<.05,  ** p<.01,  ***p<.001 
Table 13 
Paired t-tests of Executive Functioning and Verbal Ability Neuropsychological Measures for each MCI group 
 Trails B Letter Fluency Category Fluency Switching Fluency Switching Accuracy 
 MDiff t d MDiff t d MDiff t d MDiff t d MDiff t d 
MCI-both 0.00 0.00 0.0 .40 .25 .02 4.30 1.46 .05 -.30 -.20 .01 -1.90 -2.39* .30 
MCI-single 1.07 1.48 .15 .50 .59 .05 -.07 -.09 .00 -2.64 -3.44** .32 -2.64 -3.35** .30 
Reverters .67 .52 .05 -.22 -.37 .07 -.44 -.74 .14 -.89 -.546 .04 -1.22 -.97 .09 
Non-MCI -.16 -.35 .02 -.09 -.31 .02 -.11 -.22 .01 -1.18 -1.96 .07 -2.25 -3.85** .15 





 Change scores were generated for the neuropsychological measures by calculating the 
difference between Time 1 and Time 2, such that positive scores indicated an improvement 
over time. Correlations between the Time 1 postal questionnaires and neuropsychological 
change scores indicate the relationship between initial postal questions and change over time. 
These correlations are presented in Table 14. Moderate correlations are seen between 
IQCODE (SR) and both BVMT-R and RAVLT Delayed Recall, indicating a negative 
relationship between IQCODE (SR) memory difficulties and delayed verbal recall. The 
IQCODE (IR) was negatively correlated with both Delayed Recall and Total Recall on the 
RAVLT, as well as positively correlated with Trails A. Finally, the SAGE was negatively 
correlated with both Verbal Switching measures and with the ACE-III, indicating a 
relationship with this screening tool and measures of executive functioning. The negative 
correlations between IQCODE measures and neuropsychological test scores indicate that as 
individuals reported more current difficulties they tended to show decreased performance on 


















Correlations Between Time 1 Postal Questionnaires and Neuropsychological Change Scores 
 IQCODE (SR) IQCODE (IR) SAGE 
BVMT-R    
- Delayed Recall -.265* -.036 -.087 
- Total Recall -.085 .036 -.122 
RAVLT    
- Delayed Recall -.390** -.311* .000 
- Total Recall -.299 -.309* -.099 
TMT    
- Trails A .132 .241* -.190 
- Trails B .060 .029 -.125 
Verbal Fluency    
- Letter Fluency .029 .092 .077 
- Category Fluency .070 .114 -.202 
- Switching Fluency .051 .070 -.333** 
- Switching Accuracy .007 -.040 -.252* 
ACE-III .126 .071 -.243* 
* p<.05,  ** p<.01 
 Given that the MCI categorisation was based on neuropsychological scores below 
age-adjusted norms, an overall change score was calculated as a criterion of decline by 
averaging change from Time 1 to Time 2 on the four memory age-adjusted standard scores 
collected (BVMT-R and RAVLT) which represent standardised measures normed so that 
M=100, SD=15. The overall change score for the sample had a mean of  -3.08, 95% CI         
(-12.15, 5.98) and SD=39.94. The sample was separated according to diagnostic category, 
which showed the average change was relatively small for MCI-both and non-MCI groups, 
while as expected, the MCI-single and reverter groups showed large changes over time (MCI-
both M=-6.65, SD=36.3; MCI-single M=-51.41, SD=28.06; reverters M=45.78, SD=29.68; 
and non-MCI M=3.11, SD=28.96). Between group differences were tested using a one-way 
ANCOVA again controlling for age and sex, F(3,71)=20.38, p<.001, η
2
=.46.  
A multiple regression was conducted to look at whether the postal measures at Time 1 





dependent variable, with both Time 1 IQCODEs and the SAGE as independent variables. 
These screening measures statistically significantly predicted change in neuropsychological 
scores over time F(3,59)=3.73, p=.016, R
2
=.16 with Beta weights of IQCODE (SR)= -.326 
(p=.042), IQCODE (IR) = -.080 (p=.623), and the SAGE=-.181 (p=.152). However, only the 
IQCODE (SR) added significantly to the prediction model and predicted unique variance in 
the change score, Ŷ=-40.70Χ+228.33, p=.031.  
 A further regression was calculated using the IQCODE (SR) and age to explore any 
relationship between age and self-report scores. This analysis indicated that age did not have 
a main or interaction effect on predicting memory change over time. Analysing the predictive 
relationship between the IQCODE (SR) and memory change showed a significant result in 
the absence of the other postal measures F(1,71)=11.77, p=.001, R
2
=.142 with a regression 
equation of  Ŷ=-44.35Χ+136.83 and Beta weight=-.377. As IQCODE (SR) scores increase a 
decrease in memory change scores can be seen, demonstrating that increasing self-reported 
memory difficulties are able to predict impaired performance on standardised 
neuropsychological memory measures. 
 The regression equation was used to estimate the memory change of non-returners 
based on Time 1 IQCODE (SR) scores, and this showed a predicted average memory change 
of -4.64. This did not represent a significant difference from the measured average change of 
returners (p=.589). 
 5.3.3 MCI Prediction 
 ROC curves were calculated for each of the three postal measures to predict MCI 
categorisation at Time 1, Time 2, and an overall diagnostic classification. At Time 1 the 
IQCODE (IR) had an optimal cut-off of 3.30, giving sensitivity of 53% and specificity of 





The other two postal measures did not have significant AUCs when making predictions at 
Time 1, with IQCODE (SR) AUC=.574, p=.347, and SAGE AUC=.562, p=.418. This implies 
that only informant-reports demonstrated predictive utility at rates higher than chance. 
 ROC curves for the three postal measures were again calculated for Time 2 postal 
measures against Time 2 MCI categorisation. The IQCODE (IR) was again significant, 
AUC=.686, p=.009, OR = 16.38, 95% CI (2.13, 126.10) with an optimal cut-off of 3.03 
which gave sensitivity of 75% and specificity of 53%. The IQCODE (SR) was not significant 
for the Time 2 comparison, but the trend was in the expected direction with AUC=.638, 
p=.054. The SAGE was significant, AUC=.676, p=.014, OR = 1.27, 95% CI (1.03, 1.57) with 
an optimal cut-off at 20.5 which gave sensitivity of 92% and specificity of 44%. Predictive 
utility was therefore demonstrated by both the IQCODE (IR) and the SAGE, which were able 
to predict cases of MCI at Time 2. 
 Finally, the predictive ability of the postal measures at Time 1 was explored by 
calculating ROC curves using Time 2 MCI categorisation as the outcome variable.  The 
IQCODE (IR) again had a statistically significant ROC curve, AUC=.677, p=.019, OR = 
6.07, 95% CI (0.95, 38.88) with an optimal cut-off at 3.26 which gave 54% sensitivity and 
84% specificity. The AUC for the IQCODE (SR) was also statistically significant, 
AUC=.711, p=.004, OR = 9.93, 95% CI (1.06, 93.53) with the cut-off at 3.34 giving 52% 
sensitivity and 90% specificity. This implies the IQCODE (SR) may be more useful for 
predicting subsequent declines than the previous ROC statistics indicated, given that it was 
able to predict future declines at statistically significant rates. The predictive ability of the 
IQCODE (IR) was also demonstrated over time. The Time 1 SAGE was not able to make 
predictions at Time 2 better than chance, AUC=.547, p=.509. The AUC for these ROC curves 






AUC of Postal Measures Predicting Dichotomous MCI Classification 
 MCI Status (Time 1) MCI Status (Time 2) 
IQCODE (SR) Time 1 .574 .711** 
IQCODE (IR) Time 1 .698* .677* 
SAGE Time 1 .562 .547 
IQCODE (SR) Time 2  .683 
IQCODE (IR) Time 2  .686** 
SAGE Time 2  .670* 
* p<.05,  ** p<.01 
5.4 Discussion 
 The present focus of inquiry aimed to explore the relationship between postal 
screening tools and cognitive changes over time. In particular, it was hoped that brief 
screening tools would offer utility for predicting subsequent declines over time between 
testing sessions. MCI represents an area of interest in research focused on age-related 
cognitive declines, given that these individuals appear to be more at risk of experiencing 
progressive impairment, such as AD, than older adults in general. If older adults experiencing 
the first stages of cognitive decline could be identified effectively then interventions aimed at 
slowing or halting such declines could be trialled and implemented, but to date difficulties in 
making such identification has limited potential interventions. Three postal measures were 
included in the present research, which allowed a variety of information to be collected, and 
also reduced some of the limitations present in previous work testing multi-stage MCI 
screening. 
 Participants were categorised as having MCI based on the criteria suggested by 
Petersen and updated by the NIA (Albert et al., 2011; Petersen et al., 1997) and this led to 





experiencing decline over time to meet criteria at Time 2; individuals who did not meet MCI 
criteria; and participants who appeared to revert to normal cognition between Time 1 and 
Time 2. Overall this led to 42.9% of the present sample meeting MCI criteria at some point 
across the study, including those who reverted over time. This proportion was higher than 
expected, and outside of many estimates of prevalence (Hänninen et al., 2002; Petersen et al., 
2001), however, estimates have been reported as high as 53.8% (Koivisto et al., 1995). There 
are several possible reasons for such observed discrepancies between studies, and in 
particular the use of different MCI diagnostic criteria, or different criterions of decline are 
likely to have an impact (Hänninen et al., 2002). Inclusive MCI criteria were used for the 
present study in order to provide the best opportunity to demonstrate screening utility of the 
measures used. Given the serious nature of MCI and subsequent declines it can be useful to 
use liberal criteria in order to ensure a reasonable sensitivity is achieved. The other 
interesting group were the nine participants who appeared to revert from impaired to healthy 
cognition in the 12 months between testing sessions. The present study was not set up to 
explore the reasons behind reverters, but some possible reasons why this pattern occurs have 
been suggested previously, including psychiatric conditions or initial test-taking difficulties 
(Kumar et al., 2006; Sachdev et al., 2013). While reverters do not comfortably fit into the 
idea of a linear pattern from early impairment to progressive decline, these individuals are 
ubiquitous in the research area, often in high proportions (Busse et al., 2006; Ganguli et al., 
2011; Gauthier et al., 2006). 
 The proportion of participants who chose not to take part in the second stage of the 
present research was higher than expected, and represents a potential bias due to the 
decreased data at Time 2. However, several characteristics of the sample limit this potential 
issue. In particular, those who did not return were considerably more likely to have been 





related declines. The conversion rate of MCI to dementia is estimated at between 5.6% 
(Ritchie et al., 2001) and 41% (Geslani et al., 2005) and so it is possible that those falling into 
this category would be less likely to be able or willing to participate in further research. A 
related possibility involves health more generally, whereby a number of participants 
contacted indicated interest in taking part, but were unable to due to physical health, injury, 
or scheduled surgery. It is unclear whether these individuals’ cognitive status may have been 
related to physical difficulties or illness, but these were clear barriers to participation, and 
there are strong links between physical health and age-related cognitive decline (Etgen et al., 
2010; Heyn et al., 2004). It is therefore not necessarily problematic to have participant 
attrition this high, and these individuals not taking part at Time 2 does not invalidate the 
present results, due to the increased likelihood that they may have declined further, which 
would have supported the current findings. 
 Self- and informant-report postal measures tended not to change over time, with both 
versions of the IQCODE showing no significant differences. This was to be expected given 
that the informant version has high reported test-retest reliability (Jorm, 1994), and the self-
report version appears to have similar psychometric properties (Chapter 3). In contrast the 
SAGE did demonstrate a significant decrease in average score over time, indicating that 
overall individuals had more cognitive difficulties at Time 2 than Time 1. When pairwise 
comparisons over time were made for each MCI category the only statistically significant 
differences were observed among participants categorised as MCI-single on the IQCODE 
(SR) and the SAGE. This was particularly interesting given the nature of the MCI groups, 
and in particular reverters demonstrated an improvement across standardised cognitive tests 
over time, yet did not demonstrate a significant improvement on the SAGE, which is a 
cognitive screening tool. Moreover, the reverters also did not demonstrate significant change 





IQCODE, could be due to the different areas that each are assessing, and while the present 
study was not set up to explore such a finding it will be interesting to explore in future 
research. It is also possible that self- and informant-reports remain unaffected by transient 
cognitive declines that result in variable neuropsychological performances, which may have 
resulted in some false positives by the screening tool that can then be clarified with full 
neuropsychological batteries. However, it is important to note that for screening tools at least, 
it appears more beneficial for higher sensitivity with false positives, than to potentially miss 
some individuals and limit any possible early intervention efforts to ameliorate or halt further 
decline.  
 The only overall significant differences on neuropsychological measures over the 12-
month period were Switching Fluency and Switching Accuracy from Verbal Fluency. The 
lack of change in memory scores was somewhat explained when the MCI groups were looked 
at separately, where differences between MCI-single and reverters were seen. Diagnosis of 
MCI was made using a memory criterion, so those meeting MCI at Time 2 but not Time 1 
performed more poorly on memory measures during the second testing session; in particular 
decreased performance on the two BVMT-R scales appeared to indicate difficulty. In contrast 
the reverters appeared to improve on this measure, which accounted for them not meeting 
MCI diagnostic criteria at Time 2. It was interesting that changes on the verbal memory 
measures were much smaller, with none approaching statistical significance. 
 On the other neuropsychological measures there were differences seen on the 
Switching Accuracy scale from Verbal Fluency, where three of the four groups changed over 
12 months. There was also a large mean difference between scaled scores on Category 
Fluency for participants in the MCI-both group, although this did not reach significance, 





being observed on Switching Accuracy no significant differences were seen on Trails B, 
which is interesting given the overlap in executive functioning that both measure. 
 It was expected that the three postal measures used in the present study would be 
positively correlated with the neuropsychological memory change scores, given that these are 
purported to assess cognitive change with a particular focus on early memory difficulties.  
The correlations for Time 1 postal scores against neuropsychological change scores indicated 
that there were significant negative correlations between the IQCODE (IR) and both RAVLT 
conditions, while the IQCODE (SR) was negatively correlated with changes on delayed recall 
conditions from both the RAVLT and the BVMT-R. Higher IQCODE scores indicate 
increasing memory and ADL impairment, and so it was expected that these scores would 
increase as BVMT-R and RAVLT scores decreased. Delayed recall is likely to be the best 
predictor of decline, as this is often the first sign of age-related cognitive decline (Small et al., 
1995). The lack of significant correlations between the SAGE and changes on memory 
measures was unexpected, although the SAGE was significantly correlated with changes on 
the ACE-III, which is a more comprehensive measure of a similar range of cognitive 
processes to the SAGE. This may indicate that the SAGE is related to cognitive change more 
generally than the IQCODEs are, while these are better specific predictors of memory 
changes. 
 There were significant differences between MCI groups based on an average 
neuropsychological memory change score, but more interesting was that only the IQCODE 
(SR) added to the prediction when regression analyses was conducted. Overall the regression 
indicated that 16% of the variance in neuropsychological memory change scores were 
accounted for by these tests. Given the aim of the present study was to look at making 
predictions of decline from brief screening, as an indication for using multi-stage cognitive 





informant-reports of memory decline and difficulties with ADL are predictive of declines on 
age-adjusted standardised measures that are strongly associated with MCI. Interestingly, 
adding age to the regression analysis did not increase the predictive ability. Age has long 
been established as strongly linked to dementia and cognitive decline, with increasing 
prevalence of all forms of dementia as age increases (M. K. Aronson et al., 1991; Wimo, 
Jonsson, & Winblad, 2006). It was therefore interesting that age was not a factor in the 
present study, with no significant difference in age observed between the four MCI groups. 
One possibility is that a combination of the sample size and the relatively restricted age range 
resulted in no significant effect of age being observed. The average age of 75.04 was also 
fairly high, which may have reduced the statistical impact that age had on differentiating 
cases of MCI from cognitively healthy older adults. 
 The predictive utility of the postal screening tools was assessed through the use of 
ROC curves to see how well these tools could indicate likely cases of MCI. At the Time 1 
testing only the IQCODE (IR) had a statistically significant AUC, indicating that through 
using this test 69.8% of cases could be correctly identified. While ideally a screening tool 
would have a better predictive rate than this, it still represents a predictive accuracy 
significantly better than chance, and fulfils the aim of identifying individuals most at risk in 
order to inform more extensive testing. The cut-off of 3.30, which maximised the sensitivity 
and specificity of the measure, was similar to previous research using the IQCODE to 
identify MCI, where a cut-off of 3.19 was optimal (Li et al., 2012). The difference between 
these two values could be due to the different response format, where in the present study this 
was used as a postal tool, instead of being administered face-to-face. It would be interesting 
in future to directly compare the response format and determine whether this does have an 





 Predictions using the postal screening tools at Time 2 indicated more predictive 
validity than at Time 1. The IQCODE (IR) again demonstrated a significant result, with 
68.6% of cases being correctly identified based on the AUC, although the optimal cut-off 
based on this analysis was 3.03. The optimal cut-off is found by maximising sensitivity and 
specificity, but because the purpose of screening measures is to identify likely cases the 
sensitivity is more important, and so while a cut-off of 3.03 is close to the expected score of 
non-impaired individuals, it gave a sensitivity of 75%. The IQCODE (SR) did not statistically 
significantly predict cases of MCI, but was trending in the right direction with an AUC of 
.638 and a p-value of .054, meaning that this would likely reach significance had the sample 
size been larger. The SAGE had a cut-off of 20.5, which is considerably higher than the cut-
off given by the test development study at 16 (Scharre et al., 2010). As with the IQCODE it 
would be interesting to assess whether the response format has had an impact on scores on 
this test, given that it has not been utilised as a postal screening tool previously. There were 
also a number of participants who indicated that they did not follow the instructions when 
completing this tool. In particular, several participants volunteered that they had checked the 
date on a calendar before responding. Recall of the current date is a good standalone measure 
of memory and orientation (O'Keeffe et al., 2011), and so it is unclear how much of an 
impact it has if this is not being answered appropriately, particularly given that this accounts 
for 4 of the 22 points possible on the SAGE.  
 The third set of ROC curve analyses explored the possibility that screening responses 
at Time 1 could predict MCI cases at the 12-month follow-up, and both versions of the 
IQCODE demonstrated utility for predicting future declines. In particular, despite not 
meeting significance in the previous comparisons, the self-report version correctly identified 
71.1% of MCI cases with a cut-off of 3.34. This was similar to the cut-off suggested by the 





the use of postal screening to indicate individuals likely to have MCI, and also to predict 
individuals likely to experience decline from healthy cognition to MCI over a 12-month 
period. 
 The present study aimed to explore the use of postal screening measures to indicate 
likely cases of MCI, and to predict incident cases over a 12-month period. This was 
undertaken through the use of three postal screening tools, and administering a 
neuropsychological battery of tests to all participants assessing the most common areas of 
early cognitive decline. The results supported the idea that postal screening tools have utility 
for predicting decline, and offer evidence that cognitive screening can be undertaken without 
the large time and financial costs that have typically been associated with this. As predictions 
are able to be made based on postal measures, the use of these as a first-line screening 
modality is therefore supported from the present results. More work is needed to explore 
differences based on response format of the postal measures used, and in particular whether 
the SAGE remains as useful a test as previous research shows, despite some individuals not 
following all instructions for the measure. Yet despite possible limitations the results show 
the potential benefits of multi-stage screening, and the use of such measures for predicting 





6. Effect of Life-Course Participation in Stimulating Activities 
6.1 Introduction 
 Age-related cognitive declines, and specifically MCI, represent an increasing health 
concern for older adults across industrialised nations and the developing world (Anderson & 
Hussey, 2000; Kalaria et al., 2008). MCI is a neurodegenerative condition representing a 
stage of cognitive decline beyond normal aging but not meeting full diagnostic criteria for 
dementia (Ritchie & Touchon, 2000). Individuals experiencing early cognitive declines are a 
heterogeneous group, and it has typically been difficult to identify such individuals for 
research or treatment. There have been significant variations in reported prevalence rates of 
MCI, along with diagnostic instability and many individuals appearing to revert back to 
normal cognition, having previously been identified as cognitively impaired. Moreover, there 
is significant variation in the rates with which individuals with MCI progress to dementia, 
with the conversion rate of MCI to dementia estimated at between 5.6% (Ritchie et al., 2001) 
and 41% (Geslani et al., 2005) per year; significantly higher than the 1 to 2% of cognitively 
intact older adults expected to develop AD over 12 months (Petersen et al., 1999).  
 One hypothesis for differences in the rate individuals’ progress to dementia is the 
theory that staying cognitively and physically active may protect against future declines and 
help maintain cognitive functioning (Podewils et al., 2005). There is an established 
relationship between decreasing engagement in cognitively and physically stimulating 
activities and incident cognitive decline (Fratiglioni, Paillard-Borg, & Winblad, 2004; 
Verghese et al., 2006), but the causal direction of this has not yet been established. It is 
currently unclear whether increasing cognitive decline leads to withdrawal from activities 
(James et al., 2011) or that continued engagement offers some protection from incident 





latter via the neural reserve hypothesis (Stern, 2002), where staying cognitively, physically, 
and socially active helps maintain cognition even in the presence of neuropathology (Wilson 
et al., 2005). Research linking frequency of engagement with each of these activity types 
consistently demonstrates a protective effect from developing cognitive impairment over 
time, as well as promoting physical health, which also has a beneficial impact on cognition in 
old age (Heyn et al., 2004; Lautenschlager et al., 2008).  
 Wilson (e.g., (Wilson et al., 2005; Wilson et al., 2000; Wilson et al., 2013)) has 
expanded further on the concept of neural reserve, by exploring how cognitively stimulating 
activity over the life-span may increase neural reserve and offer protection from cognitive 
decline. In particular, involvement in leisure activities with cognitive, social, and physical 
components during mid-life and adulthood have been linked to improved memory 
functioning (Christensen & Mackinnon, 1993), and a decreased likelihood of dementia in old 
age (Whitmer et al., 2005). One of the ways this may occur is through increased 
synaptogenesis associated with cognitive and physical activity across the lifespan (Churchill 
et al., 2002). Post-mortem studies have demonstrated variable levels of impairment between 
older adults despite neuropathology associated with Alzheimer’s disease (AD) that would be 
expected to cause significant cognitive impairment (Boyle et al., 2013; Riley et al., 2002; 
Satz, 1993). It is therefore possible that lifestyle factors may contribute to the resilience of the 
brain, meaning that more extensive neuropathological changes need to occur before an 
observable impact is seen (Kempermann, 2008). 
 Given the observed difficulties in reliably identifying individuals at risk of age-related 
cognitive declines, and the unreliability of such diagnoses, the inclusion of information 
regarding current frequency of activity participation may improve the diagnostic processes. In 
particular the rate of disease progression from MCI to dementia is an important consideration 





factors that are often not measured (Hultsch, Hertzog, Small, & Dixon, 1999). Given that 
research showing late-life leisure activity having an impact on the disease expression of MCI 
is widespread, it is important to consider the impact of cognitive reserve on the prognosis of 
MCI, and the expected heterogeneity of rates of change between individuals. While some of 
the variation is likely due to methodological and sampling differences, it is also possible that 
some of this variation may be due to engagement in stimulating activities, and therefore may 
be able to be quantified in screening. 
 The present study aimed to explore whether late-life engagement with cognitive, 
physical, and social activities offered protection from cognitive decline over a 12-month 
period. Specifically, it was expected that more frequent participation in activities would be 
related to a reduced degree of decline over a one-year period, compared to individuals with 
less frequent activity. It was hypothesised that more frequent cognitive, physical, and social 
engagement would mitigate decline over time, and keep at risk individuals cognitively intact. 
Frequency of cognitive activity across the lifespan was also assessed, and it was hypothesised 
that a higher frequency of cognitive activity would be related to decreased cognitive 
impairment. Furthermore, engagement in cognitive, social, and physical leisure activities 
were explored through the use of a postal questionnaire, with the view to exploring whether 
such information is useful for improving the prediction of MCI in a community sample. It is 
possible that the reliability of MCI diagnosis could be improved by factoring in the protective 
effects of cognitive, physical, and social activity on neural health, as well as these factors 
contributing to estimations of ongoing cognitive decline. 
6.2 Method 
6.2.1 Participants 





older adult members in Christchurch, NZ (e.g., Rotary and Probus clubs), who in turn passed 
on project information to their members. An advertisement was placed in Age Concern, a free 
newsletter with an older adult target population. Individuals were also contacted from the 
NZBRI volunteer database, which contained contact information for 1,300 individuals who 
were cognitively healthy at the last point of contact. In total 145 individuals indicated interest 
in taking part in the research, with 114 completing stage one and 78 taking part at Time 1 and 
Time 2. However due to the specific analyses being utilised only the 78 who completed both 
stages were included in the present analyses. The only inclusion criterion for the present 
study was that participants were 65 years or older at recruitment. The only exclusion criterion 
was that individuals did not meet diagnostic criteria for dementia at first contact, so that the 
sample would be representative of the community. All participants gave informed consent 
before taking part, and were fully informed about the purpose and nature of the study. Ethical 
approval for this research was obtained from the University of Canterbury Human Ethics 
Committee. 
6.2.2 Instruments 
 Four questionnaires were administered as part of the initial postal screening in order 
to collect a variety of information, in particular any change from previous levels of 
functioning, along with early signs of cognitive deficits. Specifically, self-report and 
informant-report versions of the Informant Questionnaire on Cognitive Decline in the Elderly 
(IQCODE), and the Self-administered Gerocognitive Examination (SAGE) were posted to all 
participants. Furthermore, information about past and current engagement in cognitive, 
physical, and social activities was also collected via the General Activities Questionnaire 
(GAQ), discussed below. Neuropsychological tests assessing a range of cognitive areas, 
including memory, executive functioning, verbal fluency, and orientation were then 





6.2.2.1 Postal Screening Measures 
 The SAGE is a recently developed tool to screen for MCI and AD, and examines a 
variety of cognitive areas including: memory, executive functions, and visuospatial 
manipulation (Scharre et al., 2010). The SAGE contains 11 questions that are summed to give 
a total possible score of 22, which has some evidence for differentiating individuals with 
MCI from both healthy controls, and individuals with AD. We used an adapted version of the 
SAGE, with demographic questions that were appropriate for NZ, and modifications between 
USA and NZ terminology for money calculation questions. 
 The IQCODE includes 16 items asking about memory changes over time, as well as 
any changes in instrumental ADLs, such as handling finances or driving (Jorm & Jacomb, 
1989). The IQCODE has been used extensively as a screening instrument to look at cognitive 
changes in disorders including AD, VaD, and post-stroke damage (Cullen et al., 2007; Jorm, 
1994). There is also emerging evidence for the use of the IQCODE in detecting changes 
associated with MCI (Li et al., 2012). Each IQCODE item is scored on a five-point scale 
from Much Improved to Much Worse, and the average score is taken from the 16 questions 
(Jorm, 2004). Participants were sent two versions of the IQCODE in the present study, an 
informant report (to be completed by someone who had known them at least 10 years), and a 
self-report. Despite the questionnaire being developed for an informant to answer, there is 
some evidence that self-reports may be useful in detecting early cognitive decline (Jansen et 
al., 2008), and this measure may facilitate collecting this type of data (Chapter 2 & 3).  
 The General Activities Questionnaire (GAQ; Appendix E) was adapted for the present 
study based upon a semi-structured interview template used by Wilson in research looking at 
engagement in stimulating activities over the life-span and activity during late-life (e.g., 
(Wilson et al., 2005; Wilson et al., 2013; Wilson et al., 2002b)). The questionnaire has items 





development, childhood (6 years), teenage (12 years), young adult (18 years), and adulthood 
(35-40). Participants were asked to answer as accurately as they could for those stages of life, 
but that specific recollection of the age in question was less important than themes during 
those stages. There were three questions at childhood, and seven for each of the other three 
time points, with each item answered on a 4-point scale assessing frequency, from Every day 
or almost every day to Several times a year/rarely. Scores were averaged for each time point 
to give a measure of cognitive activity, with higher scores indicating less frequent activity. 
Questions assessing present-time activities were more varied, and included items assessing 
cognitive, physical, and social activities. In total there were 27 items regarding how 
participants spend their time at present; of these 20 had a cognitive component, 6 physical, 
and 7 social. As per item development (Wilson et al., 2005) items could load on multiple 
elements (e.g., During the last year how often did you participate in political or cultural group 
activities was considered to have both cognitive and social components (Karp et al., 2006)). 
Each of these items had the same four scale options as the previous life-stage questions, and 
average scores were calculated for the three types of activity. Given that this measure was 
developed as part of the present research the psychometric properties are unclear, however 
the semi-structured interview used by Wilson has demonstrated reasonable psychometric 
properties across a number of studies (Wilson et al., 2005; Wilson et al., 2013). 
6.2.2.2 Neuropsychological Measures 
 The BVMT-R (Benedict, 1997) is a measure of delayed and recognition visual 
memory. There are six alternate forms of the visual stimulus on the BVMT-R, which allows 
for the measure to be useful over time, and for multiple administrations. Unlike other similar 
measures of visual memory there is less possibility of practice effects due to the  multiple 
equivalent forms (Benedict et al., 1996). Test-retest reliability is reported at .63 to .92 for 





measure also appears to have good construct validity, correlating strongly (.62 to .77) with 
other memory and visuospatial construction measures (e.g., the Hopkins Verbal Learning 
Test and the ROCF), and only weakly correlating with tests of language ability (.25 to .30; 
e.g., Boston naming test and Verbal Fluency) (Benedict et al., 1996). 
 The RAVLT (Rey, 1964) offers a measure of delayed verbal memory, as well as a 
recognition memory task. It has been used extensively over time to assess memory 
difficulties, and has reported test-retest reliability of .51 to .72 for the delayed and recognition 
trials (Delaney et al., 1992). It also correlated well with other verbal learning and memory 
tasks such as the CVLT at .33 to .47 and the Verbal Selective Reminding Test at .58 to .69 
(Crossen & Wiens, 1994; Macartney-Filgate & Vriezen, 1988). 
 The TMT (Reitan, 1958) offers measurement of executive functioning, processing 
speed, and visual scanning. This test tends to correlate fairly highly with other visual 
searching tasks (e.g., Digit Symbol from the WAIS-III of .63) (Lezak, 2004; Sanchez-Cubillo 
et al., 2009). The TMT is also less reliant on working memory than other measures used, and 
so is likely to be less affected by memory decline (Kortte et al., 2002).  
 Four Verbal Fluency subscales (Letter Fluency, Category Fluency, Switching 
Fluency, and Switching Accuracy from the D-KEFS (Delis et al., 2001)) were assessed as a 
further measure of executive functioning, as well as divided attention and verbal fluency 
ability (Gomez & White, 2006). In older adults Verbal Fluency has a reported test-retest 
reliability of .70 or greater (Snow et al., 1988), and only has modest correlations with 
memory measures, meaning discretely memory difficulties should not impact upon 
performance on this test (Ruff et al., 1997). 
 The ACE-III (Noone, 2015) is a brief tool used to detect likely cases of MCI by 





verbal fluency. The ACE-III subscales correlate strongly with the tests of the constructs they 
claim to measure, meaning this test has good content validity, and overall correlated strongly 
with the ACE-R (.99) indicating that the many validation studies completed on the previous 
version are likely to remain valid (Hsieh et al., 2013). Together these neuropsychological 
tests briefly measure the cognitive areas most likely to demonstrate early cognitive deficits, 
and have been shown to be sensitive to detecting MCI and early AD (Aggarwal et al., 2005; 
Busse et al., 2006). 
6.2.3 Procedure 
 The screening measures were initially mailed to all consenting participants. Three 
questionnaires (the SAGE and both versions of the IQCODE) were sent to screen cognitive 
functioning. The fourth, the GAQ, asked about previous and current levels of activity. 
Implied consent was obtained by telephone, and written consent was then collected when 
participants attended the neuropsychological testing session. Test administration was in the 
same order for all participants, and was conducted by a clinical psychology PhD student 
trained in their administration. The testing took between 50-80 minutes for each participant. 
 After 12 months all participants who completed the first stage of the research were 
again contacted and offered participation in the second stage of the research. For those who 
chose to take part postal measures were again sent out. This was followed by 
neuropsychological testing using the same tests, but with alternate forms where available. 
6.2.4 MCI Categorisation  
 Following the neuropsychological testing participants were classified as MCI or non-
MCI at both time points. Classification was based on the Petersen criteria (Albert et al., 2011; 
Petersen et al., 1997) including subjective memory complaints identified through self-report 





norms on neuropsychological measures; relatively intact ADLs; generally intact cognitive 
functioning; and not meeting diagnostic criteria for dementia. This led to four MCI 
categories: non-MCI who did not meet MCI criteria at either time point; MCI-single who 
appeared to decline from Time 1 by meeting MCI criteria at Time 2; MCI-both who met 
criteria at both time points; and Reverters, who met criteria at Time 1 but appeared to revert 
to normal cognitive functioning by Time 2. 
6.2.5 Data Analysis 
 Initially descriptive statistics for postal measures were calculated, along with Analysis 
of Covariance (ANCOVA) to test for changes on these measures over time with Time 1 as a 
covariate, time 2 scores as the dependent variable, and MCI category as a factor. A 
discriminant analysis was then calculated to assess whether MCI groups differed on a linear 
combination of variables including all postal screening tools, age, and sex. Following this, 
ANCOVA were conducted for the neuropsychological measures, looking at patterns in 
responding and for changes over time, these were again used so that age and sex could be 
treated as covariates. Between-group differences of the four MCI categories were also 
conducted. Finally, multiple regressions were used to look for potential moderating effects of 
current cognitive activities on change in neuropsychological measures. 
6.3 Results 
6.3.1 Participants 
 Participants (n=78; 49 females and 29 males) were aged between 65 and 83 years at 
the time of testing (M=74.79; SD=5.39). In total 10 participants met MCI criteria at both 
testing points (MCI-both), 15 at just Time 2 (MCI-single), 9 reverted from MCI to normal 
cognition (reverters), and 44 did not meet MCI criteria (non-MCI). The ages of participants in 





participants were similar to the expected distribution for older adults in Canterbury based on 
District Health Board Data from the 2013 census, with 94.9% NZ European, 1.3% Maori, and 
3.8% other (Statistics New Zealand, 2013).  
6.3.2 Postal Measures Analyses 
 Descriptive statistics for each of the postal measures were calculated for Time 1 and 
Time 2, and are shown in Table 16, along with the mean scores for the historical activities. 
The mean scores of the SAGE and IQCODE (IR) were lower at Time 2, while the IQCODE 
(SR) was higher, indicating greater cognitive impairment. Lower scores on the SAGE 
indicate increased cognitive difficulty, while higher scores on the IQCODEs indicate a higher 
degree of memory and ADL difficulty. Of the current GAQ items, physical activity was the 
most frequently reported, although it had the largest variation at both Time 1 and Time 2. 
Social activities were reported the least frequently. During teenage years there was the lowest 
average frequency of cognitive activity reported, and the highest frequency was reported 
during adulthood. The largest amount of variation was seen in cognitive activity during 
childhood. Dependent t-tests were calculated to determine whether significant change 
occurred on these postal measures for the sample as a whole. Scores on the SAGE were 
significantly different over time, with a lower average at Time 2 indicating increased 
cognitive difficulty, t(77)=2.91, p=.005. Frequency of physical activity also decreased 
significantly, t(77)=-4.60, p<.001. The other comparisons were not significantly different, 
although frequency of social activities approached significance, with a decrease in activity 










Descriptive Statistics for Postal Questionnaires at Time 1 and Time 2 
 Time 1 Time 2 
 Mean  SD Mean SD 
SAGE 19.603 1.983 18.872* 2.371 
IQCODE (SR) 3.150 .3444 3.200 .285 
IQCODE (IR) 3.137 .331 3.130 .373 
GAQ     
    - Cognitive 1.066 .325 1.031 .293 
    - Physical 1.555 .587 1.390*** .5389 
    - Social .797 .345 .736 .412 
Historical Activities     
- Child 1.154 .828   
- Teenager .958 .560   
- Young Adult 1.030 .573   
- Adult  1.280 .509   
* p<.05,  ** p<.01, ***p<.001 
 To test whether changes in the postal measures occurred similarly across groups, 
ANCOVAs were calculated, with Time 2 scores as the dependent variable, Time 1 scores as a 
covariate, and MCI category as a factor (including all four MCI groups mentioned 
previously). These were calculated for each of the postal questionnaires, and are presented in 
Table 17. The only significant change over time was between IQCODE (SR) scores with the 
average score increasing significantly, indicating a greater degree of impairment. Although 
the SAGE and IQCODE (IR) did not reach significance both were trending in the anticipated 
direction, with a higher average IQCODE (IR) and lower average SAGE indicating more 











ANCOVA Change Scores for Postal Questionnaires 
 F df pη
2
 
SAGE 2.118 3, 73 .087 
IQCODE (SR) 12.792*** 3, 68 .565 
IQCODE (IR) 2.781 3, 62 .135 
GAQ (Cognitive) 1.143 3, 73 .047 
GAQ (Physical) .083 3, 73 .003 
GAQ (Social) .090 3, 73 .004 
* p<.05,  ** p<.01,  *** p<.001 
 The participant sample was then divided according to MCI category and paired t-tests 
for the postal questionnaires were calculated looking for differences over time as post-hoc 
analyses of these group data. These t-tests are presented in Table 18. Significant changes 
were seen on the SAGE and IQCODE (SR) for MCI-single participants, with decreasing 
SAGE and increasing IQCODE (SR) indicating increasing impairment. There was also a 
significant decrease in physical activity for non-MCI participants. No change over time was 
seen in MCI-both and Reverter groups. Correlations of each of the paired samples are 
presented in Table 19, where all groups showed significant positive correlations for cognitive, 
physical, and social activities. Screening measures for non-MCI participants were all 
significantly correlated, but only the IQCODE (SR) for MCI-both and MCI-single, and the 






Paired Sample t-tests for Postal Questionnaires for each MCI Category 
 SAGE IQCODE (SR) IQCODE (IR) GAQ (Cognitive) GAQ (Physical) GAQ (Social) 
 t p t p t p t p t p t p 
MCI-Both 1.583 .148 -2.067 .069 -.364 .725 -1.387 .199 -1.094 .302 -.476 .646 
MCI-Single 2.333 .035* 2.264 .043* -1.205 .251 -.616 .548 -2.145 .050 -.432 .672 
Reverters 1.251 .246 -.732 .488 -.778 .462 .010 .993 -1.492 .174 -1.414 .195 
Non-MCI .994 .326 -1.232 .225 1.826 .076 -1.251 .218 -3.706 .001** -1.592 .119 
* p<.05,  ** p<.01 
Table 19 
Paired Sample correlations for Postal Questionnaires for each MCI Category 
 SAGE IQCODE (SR) IQCODE (IR) GAQ (Cognitive) GAQ (Physical) GAQ (Social) 
 r p r p r p r p r p r p 
MCI-Both .514 .129 .719 .019* .038 .923 .849 .002** .753 .012* .835 .003** 
MCI-Single .187 .505 .709 .007** .339 .258 .857 <.001*** .877 <.001*** .702 .004** 
Reverters .083 .832 .088 .837 .744 .034* .886 .001** .930 <.001*** .908 .001** 
Non-MCI .589 <.001*** .673 <.001*** .746 <.001*** .830 <.001*** .829 <.001*** .686 <.001*** 





6.3.3 Discriminant Analysis 
 It had been hypothesised that cognitive screening tools and participants’ frequency of 
lifetime cognitive activity would be related to cognitive decline, and so a discriminant 
analysis was run to test whether the four MCI groups differed significantly on these variables. 
This analysis contained 11 independent variables collected at Time 1 (Age, SAGE, IQCODE 
(SR), IQCODE (IR), GAQ historic: Child, Teenager, Young Adult, Adult, and GAQ present: 
Cognitive, Physical, Social). Discriminant analysis tests whether groups differ on a linear 
combination of predictor variables, and in the present analysis none of the variables 
statistically significantly discriminated between groups. The best result involved a 3-function 
solution, using 3 factors based on linear combinations of the input variables that was 
somewhat able to statistically discriminate between the four groups. However, while trending 
towards significance this was not a significant result, Wilks λ=.413, χ
2
= 45.564, df=33, 
Canonical correlation=.642, p=.071.  
 A stepwise discriminant analysis was then calculated to look for individual significant 
predictors of group differences. Due to the large number of potential predictors in the initial 
calculation, a stepwise follow-up allows individual variables to be looked at in regard to their 
linear predictive value on the four groups. The IQCODE (IR) was the only statistically 
significant variable in the equation, Wilks λ=.792, χ
2
= 13.16, df=3, Canonical 
correlation=.456 p=.004. This result indicates that IQCODE (IR) scores are able to 
discriminate between MCI groups and that clear between-group differences can be seen based 
on this measure. 
6.3.4 Neuropsychological Measures Analyses 
 Scores for change over time on the neuropsychological memory measures were 





and paired t-tests for each of these are presented in Table 20. Overall, these show that 
BVMT-R Delayed Recall scores decreased over time while Total Recall increased. The 
opposite was seen for the RAVLT, with a positive average change score on Delayed Recall 
but negative change on Total Recall. However, none of the changes over time were 
statistically significant for the overall sample. 
Table 20 
Descriptive Statistics of Neuropsychological Change Over Time 
 Mean SD t Minimum Maximum 
BVMT-R Delayed Recall -3.571 16.997 1.856 -48.00 46.50 
BVMT-R Total Recall .2942 16.996 -.153 -39.00 57.00 
RAVLT Delayed Recall .1154 15.689 -.065 -50.00 75 
RAVLT Total Recall -.1945 12.648 .136 -30.00 32.48 
 
 ANCOVA were used to look for change over time on neuropsychological measures in 
order to determine whether change was detected across these from Time 1 to Time 2. As 
above, these were calculated with Time 2 scores as the dependent variable, Time 1 as a 
covariate, and MCI as the independent variable. The results of these analyses are shown in 
Table 21, and indicated significant differences on all four memory measures, but not for the 
ACE-III. 
Table 21 




BVMT-R Delayed Recall 25.975*** 1.07 
BVMT-R Total Recall 29.331*** 1.21 
RAVLT Delayed Recall 5.864** .241 
RAVLT Total Recall 4.269** .175 
ACE-III Total 1.661 .068 
* p<.05,  ** p<.01,  *** p<.001 
 Finally, correlations were used to look for linear relationships between postal 





presented in Table 22 and show that late-life activities were not significantly related with 
other postal measures, or with cognitive change scores. There was a significant negative 
correlation observed between the IQCODE (SR) and the neuropsychological change score, 
indicating that as IQCODE (SR) scores increased performance on neuropsychological 
memory measures decreased. 
Table 22 
Correlations of Time 1 Postal Measures and Neuropsychological Change Score 
 Cognitive Physical Social Change Score 
 r p r p r p r p 
SAGE .104 .364 .095 .407 -.048 .676 -.125 .275 
IQCODE (SR) -.104 .379 -.099 .404 .024 .843 -.377 .001** 
IQCODE (IR) -.152 .217 -.146 .236 -.063 .612 -.206 .091 
Change Score -.003 .979 .154 .178 .067 .557   
* p<.05,  ** p<.01,  *** p<.001 
6.3.5 Moderation Analyses 
 Moderation analyses were conducted between Time 1 postal measures and Time 1 
participation in activities to assess the possible interaction of activity on subsequent cognitive 
declines. Activity was hypothesised to moderate the rate of change, where individuals with 
higher frequency of stimulating activity would demonstrate less cognitive decline over the 
12-month period. GAQ engagement in activities and postal screening measures were used as 
predictor variables, with the mean neurological change score, from the standardised memory 
measures, used as an outcome measure. Analyses were conducted using hierarchical 
regressions, with predictors entered in the first step and the interaction term based on centred 









Two-Step Regression Interaction Effects 
Predictors R
2
 Change F  df 
SAGE x Cognitive .002 .017 1,74 
SAGE x Physical .046 3.75 1,74 
SAGE x Social 0.00 0.00 1,74 
IQCODE (IR) x Cognitive .085 6.28* 1,64 
IQCODE (IR) x Physical .007 0.49 1,64 
IQCODE (IR) x Social .044 3.12 1,64 
IQCODE (SR) x Cognitive .061 5.29* 1,69 
IQCODE (SR) x Physical .001 0.06 1,69 
IQCODE (SR) x Social .059 5.18* 1,69 
* p<.05 
A significant moderation was seen between the IQCODE (IR) and GAQ current 
cognitive activities, R
2
change=.085, (F 1,64)=6.279, p=.015 where those participating in 
cognitively stimulating activities showed a positive change over the 12 months, while those 
with low reported frequency of activity had negative change and demonstrated worse 
performance on the neuropsychological measures. A similar trend was shown between the 
IQCODE (SR) and current cognitive activities, R
2
change=.061, (F 1,69)=5.294, p=.024, with 
more frequent cognitive activity appearing to be protective. The IQCODE (SR) also 
demonstrated a significant moderation relationship with social activities, R
2
change=.059, (F 
1,69)=5.182, p=.026 where more frequent social engagement also appeared to be protective. 
The interaction between the IQCODE (IR) and social activities was approaching significance, 
R
2
change=.044, (F 1,64)=3.119, p=.082, with a clear similarity to the previous moderations 
in the observed trend. The only interaction approaching significance from the SAGE was 
with physical activities, which was interesting given that physical activities did not approach 
a significant effect from the other measures, R
2
change=.046, (F 1,74)=3.754, p=.057. The 
three significant moderations are displayed on Figure 6. For all three moderations lower 





change), while higher frequency of activity was associated with less cognitive decline or even 












Figure 6. Interaction effects demonstrating the moderation of stimulating activity on 
cognitive decline. 
6.4 Discussion 
 The present research was designed to explore the relationship between cognitive 
decline and engagement with cognitively, physically, and socially stimulating activities. It 
was hypothesised that more involvement with such activities would protect individuals 
against cognitive declines over a 12-month period. There is ongoing debate about the impact 
that staying cognitively, physically, and socially active in late-life can have on preventing or 





data supports the theory of neural reserve and the possibility that staying active may offer 
protection from cognitive decline (Perani & Abutalebi, 2015; Stern, 2002). Furthermore, it 
has been hypothesised that cognitive activity throughout life may offer late-life protection 
from declines (Wilson et al., 2013). AD and other age-related cognitive declines are an 
increasing health and social burden due to ageing populations, yet difficulty remains in 
identifying individuals most at risk of developing such conditions, and by extension being 
able to offer interventions for slowing or halting such decline (Acevedo & Loewenstein, 
2007). Consequently, there is great need for accurately identifying individuals in early stages 
of decline, and the present study aimed to demonstrate the utility of considering frequency of 
stimulating activities in making predictions about declines. 
 Comparison of postal screening measures over time for all participants indicated that 
only the IQCODE (SR) was significantly different between testing sessions, whereas the 
other screening measures were trending in the expected direction but did not reach 
significance. This was unexpected given that 15 participants appeared to decline from normal 
cognition to MCI over the course of the 12 months. One possibility from this is that over a 
relatively short space of time individuals may be more sensitive to detecting changes than 
those who know them well, particularly if they are able to compensate for some of these 
difficulties. This trend was further supported when looking at paired sample t-tests between 
testing periods for each of the postal measures, with significant changes only being seen on 
the SAGE and the IQCODE (SR) for MCI-single participants, and for physical activities of 
non-MCI participants. However, given that participants in the MCI-single group had 
demonstrated an objective decline it was expected that this would be reflected in scores on 
the postal measures. Moreover, it was expected that informants would notice such changes 
over the one-year period and this would be reflected on the IQCODE (IR). There did appear 





would support the idea that participation in physically stimulating activity decreases as 
cognitive declines present. It is possible that with a larger sample size in each group more 
results may have reached significance. 
 Given that the Reverter group appeared to improve from mildly impaired to normal 
cognition it was expected that this group would also show significant differences on postal 
measures over time. One possibility explaining the lack of significant differences for this 
group is that the postal screening measures were giving an accurate portrayal on the 
individual at Time 1, which then did not change, so whatever had caused the discrepancy 
(e.g., depression, stress, or test-taking behaviours) was not reflected in postal screening 
measures. This would offer support for the concept of using screening tools such as these for 
identifying the most at risk individuals, even in the case of other factors impacting a given 
presentation. Future research exploring this possibility would be useful to clarify whether or 
not measures like the SAGE and the IQCODE are resistant to transient cognitive decline. The 
idea of reverters is ubiquitous in research on MCI and age-related decline, but it is not 
entirely clear why this pattern is consistently seen (Ganguli et al., 2011; Sachdev et al., 2013). 
Ongoing work exploring the difference between this group and those who continue to decline 
will be important to establish in future, and in particular establishing whether these 
individuals present differently on some tests that would allow for differentiation from older 
adults likely to progress to dementia. 
 A disparate pattern was seen in the correlations of each measure over time, 
particularly in the Reverter group. There was only a very weak relationship between scores at 
Time 1 and Time 2 for the SAGE and the IQCODE (SR), whereas the IQCODE (IR) had a 
strong relationship. This could indicate a lack of consistency between responding, but again 
given the cognitive changes observed in this group, and the small sample, this needs to be 





 Following these comparisons, a discriminant analysis was conducted to assess 
whether any of the variables from the postal screens were able to discriminate between the 
four MCI groups. Overall, there was no linear function that significantly discriminated the 
groups, although a trend towards significant between-group differences on this measure was 
encouraging. It was unclear why the groups were not able to be discriminated using these 
variables, as it was expected that the current frequency of activities, self- and informant-
reported memory and daily functioning, and age, would all be different between these groups. 
One possibility for why between group differences were not observed is the heterogeneity of 
older adults and limited power of the sample in the present study, and it is possible that with a 
larger sample size more definitive results would have been observed. 
 The stepwise discriminant analysis indicated that only informant-reports of decline 
were consistently discriminating between groups, but what was more interesting was that age 
did not significantly discriminate between MCI groups. This was surprising given the 
extensive evidence for the impact of age in late-life cognitive decline (Ott et al., 1995; 
Petersen et al., 2001; Petersen et al., 1997). However, it is possible that the relatively high 
average age (74.79 years) may have had an impact on this, whereby a high proportion of old 
but cognitively intact participants may have skewed this result compared to previous 
epidemiological studies. Such a sampling artefact is unfortunate, but difficult to prevent when 
assessing community samples requiring volunteers. Future research expanding on the present 
findings by stratified sampling may be useful for determining whether this finding disappears 
with a larger range of older adults. 
 The observed interaction between activity participation and incident cognitive decline 
was as hypothesised, although less significant relationships than expected were seen between 
screening measures and frequency of activity. Higher frequencies of cognitive and socially 





12-month period, with individuals reporting higher frequency of engagement with these less 
likely to demonstrate objective cognitive decline. However, the expected impact of physical 
activity was not observed in the present analyses, and it is unclear why this was not seen. One 
possibility is in the measure used, which was more strongly aimed at cognitive activity 
participation, and so may have missed some of the range of physically stimulating activity 
that older adults engage in. What to include in such measures varies widely between studies, 
with differences in reported frequency based on how many response options were available 
and how complex the screening tool is (Sofi et al., 2011). Repeating the present analyses with 
a more comprehensive measure of physical activity would be useful to determine whether a 
true effect exists that was not measured, or whether the impact of socially and cognitively 
stimulating activities is more significant for preventing incident cognitive decline. 
 Despite the significant interaction effects there were no significant differences in 
reported activity between groups over time for the MCI groups. Furthermore, there was no 
significant relationship between participants’ frequency of activity and neuropsychological 
change scores. Given previous findings of decreasing likelihood of cognitive impairment with 
increasing activity, the lack of a linear relationship between activities and neuropsychological 
change scores was unexpected. One possible explanation for this is that the particular 
individuals who volunteer for research such as this are more likely than the population in 
general to engage in stimulating activities. In particular, several of the present sample were 
recruited through community groups such as Rotary, which present social and cognitively 
stimulating opportunities to older adult members. Looking at this relationship again in future 
work with a sample recruited from more diverse sources may change the observed trend. 
Moreover, it is possible that 12 months was too short a follow-up period to detect changes in 
activity participation, and that a longer follow-up would help to detect the impact of 





 Differences observed in the present research from Wilson’s work on stimulating 
activities may reflect differences in response format (e.g., (Wilson et al., 2005; Wilson et al., 
2002a; Wilson et al., 2002b)). In particular, reducing the number of response options may 
have led to less variation in responding than in previous research. This point was raised by 
several participants, who wanted a Never response in addition to what was available, and if 
this was added there would have been more variation possible amongst respondents. Trialling 
the GAQ as a postal screening tool with a fifth option would be useful to determine whether 
this measure can add information above what was identified in the present research. It would 
also be useful to collect information about activities via a semi-structured interview alongside 
the postal GAQ to test whether response format or social desirability was having an impact 
on the frequency of reported engagement with particular activities. The present study was not 
set up to measure socially desirable responding, nor to test whether the response format 
impacted on reported activity. 
 The present study identified a number of patterns of decline in a representative 
community group, including some evidence for the use of both informant- and self-reports in 
identifying those at risk of cognitive declines. It was expected that the level of engagement 
with cognitively, physically, and socially stimulating activities would have an impact on 
decline over a 12-month period, and some evidence of this was shown. Repeating these 
measures over further time-points would be useful to see whether ongoing high levels of 
activity offer any protection against incident cognitive decline, and what impact physical 








7. Exploring Subtypes of MCI Using Cluster Analysis 
7.1 Introduction 
Mild cognitive impairment (MCI) represents a stage of decline beyond normal aging, 
but not meeting full diagnostic criteria for dementia. There have been a number of attempts to 
operationally define diagnostic criteria for MCI, but yet there remains a lack of a universally 
recognised definition. However, the most common diagnostic criteria of MCI are those 
proposed by Petersen (Petersen et al., 1997) and expanded on by the NIA (Albert et al., 
2011), and include: subjective reports of memory impairment; quantifiable deficits on a 
standardised neuropsychological test; relatively intact ADLs; otherwise normal cognition; 
and the absence of dementia. MCI is theorised to represent prodromal dementia, which is 
supported by epidemiological studies reporting the annual conversion rate of MCI to AD 
between 5.6% (Ritchie et al., 2001) and 41% (Geslani et al., 2005), which is significantly 
higher than the approximately 1 to 2% expected annually for cognitively intact older adults 
(Petersen et al., 1999). 
 As the concept of and research into MCI has progressed it has been hypothesised that 
the initial operational definition of MCI was deficient, and that considering primarily 
memory deficits precludes identifying prodromal cases of dementias other than AD (Petersen 
et al., 2001). Resultantly, subcategories of MCI have been theorised as likely to have varied 
outcomes, with amnestic MCI likely to develop to AD, non-amnestic MCI to develop into 
FTD, and multiple-domain deficits developing to VaD (Busse et al., 2003; Petersen et al., 
2001; Rasquin et al., 2005; Yaffe, Petersen, Lindquist, Kramer, & Miller, 2006). However, 
there remain difficulties with these multiple diagnostic categories, and in particular the 
number of cognitive domains assessed has led to different findings between studies, with 
little agreement in how many domains need to be included (Busse et al., 2006). Moreover, 





significant movement between MCI subgroups over time (Busse et al., 2003). Overall, 
current evidence indicates that outcomes are worse for individuals diagnosed with amnestic 
MCI, and their conversion to all types of dementia is higher than those diagnosed with non-
amnestic MCI (Busse et al., 2006; Matthews et al., 2008).  
 The cognitive deficits first noticed tend to vary somewhat between dementia 
diagnoses, with memory declines seen first in AD, and executive functioning decline 
preceding FTD (Mioshi, Hsieh, Savage, Hornberger, & Hodges, 2010; Stopford et al., 2012). 
This presents a challenge in assessing for early cognitive decline, as taking amnestic, non-
amnestic, and multiple-domain MCI into consideration creates a larger burden on testing, and 
leads to difficulties in assessing the accuracy of screening (B. C. Stephan, Kurth, Matthews, 
Brayne, & Dufouil, 2010). Moreover, once multiple domains are impaired the difference 
between MCI and dementia becomes blurred, and it becomes challenging to differentiate 
these. It is also unclear at present whether the trajectory of decline necessarily follows these 
subcategories of MCI, with evidence that individuals classified as amnestic MCI tend to 
develop dementia of all types at higher rates than other subcategories (Busse et al., 2006). 
This raises the question of whether subcategories of MCI are actually separate presentations, 
or whether such differences are just part of the heterogeneity of older adults experiencing 
declines. 
 One method of assessing differences among individuals with data from a range of 
cognitive instruments is to cluster participants based on their scores using latent class analysis 
(LCA). LCA assumes that categorical indicators are flawed measures of an underlying and 
unobserved construct, which can be validated using statistical techniques (Rindskopf & 
Rindskopf, 1986). The observed relationships between variables within each cluster grouping 
are occurring with the combination of that class, meaning that the class explains the observed 





discrepancies between groups can be calculated in such a way so as to indicate the most 
similar cases, and therefore demonstrate whether individuals with diverse early cognitive 
declines are statistically separate from cognitively intact older adults (Fraley & Raftery, 
1998). If these groups are distinct across a range of cognitive measures this would support the 
idea of categorically distinct subgroups of MCI, which is expected if amnestic, non-amnestic, 
and multiple-domain MCI represent prodromal forms of different dementias. In contrast it 
may be useful to consider early declines more generally, and attempt to screen for early 
difficulties before trying to differentiate the likely trajectories of decline.  
 One further diagnostic challenge regarding MCI is in the fundamental difficulty of 
applying categorical criteria to a continuous disorder. Because cognitive declines are 
progressive it is difficult to accurately decide where cut-offs should be, and some of the 
epidemiological disagreement in previous research has involved whether 1.0 (Busse et al., 
2006; Ritchie et al., 2001) or 1.5 (Geslani et al., 2005; Petersen et al., 1999) standard 
deviations below age-adjusted norms represent objective cognitive deficits. Using LCA offers 
a further advantage given that it is an atheoretical analysis, meaning the clustering is made 
independently of cut-offs or diagnostic thresholds. If discernible differences exist between 
cognitively intact individuals and those suffering MCI then these should be represented in the 
cluster solution irrespective of whether the individuals meet diagnostic cut-offs on tests. 
 The current study aimed to: 1) Use LCA to cluster individuals using a range of 
neuropsychological information, and to determine the optimal number and distribution of 
clusters; 2) Assess diagnostic reliability by comparing and contrasting the clustering results 
with diagnostic MCI cut-offs; and 3) Explore whether subcategories of MCI aid first-line 
screening in a representative New Zealand sample. This was explored through the use of 
postal screening and standardised neuropsychological measures administered twice, with 12 







 Participants were recruited by a variety of means from older adults in Canterbury, NZ. 
Initially local community groups with older adult members, such as Rotary and Probus, were 
contacted and in turn passed project information on to interested individuals. An 
advertisement was also placed in Age Concern, a free local newsletter with an older adult 
target population. Finally, participants were recruited from the NZBRI volunteer database, 
which contained contact information for 1,300 older adults who were physically and 
cognitively healthy at the last point of contact. The volunteer list was randomised before 
recruitment to prevent particular demographic variables being over-represented.  
From these collection methods, 114 participants took part in the first stage of testing, 
including postal screening and a neuropsychological examination. After 12 months these 
participants were again contacted and offered participation in the second stage of research, 
looking for any changes over time. In total 78 participants completed both stages of the 
research. The only exclusion criteria applied to the current sample was that participants had 
not received a diagnosis of dementia, in order that they represent the local older adult 
community as closely as possible. The only inclusion criteria for the present research was that 
participants were 65 years or older at the first point of contact. All participants gave implied 
consent at first contact, and written informed consent at the neuropsychological testing 
session. All participants were fully informed about the nature of the study. Ethical approval 
for this research was obtained from the University of Canterbury Human Ethics Committee. 
7.2.2 Instruments 
 A range of instruments were used to collect a variety of information about current 





cognitive areas including memory, executive functions, orientation, and attention were 
collected (Beversdorf et al., 2007; Fischer et al., 2007). 
7.2.2.1 Postal Screening Measures 
 The SAGE (Scharre et al., 2010) is a recently developed standalone screening 
measure developed to detect early cognitive deficits by briefly assessing a range of cognitive 
constructs. The SAGE contains 11 questions worth differing amounts adding to a maximum 
score of 22, with the total score showing some utility in differentiating individuals with MCI 
from both healthy individuals and those with dementia (Scharre et al., 2010). Included in the 
11 items are questions assessing memory, orientation, executive functions, and visuospatial 
manipulation. For the present study, an adapted version of the SAGE was used, with 
modified demographic options reflecting the New Zealand population, and adjustments made 
to terminology for money calculation questions. 
 The IQCODE (Jorm, 1994) was used to assess changes over time in memory and 
instrumental activities of daily living, such as handling finances. The IQCODE involves an 
informant answering 16 questions about any observed changes in daily functioning and 
everyday memory tasks over the preceding 10 years. Responses are scored on a five-point 
Likert scale, from Much Improved to Much Worse, with the average taken of the 16 items, 
and higher scores indicating greater impairment. The IQCODE has been used in assessment 
for a range of cognitive disorders, including AD, VaD, and post-stroke damage (Cullen et al., 
2007; Jorm & Jacomb, 1989). This tool has also been used in a variety of formats including 
face-to-face interviews, telephone interviews, and pen-and-paper completion, all of which 
appear to have similar psychometric properties (Jorm, 2004). While the IQCODE was 
developed as an informant report there is emerging evidence of the psychometric properties 
of using this as a self-report measure, so a version with modified instructions was used to 





 The GAQ was developed for the present research based upon a semi-structured 
interview template used by Wilson in research exploring the relationship between stimulating 
activities over the lifespan and cognitive decline (e.g., (Wilson et al., 2005; Wilson et al., 
2000; Wilson et al., 2002b)). This questionnaire assesses the frequency of cognitively 
stimulating activities including reading, writing, and playing games such as checkers or 
crosswords. Frequencies of cognitive activity were asked about at four approximate 
developmental points, childhood (6 years), teenage (12 years), young adulthood (18 years), 
and adulthood (35-40). At each stage participants were asked to respond as accurately as they 
could, but that specific ages were less important than the trend they experienced during these 
stages. Each question was answered on a 4-point Likert scale assessing frequency, with 
options from Every day or almost every day to Several times a year/rarely. The measure of 
cognitive activity was taken by using the average at each age-point. Questions assessing 
engagement in current activities were more extensive, and 27 items were used to explore 
current activities, including items exploring the frequency of participation in cognitive, 
physical, and social activities. Each item could contribute towards multiple elements, given 
that many activities cannot be narrowed down to only representing one such factor (Karp et 
al., 2006; Wilson et al., 2005). Of the 27 items 20 contained a cognitive component, 7 a 
social component, and 6 a physical component. Each of the present activity questions had the 
same 4-point frequency scale as the historical questions, and average scores were calculated 
for cognitive, social, and physical activities respectively. 
7.2.2.2 Neuropsychological Measures 
 A brief neuropsychological battery was administered to all participants, in order to 
briefly measure a wide range of aspects of cognition. The BVMT-R (Benedict, 1997) was 
developed to provide a brief and reliable measure of visual working and delayed memory, as 





1996). Test-retest reliability for the delayed and total memory conditions is reported at .63 to 
.92, with high inter-rater reliability, and convergent validity with other measures of delayed 
visual memory (Benedict, 1997). 
 The RAVLT (Rey, 1964) provides a second memory measure, and assesses working 
and delayed verbal memory. The RAVLT has high reported test-retest reliability, ranging 
from .51 to .86 across learning trials and delayed memory, as well as correlating highly with 
other verbal learning tests such as the CVLT (.33 to .47) (Delaney et al., 1992; Macartney-
Filgate & Vriezen, 1988). Collectively, visual and verbal delayed memory are the most 
common aspect of cognition to demonstrate early decline, and so the BVMT-R and RAVLT 
are likely to detect signs of amnestic MCI (Small et al., 1995). 
 The TMT (Reitan, 1958) provides a measure of executive functioning, along with 
processing speed and some indication of motor speed. Trails A and B have also shown some 
utility for detecting early executive functioning declines (Ashendorf et al., 2008). The TMT 
correlates highly with other visual searching tasks (e.g., Digit Symbol from the WAIS-III at 
.63) (Lezak, 2004), and performance is relatively resistant to early memory declines (Kortte 
et al., 2002). 
 Verbal Fluency from the D-KEFS (Delis et al., 2001) provides another measure of 
executive functions and divided attention, particularly through Switching Fluency and 
Switching Accuracy subscales. Letter Fluency and Category Fluency subscales also offer 
insight into verbal ability and processing speed, while all four subscales are relatively 
resistant to early amnestic declines (Ruff et al., 1997). Test-retest reliability for Verbal 
Fluency is reported at .70 for older adults, and is appropriate for repeated administration with 





 The ACE-III (Noone, 2015) is the latest iteration of the Addenbrooke Cognitive 
Examination, which was designed as a standalone measure of cognitive decline. The ACE-III 
assesses a range of cognitive constructs, including orientation, attention, memory, 
visuospatial construction, and verbal fluency. Subscales of these constructs have been shown 
to be valid, and the ACE-III is correlated highly (.99) with the ACE-R, indicating that the 
validation studies and reliability coefficients for this test remain valid (Hsieh et al., 2013). 
Collectively these areas represent those most likely to decline in MCI, and the ACE-III has 
shown some diagnostic utility for detecting early deficits (Aggarwal et al., 2005; Busse et al., 
2006). 
7.2.3 Procedure 
 Participants were initially mailed postal questionnaires (SAGE, GAQ, and both 
informant-report and self-report versions of the IQCODE) along with project information and 
consent forms. Once these had been completed participants were again contacted and 
completed a face-to-face neuropsychological testing session. When contacted, participants 
were reminded to bring hearing and visual aids as needed for the testing. The 
neuropsychological tests were administered in the same order for all participants, and were 
presented by a clinical psychology student trained in their administration. The 
neuropsychological testing took approximately one hour for each participant. 
 After 12 months all participants that completed the first stage of the research were 
contacted again and were offered participation in the follow-up study looking for changes in 
cognition over time, along with the consistency of responses on the measures used. The 
postal and neuropsychological procedure was repeated, with alternate forms administered 
where possible. Informed consent was obtained at the follow-up testing appointment, and the 







 Participants were aged between 65 and 83 years when they were initially recruited 
(M=74.79; SD=5.39), with 49 females and 29 males taking part. MCI categorisation based on 
the Petersen criteria (Albert et al., 2011; Petersen et al., 1997) was conducted at both Time 1 
and Time 2 testing.  
7.3.2 MCI Categorisation 
 Amnestic MCI was diagnosed based on the four memory scales (Delayed and Total 
Memory from both the BVMT-R and RAVLT). Secondly, non-amnestic MCI was diagnosed 
based on measures assessing executive functioning (Switching Fluency, Switching Accuracy, 
and Trails B), given that this is a common early cognitive deficit in FTD. Finally, multiple 
domain MCI was operationally defined by participants meeting cognitive impairment criteria 
on each of the memory and executive functioning neuropsychological measures, or on the 
ACE-III, which examines a range of cognitive aspects. For each MCI subtype, a deficit of 1.5 
standard deviations below age-adjusted norms on a neuropsychological measure indicated 
impairment. 
 Table 24 shows the number of participants diagnosed in each MCI subtype, as well as 
those meeting criteria during at least one testing session. Amnestic MCI was the most 
common diagnosis observed, with non-amnestic the least common having only 7 participants 
meeting criteria across both testing sessions. MCI diagnosis was made independently for 
Time 1 and Time 2. Overall, 29 (37.2%) participants met the diagnostic criteria for MCI at 








Number of Participants Identified Using Each MCI Subtype Criteria 
 Amnestic Non-amnestic Multi-domain 
Time 1 11 6 12 
Time 2 19 5 6 
Overall 21 7 15 
  
 The ages of participants in the three MCI subtypes, as well as those not showing 
impairment, did not differ significantly F(3,74)=2.641, p=.056, η
2
=.096, (amnestic: M=76.38, 
SD=5.45; non-amnestic: M= 73.29, SD=4.92; Multi-domain: M=77.0, SD=5.08; Non-MCI: 
M=73.31, SD=5.21). Participants’ ethnicities were similar to what was expected based on 
Canterbury DHB data from the 2013 census, with 94.5% NZ European, 1.3% Maori, and 
3.8% other (Statistics New Zealand, 2013). 
7.3.3 Reliability of Diagnoses 
 Cohen’s Kappa was calculated for each MCI diagnostic group to assess the reliability 
of the Petersen diagnoses over a 12-month period. Amnestic (κ=.026) and non-amnestic 
(κ=.12) subtypes both showed a lack of consistency over time and were not statistically 
significant, while multiple-domain MCI demonstrated only fair consistency κ=.28, p=.009. 
Calculating Cohen’s kappa for an overall MCI diagnosis also had only fair consistency, 
κ=.29, p=.011. 
 One possible factor affecting the reliability of MCI diagnostic categories were those 
appearing to revert from impaired to healthy cognition over the 12-month period between 
testing. Cross-tabulation of MCI diagnosis over time indicated that a large proportion of 
individuals reverted in two of the three MCI subtypes, with 7 of 11 (63.6%) amnestic MCI 
cases, 4 of 6 (66.7%) non-amnestic MCI cases, and 1 of 12 (8.3%) multiple-domain MCI 
appearing to revert to normal cognition. This large reversion rate indicates that the MCI 





consistent over time, and that most of the initially-impaired individuals were experiencing 
transient declines rather than age-related cognitive decline. However, nine individuals 
(32.1%) moved between MCI subtypes, meaning their neuropsychological profiles were 
inconsistent, while still showing deficits on some measures. This indicates further 
unreliability of the diagnostic subtyping of MCI amongst the present sample, and in the case 
of two participants who moved to multiple-domain MCI this may represent further cognitive 
decline. 
7.3.4 Cluster Analysis using LCA 
 Model-based clustering using LCA was used to assess and identify heterogeneity in 
the data, and as an alternative means to the Petersen criteria of categorising participants. This 
also allowed an exploration of whether individuals meeting diagnostic cut-offs would appear 
different from older adults in general, and be identifiable without a priori considerations 
being used to separate classes within the sample. Model-based clustering was run using the 
Mclust package in R using data collected at Time 1, (Fraley, Raftery, & Scrucca, 2012; Team 
R Core, 2014). All variables were standardised prior to analysis and included: Current 
cognitive, physical, and social activity frequency; BVMT-R Total and Delayed Recall; 
RAVLT Total and Relayed Recall; Letter, Category, and Switching Fluency and Switching 
Accuracy; Trails A and B; and the ACE-III Total score. Results from the Mclust algorithm 
showed that the optimal solution included two clusters, and subsequently K-means clustering 
was used to determine cluster membership for individual cases.  
 Figure 7 displays the average z-scores for both clusters on the neuropsychological 
measures and the GAQ current activities. The average scores for cluster 1 are consistently 
higher than cluster 2, and all are significantly different between groups, except on Trails A 





Participants were significantly older in cluster 2 (M=76.67, SD=4.96) than cluster 1 
(M=73.63, SD=5.37), t(76)=-2.50, p=.014, d=0.58. 
Figure 7. Mean neuropsychological test z-scores for each cluster group at Time 1. 
 Scores across the neuropsychological measures and GAQ activity frequency were 
then plotted for data collected at Time 2 based on the clustering results, and these are shown 
in figure 8. All tests were significantly different between cluster 1 and cluster 2 at Time 2, 
























Figure 8. Mean neuropsychological test z-scores for each cluster group at Time 2. 
 Based on the similar distribution of scores between Time 1 and Time 2 a second 
cluster analysis was conducted using Time 2 data. The cluster solutions were then compared 
using Cohen’s Kappa, which demonstrated a very high level of agreement κ=.748, p<.001. 
This indicates that despite some change over time in those showing cognitive decline and 
those reverting to normal cognition there were two clear and consistent groups observed. As 
with the initial cluster solutions these groups were then graphed for Time 1 and Time 2, 
displayed on Figure 10 and Figure 11 respectively. Both figures indicate the clear observed 
differences between the two cluster groups based on standardised neuropsychological and 
































































Figure 9. Mean neuropsychological test z-scores for the second cluster solution (Time 2 data) 









Figure 10. Mean neuropsychological test z-scores for the second cluster solution (Time 2 





 Repeated measures ANOVA were then calculated to look for differing rates of change 
over time between participants in the two groups. None of these demonstrated a significant 
interaction effect between difference over time and cluster group participation. The only 
significant main effect was seen on Switching Accuracy, F(1,76)=5.346, p=.023, pη
2
= .066. 
This demonstrates that on average rates of change were generally similar between groups 
over time. 
 Independent t-tests were used to calculate the differences between the two cluster 
groups on historical cognitive activities, and these are presented in Table 25. Each 
comparison indicates that there was a significant difference in the frequency of cognitive 
activity between individuals in cluster 1 and cluster 2 during childhood, teenage, young 
adulthood, and adulthood. In each case those in cluster 1 demonstrated a higher frequency of 
cognitive activity than those in cluster two. These results provide an external validation of the 
differences between clusters, as historic activities were not included in the clustering model 
but were hypothesised to be related to cognitive impairment. 
Table 25 
t-Test Results for Frequency of Lifespan Cognitive Activity. 
 t p d Mean Difference 
Child 2.26 .027 .53 .428 
Teen 4.84 <.001 1.13 .555 
Young Adult 3.25 .002 .75 .414 
Adult 3.16 .002 .74 .355 
 
7.3.5 Relationship Between Cluster Group and Diagnostic Group 
 Given the reliance on diagnostic criteria for determining individuals demonstrating 
characteristics of age-related cognitive decline, these were compared to the result of model-
based clustering. Diagnostic criteria such as those proposed by Petersen (Petersen et al., 





separates individuals into a number of groups that maximise distances between clusters. 
Therefore, it is useful to explore the similarity between these two methods of differentiating 
individuals for consistency in identifying those with impaired cognitive performance. Table 
26 shows the number of participants with each MCI subtype diagnosis that were in cluster 
group 1 and cluster group 2 based on the Time 1 clustering solution. The most interesting 
finding was that more individuals in the non-amnestic MCI group were in the higher 
performing cluster, whereas the expected pattern was seen for amnestic and multiple-domain 
MCI, with most cases in cluster group 2.  
Table 26 
Cross-Tabulation between Cluster Groups and MCI Diagnostic Subtypes 
 Cluster Group 1 Cluster Group 2 
Time 1   
- Amnestic MCI 2 9 
- Non-amnestic MCI  4 2 
- Multiple domain MCI 1 10 
Time 2   
- Amnestic MCI 7 12 
- Non-amnestic MCI 4 1 
- Multiple domain MCI 0 6 
 
 Fisher’s exact test was used to quantify the relationship between cluster group and 
MCI diagnostic categories by comparing each of these separately. Amnestic MCI 
demonstrated significant differences from the expected frequencies, indicating a strong 
relationship between cluster grouping and diagnostic criteria at Time 1 (p=.002) and Time 2 
(p=.012). Multiple-domain MCI likewise showed significant results at Time 1 (p<.001) and 
Time 2 (p=.002). Non-amnestic MCI did not show a significant relationship at either Time 1 
(p=.577) or Time 2 (p=.358). This indicates that the results of the cluster analysis were 






7.3.6 Clinically Significant and Reliable Changes 
 A further means of assessing the reliability of changes from Time 1 to Time 2 
involves calculating reliable and Clinically Significant Change (CSC). Memory measures 
were used, given their particular use in detecting subsequent declines and the sensitivity of 
the BVMT-R and RAVLT for this purpose (Small et al., 1995; Trivedi et al., 2006). Change 
scores were calculated for the four memory measures, Total and Delayed Recall on the 
RAVLT and the BVMT-R. For each participant CSC was noted if the changes in age-
adjusted normative scores were greater than 1.5 standard deviations, or alternatively if 
participants’ scores decreased enough for them to meet the cut-off for MCI. The descriptive 
statistics for these change scores and the frequency of CSCs can be seen in Table 27, and 
indicate a large amount of variation across these measures, while the means remain close to 
zero overall. Negative values indicate a decrease in score between Time 1 and Time 2.  
Table 27 
Descriptive Statistics and Clinically Significant Change Frequency for Memory Tests 
 Mean SD Minimum Maximum CSC 
BVMT-R      
- Total Recall 0.294 17.00 -39.00 57.00 25 
- Delayed Recall -3.57 17.00 -48.00 46.50 27 
RAVLT      
- Total Recall -0.19 12.64 -30.00 32.48 20 
- Delayed Recall 0.12 15.69 -50.00 75.00 13 
 
 Reliable change was then calculated based on criteria proposed by Jacobson and 
Truax (Jacobson & Truax, 1991) where:  
𝐶ℎ𝑎𝑛𝑔𝑒






Test-retest reliability values used were previously established through normative studies, with 
BVMT-R Total Recall = .92, Delayed Recall = .63 and RAVLT Total Recall = .78, Delayed 
Recall = .51 (Benedict, 1997; Delaney et al., 1992; Schmidt, 1996). 
 Initially all reliable changes were looked at, including those who appeared to decline 
and those appearing to improve over the 12-month period. This resulted in 11 (14.1%) 
individuals on the BVMT-R Total Recall, 4 (5.1%) on Delayed Recall, 3 (3.8%) of RAVLT 
Total Recall, and 3 (3.8%) of RAVLT Delayed Recall scores showing reliable changes. 
Clinically significant and reliable changes over time were then compared using Fisher’s exact 
test, which indicated a high level of agreement between these dichotomous categorisations 
for each of the four comparisons (BVMT-R Total Recall p<.001, Delayed Recall p=.012; 
RAVLT Total Recall p=.013, Delayed Recall p=.004). Of the reliable changes observed 5 of 
the 11 BVMT-R Total observations represented a reliable decrease, meaning over half of 
these changes were participants significantly improving on this measure over 12 months. A 
similar pattern was observed across the other three memory measures, with 1/4 on the 
BVMT-R Delayed Recall, 1/3 RAVLT Total Recall, and 2/3 RAVLT Delayed Recall 
observations also representing declining performances over 12 months. From this it can be 
seen that approximately half of the reliable changes represented individuals improving on 
these standardised psychometric measures. There was no significant difference in age 
between those who reverted to normal cognition and those who declined over the intervening 
period t(16)=.557, p=.585 (Reverters M=74.7, SD=6.40; Impaired M=76.13, SD=3.72). 
7.4 Discussion 
 The present study aimed to explore the distribution of cognitive difficulties amongst a 
representative community sample of older adults aged 65 years and over. Specifically, LCA 





based on a range of neuropsychological information. Diagnostic reliability of MCI subtypes 
was also assessed by comparing and contrasting diagnostic criteria with the cluster analysis 
solution. Finally, clinical significance in cognitive changes was explored, and the 
appropriateness of diagnosis and labelling reviewed in relation to the degree of impairment 
seen in individuals. 
 One of the difficulties for ongoing research into early signs of dementia is in 
accurately diagnosing the prodromal stages of the disease processes. A number of ways of 
defining this have been suggested, but the most commonly accepted is MCI, and more 
specifically MCI as defined by Petersen (Petersen et al., 1997). Issues have arisen with this 
operational definition of prodromal dementia, given the focus on discretely memory 
difficulties (Petersen et al., 2001), which has led to theorising that a different presentation 
could be indicative of FTD and VaD (Yaffe et al., 2006). However, these subtypes of MCI 
have only been differentiated in clinical settings (Rasquin et al., 2005), and often with 
difficulties separating MCI groups apart (Busse et al., 2003; Klekociuk & Summers, 2014). 
In the present research a randomly selected community sample were tested in order to 
ascertain whether these distinct MCI subgroups were observed, and whether separating 
individuals into these categories made sense in the context of a range of neuropsychological 
data. By collecting a range of cognitive information and utilising cluster analysis algorithms 
to cluster data without a priori theoretical considerations any common elements between 
individuals can be looked for, and if subtypes of MCI are distinct then these should be clear 
when clustering occurs. 
  Three subtypes of MCI were explored in the present research, and in total 21 
participants met criteria for amnestic MCI, 7 for non-amnestic, and 15 multiple-domain. This 
meant that during across both testing sessions 43 participants (55.1%) met criteria for MCI; 





amongst older adults (Koivisto et al., 1995). It is also possible that the age of participants 
contributed to this high rate of MCI, given that the incidence of cognitive decline increases 
with age (M. K. Aronson et al., 1991), and the average age of participants in the present study 
was 74.79 years. The ages of participants in each MCI group were not significantly different, 
nor were these different from those that did not meet MCI criteria. The three MCI diagnostic 
subtypes were not consistent over time, and there was a large amount of variation within and 
between subtypes, with the diagnostic grouping shifting, as well as individuals appearing to 
revert to normal cognition over the 12 months between testing. By grouping all MCI cases 
together the consistency improved somewhat, and was statistically significant. This finding 
provides evidence for the view that subtyping MCI may not be a helpful way of 
conceptualising variation in cognitive declines, given that outcomes appear unrelated to the 
subtype diagnosed (Busse et al., 2003; Fischer et al., 2007). In particular, it may be more 
useful to consider cases of MCI more generally, and use a broad diagnostic consideration to 
identify cognitive changes rather than to attempt to make predictions about eventual 
prognosis and type of incident dementia. 
 Reverters are a ubiquitous group within research on cognitive decline and MCI (e.g., 
(Ganguli et al., 2011; Nordlund et al., 2010; Ritchie et al., 2001)), and the same was seen in 
the present results with 11 participants reverting between Time 1 and Time 2 across the MCI 
subgroups. A number of possibilities for reversion to healthy cognition have previously been 
offered, and some of these have been discussed previously in Chapters 3 and 4. The present 
analyses did not explore this further, but reverters continue to be a limitation on research into 
cognitive decline, and add to the complexity of assessing diagnostic stability. 
 Using cluster analysis to determine whether meaningful subgroups are present in the 
data allows exploration of whether participants with different MCI subtype diagnoses are 





1998). Moreover, clustering can demonstrate whether a brief screening battery would allow 
these individuals to be differentiated from cognitively intact older adults. The initial 
clustering solution was made based on the range of neuropsychological data collected at 
Time 1, including: measures of memory; executive functioning (including divided and 
sustained attention, task switching, and mental flexibility); visuospatial ability; and 
orientation. This analysis provided clear evidence that the participant sample formed two 
distinct clusters, with significant differences between the means of standardised scores on the 
neuropsychological measures and frequency of activity participation. The differences 
between these two groups were then maintained over time, despite individuals within each 
cluster group who declined or reverted over time. This provides further evidence for a more 
general conceptualisation of early cognitive decline, where the overall neuropsychological 
pattern supports the idea of those experiencing cognitive difficulties and those who are 
cognitively intact, rather than particular distributions reflecting MCI subtypes as meaningful 
and discrete entities. Cluster analysis results based on Time 2 data largely agreed with the 
optimal cluster solution from Time 1, with a high level of agreement between these 
classifications, although this cluster solution did not completely separate cognitively impaired 
and cognitively intact individuals.  
 Of particular interest was the difference between cluster groups on the frequency of 
lifetime cognitive activity, with significantly higher rates of activity seen at each age-point 
for those in the cognitively intact cluster group. This finding is in line with previous work on 
the importance of life-course cognitive activity for late life cognitive health (e.g., (Wilson et 
al., 2005; Wilson et al., 2013)), where those who have engaged throughout life are less likely 
to meet diagnostic criteria for MCI. This also provides external validation for the cluster 
analysis as a meaningful way of separating the participant sample into those who are 





clear between-group differences were observed on a variable expected to converge with late-
life cognitive health. It must be noted that a possible limitation to this finding is that the 
differences between these groups may be due to an external variable such as intelligence, 
which was not measured in the present study, and so could not be controlled for. 
 The two groups identified on the basis of the clustering solution were further 
compared with categorical diagnostic groups based on the Petersen MCI criteria, with the 
adaptation for varied change in cognition leading to the MCI subtypes (Busse et al., 2003; 
Petersen et al., 1997). Due to the small expected frequency of MCI cases Fisher’s exact test 
was used, which demonstrated that amnestic and multi-domain declines lined up with the 
cluster solution at rates higher than chance. While applying categorical classification criteria 
to continuous cognitive variables is inherently problematic, this still demonstrates that the 
diagnostic criteria are able to identify the same individuals as a cluster solution using the full 
range of neuropsychological data available. The importance of this is in supporting the 
ongoing use of diagnostic cut-offs when identifying likely cases of MCI, despite the varied 
psychometrics that may be used in making such a diagnostic decision. If a range of aspects of 
cognition and varied tests collectively identify those most likely to be experiencing decline, 
then it is also possible that the particular tests used may not have a significant impact on the 
decision of who is likely to meet such criteria for decline. Future research into what impact 
varying the psychometrics used would have on subsequent cluster analysis results and 
diagnostic classification would be useful. 
 An additional consideration regarding individuals who appear to have experienced 
cognitive decline over time is the actual impact that any changes in cognition may have had. 
To this end, clinically significant and reliable changes were assessed amongst the participant 
sample. Given the reliance on 1.5 standard deviations below age-adjusted norms to indicate 





standard deviations initially suggested as a cut-off for assessing CSC (Jacobson, Follette, & 
Revenstorf, 1984). Practically, this meant that if individuals had a high baseline performance 
they could still demonstrate a clinically significant decline, even without meeting the 
diagnostic threshold. A significant limitation of using diagnostic cut-offs that rely on age-
adjusted norms is that high functioning individuals need to decline a lot further than those in 
the average range in order to be 1.5 standard deviations below age-adjusted norms. The 
present results indicated that a large number of participants demonstrated CSC from Time 1 
to Time 2, although the sample means demonstrated that overall the scores stayed fairly 
constant.  
 As well as assessing whether changes were clinically significant it is also important to 
establish whether changes are greater than would be expected based on simple measurement 
unreliability (Jacobson & Truax, 1991). Fewer individuals demonstrated reliable changes 
than CSC, lending some evidence to the possibility that the variation on the 
neuropsychological measures presents a possible limitation in confidently diagnosing 
cognitive decline. Older adults represent a heterogeneous group with large within-group 
variation expected, even before factoring in the impact of cognitive decline. However, in 
practice making a diagnosis of cognitive decline does not rely on a specific change, instead 
cut-offs are used to diagnose. Comparing the CSC and reliable changes using cross-tabulation 
indicated that reliable changes were seen amongst both reverters and participants 
experiencing cognitive decline. This is a useful validation of the changes over time detected 
in the present analyses, where significant improvement and decline on neuropsychological 
measures were reliable and greater than the expected variation of the measures used. 
 A number of limitations are important considerations in the present analyses. In 
particular, the diagnosis of MCI subgroups was only able to be completed using limited 





evidence was available. In future, additional testing should be conducted to improve the 
diagnostic reliability of MCI subgroups, and therefore to see if this has an effect on the 
stability of such groups over time. The sample size in the present research was also relatively 
small for detecting meaningful differences in diagnostic categories, and it is not clear whether 
true between-group differences were being observed for MCI subtypes. Future work 
exploring such diagnostic groups would benefit from significantly larger sample sizes within 
each group, and this would allow for more confidence in generalising from findings. 
 The present study assessed the use of LCA to cluster participants into groups based on 
a variety of neuropsychological information, and to compare and contrast such groups with 
established diagnostic cut-offs. The results supported the use of cluster analysis as a 
meaningful way of identifying older adults experiencing cognitive decline, and demonstrated 
a high level of agreement between statistical clustering approaches and the Petersen 
diagnostic criteria. However, from the present analyses there was less utility in differentiating 
subtypes of MCI, as these groups were inconsistent over time, and there was a large amount 
of movement between these subtypes. The results support a more general conceptualisation 
of early cognitive decline, where specific impaired aspects of cognition may not be helpful 
for making prognostic predictions, but determining early cognitive decline in general may be 





8. Overall Discussion and Conclusions 
8.1 Discussion  
 The current research explored the utility of a multi-stage screening approach for the 
detection of MCI. Specifically, postal screening tools collecting self-reports, informant-
reports, cognitive screening, and frequency of stimulating activities were all used to aid in 
this first-line detection of cognitive decline. Neuropsychological measures were used to 
validate this screening approach, and tools assessing attention, orientation, executive 
functioning, and both visual and verbal delayed memory were administered.  
 It was hypothesised that the variables collected through postal screening would be 
useful for making predictions about likely cases of MCI, and this was supported in the 
findings. In particular, the IQCODE (IR) and SAGE both demonstrated predictive rates at 
well above chance levels during the initial testing. Interestingly at the Time 1 data collection 
self-reports did not predict MCI cases to a statistically significant level. This was unexpected 
given the diagnostic requirement of self-identified cognitive decline in the original Petersen 
MCI criteria (Petersen et al., 1997), and the usefulness of considering self-reports in the 
diagnosis of MCI (B. C. M. Stephan et al., 2013). There was no difference in mean scores for 
MCI and non-MCI groups on the IQCODE (SR), although after assessing internal 
consistency of the measure it appeared that by removing several items the predictive accuracy 
improved substantially. It is unclear from the present analyses whether removing those 
particular items from self-report questionnaires like the IQCODE would improve their 
diagnostic utility, but this was an interesting finding. The items removed tended to assess 
changes to ADLs rather than in memory, which may mean focusing solely on subjective 
changes in memory functioning would provide a better scope for future screening. Clear 
differences were seen in mean IQCODE (IR) scores of participants in MCI and non-MCI 





was not seen on self-reports. A possible explanation for this finding is that informants are 
more sensitive to initial changes in memory and ADL functioning than the individuals 
experiencing a decline in cognition. In contrast, comparing Time 1 and Time 2 responses on 
the IQCODE (SR) showed that individuals in the MCI-single group who had demonstrated an 
objective cognitive decline over the 12-month follow-up period did have significantly 
different scores on this measure. There was also a difference trending towards significance 
over time for those participants meeting criteria for MCI at both Time 1 and Time 2; this is 
likely to reflect that ongoing declines were being picked up by the measure, and so using the 
IQCODE (SR) as a tool for measuring the trajectory of decline would be interesting to 
explore in future research.  
8.1.1 Screening Utility of Postal Measures 
 The informant-report IQCODE demonstrated the highest accuracy for making 
predictions about MCI of the measures trialled in the current research. ROC curve analyses 
consistently found significant results, demonstrating that the IQCODE (IR) was able to 
differentiate cognitively intact individuals from those with MCI. This pattern was seen using 
Time 1 data, and combined Time 1 and Time 2 data (without responses from participants who 
did not return for the second stage of the study). This finding was further supported using 
stepwise discriminant analysis, which showed that the IQCODE (IR) was the only variable to 
statistically discriminate between participant groups by itself. This is an important finding, as 
it lends support to the hypothesis that informant-reports can aid in the detection of early 
cognitive declines, and that these can be considered interchangeable with self-reports for 
detecting SMCs. Previous findings have indicated that IQCODE scores can be predictive of 
subsequent institutionalisation, as well as making predictions about individuals who will 
progress to dementia within two years (Jorm & Jacomb, 1989; Louis et al., 1999). The 





cases of MCI, as well as providing further evidence about IQCODE scores continuing to 
reflect ongoing decline as cognitive deterioration progresses. Following a sample group like 
the one in the current study in which some individuals progress to dementia would allow this 
relationship to be explored further. 
 The SAGE is a recently developed cognitive screening tool for assessing a range of 
aspects of cognition, which has demonstrated good psychometric properties and predictive 
validity for MCI (Scharre et al., 2010). It was hypothesised that this screening utility would 
extend to using the measure as a postal screening tool. The present results supported the use 
of the SAGE in this manner, and demonstrated that adapting it for a New Zealand population 
did not detract from the measure’s appropriateness or applicability. One large difference in 
the present results compared to those published previously was the cut-off that gave the best 
sensitivity and specificity. The present results indicated that a total score of 20.5 represented 
the optimal cut-off score, considerably higher than the 16 reported during test development. It 
was interesting that further analyses using Time 2 data reduced the diagnostic utility of the 
SAGE, and in particular this was seen when repeating the ROC curve calculations after 
removing the participants who did not take part in Time 2. There are several possibilities for 
why this was found, but the most likely reason is that the individuals who did not return and 
take part at Time 2 were more likely to be experiencing cognitive declines that those who did 
return, therefore removing them from the overall analyses reduced the frequency and severity 
of MCI for detection. This was supported by exploring the Time 1 scores of those who 
returned and those who did not, where a higher proportion of participants with MCI did not 
take part at Time 2.  
 The SAGE demonstrated good test-retest reliability, and had reasonable convergent 
and divergent validity with the neuropsychological battery administered during the present 





ongoing use of the SAGE for the detection of early cognitive declines. While showing good 
reliability, there was a significant change over time, likely reflecting the increasing cognitive 
impairment amongst the sample population over a 12-month period. Moreover, amongst the 
participants in the MCI-single group, who demonstrated cognitive decline over the 
intervening 12-month period, the SAGE did show a significant difference over time. It is 
important that a screening tool like the SAGE demonstrates high test-retest reliability, given 
that the measure should be stable over time, but conversely when a quantitative change has 
occurred the measure needs to pick this up. It was therefore interesting that those in the 
reverter group did not have a significant change over time on the measure; particularly given 
that this group demonstrated significant changes on the more comprehensive 
neuropsychological battery. It will continue to be of interest in future work on MCI to 
establish a more comprehensive profile of the individuals who revert, and to see whether 
those likely to revert have a different psychometric presentation across screening or 
neuropsychological measures. 
8.1.2 Impact of Engagement in Stimulating Activities  
 Cognitively enriching activities have been theorised to lead to improved cognitive 
outcomes in later life, including lower incidence of dementia, and reduced disease 
presentation in the presence of neuropathology. The colloquial phrase, use it or lose it, has 
extensive epidemiological research demonstrating that older adults’ neural health is promoted 
by maintaining cognitive, physical, and social activity. The present research expanded on the 
work of Robert Wilson (e.g., (Wilson et al., 2005; Wilson et al., 2002a; Wilson et al., 2013) 
by including a consideration of life-span and late-life activity frequency in the screening 
approach for detecting cognitive decline. While in the past the relationship between such 
activities and declines has been established, whether measuring ongoing activity engagement 





clear differences between the cluster analysis groups on historic cognitive activities. These 
cluster groups were based on current cognitive performance, and were divided into 
cognitively impaired and cognitively intact groups, yet for data collected for all four life-
stages the between-group difference was significant. This finding supports previous findings 
into the life-course impact of cognitive activity, as well as demonstrating that this information 
could be used in screening for possible declines. 
 Current engagement in stimulating activities was hypothesised to have a protective 
effect through reducing incident cognitive declines. A 12-month follow-up period is a 
relatively short duration for this effect to be seen, but the present results revealed three 
significant moderation effects. For all three, higher levels of activity were associated with 
less cognitive decline. A number of other moderations calculated were trending in the same 
direction, and may have reached significance if the sample size was larger, or at a later 
follow-up. The significant moderation effects involved cognitive and social activities, while 
ongoing engagement in physical activity did not demonstrate any protective ability. The lack 
of statistically significant moderations from engagement in physical activity is interesting and 
unexpected, as ongoing physical activity has previously been strongly linked to improved 
cognitive health and decreased incidence of MCI (Churchill et al., 2002; Heyn et al., 2004; 
Lautenschlager et al., 2008). One possible reason for this lack of statistical significance was 
that a significant decrease in the frequency of physical activity was reported by participants in 
the non-MCI group. There is no clear reason why the group of cognitively intact participants 
had a large decrease in physical activity, but it is possible that there was inconsistent 
reporting of physical activity at Time 1, leading to these unexpected findings at Time 2 and 
among the overall data analyses. It is also possible that the current sample group have high 
levels of physical activity participation, above what would be expected for a representative 





 There are several important implications from the findings between life-span 
cognitive activity and incident cognitive decline at late-life. Firstly, the present results 
support the hypothesis that higher frequencies of cognitive activity across all developmental 
stages have significant benefits later in life, and in particular are related to lower incidence of 
MCI. Secondly, assessment of the current frequency of activity participation demonstrated 
strong links with cognitive decline over the 12-month follow-up. In particular, assessing 
current cognitive and social frequency of activity may be useful in determining older adults 
most at risk of subsequent declines. While the current research was concerned with exploring 
the relationship between frequency of activity and cognitive decline, future work should 
assess the predictive validity of including this information in predicting outcomes over time 
for those most at risk of decline. 
8.1.3 Reliability of MCI Diagnoses 
 As discussed previously, MCI diagnoses have often been unreliable, with significant 
proportions of individuals identified as having MCI later appearing to revert to normal 
cognition. Furthermore, once subtypes of MCI are considered, the reliability of diagnoses 
decreases further, with many individuals appearing to move between subtypes. The present 
research aimed to explore whether considering subtypes of MCI in a community sample 
increased the predictive utility of screening, and whether this contributed meaningfully to a 
screening approach. Multiple-domain MCI was the only subtype to demonstrate significant 
consistency over time, with inconsistent amnestic and non-amnestic MCI subgroup 
diagnoses. Diagnostic consistency was further improved when the subtypes were combined, 
and an overall diagnostic consistency was calculated. This likely occurred because of 
movement between MCI subtypes for the participants experiencing decline, providing 
evidence that while their diagnostic grouping was inconsistent, their overall cognitive 





disagreement over diagnostic criteria, and whether subtypes of MCI should be considered 
separately, has been an ongoing argument (Busse et al., 2003; Busse et al., 2006). The present 
results support assessing for cognitive decline generally, with limited benefit seen from 
attempting to differentiate subtypes of MCI early in the process of decline. A more specific 
cognitive profile is likely to be helpful once declines begin progressing, in order to inform 
specific cognitive interventions. These non-pharmacological interventions either aim to 
compensate for a declining aspect of cognition via cognitive training (e.g., using mnemonics 
and semantic elaboration techniques to mitigate declines in working memory) or to support 
cognitive functions that remain intact via cognitive rehabilitation (e.g., rote learning social 
skills to overcome executive function deficits that cause decreased behavioural inhibition). 
Determining a specific cognitive profile is necessary for informing such interventions, and 
differentiating a subtype of MCI may add to this, but based on the current results this should 
follow a generalised determination of the presence of cognitive decline. 
 MCI subtypes were further considered in relation to participant clusters generated 
using LCA. The advantage of utilising cluster analysis with a broad range of data is that the 
resultant clusters represent the most similar individuals, with no theoretical underpinning. 
Therefore, if subtypes of MCI represented discrete and orthogonal groups then these would 
be expected to be seen on cluster analysis, given the disparate neuropsychological profile of 
each subtype. The present analyses demonstrated two clear groups based on the range of 
neuropsychological data and the current frequency of activity participation. The clustering 
solution that minimised variation within groups included one group who appeared to be 
cognitively impaired, and a cognitively intact group. This was an interesting and unexpected 
finding, given that participants did demonstrate cognitive declines in line with disparate MCI 
subtypes. However, given the unreliability of the MCI subtypes over time the statistical 





and cognitively intact participants. It is possible that with a larger sample size more groups 
would be seen, but the present results were curious given how consistent the cluster groups 
were, especially when looking for differences between cluster groups on Time 2 
neuropsychological scores. A number of participants in the cognitively intact cluster group at 
Time 1 experienced declines, and met diagnostic criteria for MCI at Time 2, similarly a 
number of cognitively impaired participants reverted to normal cognition at Time 2. Despite 
this, the between-group differences seen in the cluster solution remained at Time 2. As with 
previous findings, the cluster analysis results support the idea of assessing for generalised 
cognitive decline. The current research suggests collecting a range of neuropsychological 
information and looking across tests to determine who may be experiencing decline appears 
to be more useful than relying on measures of discrete aspects of cognition, such as memory 
or executive functioning.  
8.2 Limitations and Future Research 
 One major limitation that arose in the current research was through participants 
inconsistently following instructions on the postal measures. As previously discussed, a 
number of participants noted that they had checked the date before answering this question, 
which accounts for 4 of the 22 points on the SAGE. Given the usefulness of assessing the 
date for gathering information on orientation and memory, this presents a significant 
limitation in the present results. The SAGE included an instruction about not checking the 
date while answering this question, but it is possible that with more explicit instructions 
participants would be more likely to follow this. Given the benefit of asking participants the 
date, it would be useful to explore this in any future research using the SAGE as a postal 
screening tool. Overall, the screening utility of the SAGE was resistant to participants not 
following the instructions of the questionnaire with a statistically significant AUC from the 





supervision possible while individuals complete the measure. However, this deviation from 
the instructions is likely to have accounted for some of the reason the calculated cut-off score 
was higher than expected, with overall scores having been inflated by fewer participants 
incorrectly recalling the date. It would be interesting to assess a sample group such as the 
present one with face-to-face and postal versions of the SAGE using alternate forms, in order 
to explore the impact of response format. There were several unusual responses on both 
versions of the IQCODE that also may reflect issues with responding to the measure, and in 
particular several participants reported a large improvement over the last ten years. It is 
unlikely, but possible, that older adults experience a marked improvement in memory and 
ADL functioning, and so it is unclear whether these responses indicated response errors or 
not. 
 A further limitation of the postal screening was a number of missing responses, where 
participants only returned one version of the IQCODE. When these participants attended the 
testing session they were all prompted about returning the second response. Additionally, 
some participants required further explanation about why both self-report and informant-
report responses were required, and this was given at the neuropsychological testing session. 
Despite this prompting, a number of participants did not return the missing IQCODE, which 
led to the variation in the number of participants included across the calculated statistics. 
Increasing the response rate among those included in the study would likely have improved 
the results, although the total impact of the missing questionnaires is unclear, given that 
significant trends were seen on these measures across many of the statistics calculated.  
 A similar limitation lay in the number of individuals who dropped out of the study 
between Time 1 and Time 2, with 31.5% of the participant group electing not to return. There 
are a number of reasons why these individuals did not, or could not, take part in both stages 





was preventing them from participating. There were also several participants who could not 
be reached, and did not respond to a follow-up postal invitation to take part in the second 
stage of the research. It is unclear why these individuals could not be contacted after attempts 
over a period of several months, but among them were some of the oldest participants in the 
sample (>90 years of age). Despite the response rate, the present research still maintained an 
above average response to research involving postal questionnaires, with a meta-analysis 
concluding that among New Zealand studies the average response rate is 51% (J. V. Cook, 
Dickinson, & Eccles, 2009); the response rates of the present research were 78.6% and 68.4% 
at Time 1 and Time 2 respectively. Response rates across research involving postal elements 
also tends to only improve if incentives are offered to participants, which was not the case 
with the present study (Edwards et al., 2002; Nakash, Hutton, Jørstad-Stein, Gates, & Lamb, 
2006). It is possible that individuals identified as MCI at Time 1 who chose not to return may 
represent those with the most significant decline over time, which in turn may have precluded 
them from ongoing participation. There is also a possible limitation caused by contamination 
of the sample with individuals in the early stages of dementia. As discussed previously, there 
are significant difficulties in applying categorical criteria to continuous processes, and so it is 
likely that by using different tests and operational criteria some individuals included could 
instead have been considered as meeting criteria for dementia. This represents a common 
difficulty in assessing early declines, and the point at which MCI becomes dementia is 
contentious.  
 The present research used a relatively brief neuropsychological battery, taking 
between 50-80 minutes per participant. More comprehensive testing results in a larger range 
of cognitive constructs with which to make conclusions about aspects of current cognitive 
functioning, but is increasingly time consuming and can be aversive for participants. The 





improved through the use of more comprehensive testing. Repeating the current statistical 
clustering using more comprehensive neuropsychological testing in future would be useful to 
expand on the present findings, and to assess whether this makes any substantial difference to 
the observed results. 
 The measurement of ADLs in the present studies may also represent a limitation. 
Significant disagreement exists in the literature regarding the best way to assess this 
impairment, and the degree to which functional impairment is indicative of MCI, as opposed 
to dementia. For the present research, self-reports during the neuropsychological testing 
sessions, and responses on IQCODE questions that included instrumental ADLs, such as 
handling finances and learning to use new gadgets around the house, were used to assess 
current ADL functioning. This measurement is a possible limitation as it was not tightly 
controlled, and significant variation may have occurred based on participant reporting. 
Measurement of ADLs are also impacted by comorbidity, particularly physical health 
complaints. For the present study ADL difficulty due to comorbidities was not differentiated 
from ADL deficits due to cognitive decline; this likely overestimated the amount and 
frequency of impairment present in the reported results, but also represents a fair estimation 
of such difficulties within a community sample. 
 Intelligence was not assessed or estimated in the present study, and this represents a 
further limitation. Intelligence is strongly correlated with memory (Conway, Kane, & Engle, 
2003; Oberauer, Schulze, Wilhelm, & Süß, 2005), and moderately correlated with executive 
functioning (Ardila, Pineda, & Rosselli, 2000; Roca et al., 2009). Not having this information 
is therefore a limitation, as individuals with lower intelligence are more likely to score below 
average on standardised neuropsychological measures. There is therefore a risk that such 
individuals are incorrectly classified as MCI, and inflate the false positive rate. Furthermore, 





deficits may not be detected early. Including a measure of intelligence in future research 
would overcome this limitation, and allow estimations of cognitive decline to take 
intelligence into account. Similarly, emotional disorders such as anxiety and depression can 
have an impact on test taking performance and on memory functioning, and no data were 
collected on this in the present research (Kumar et al., 2006; Sachdev et al., 2013; Zandi, 
2004). The GAQ postal questionnaire asked about emotional disorders, but this was not 
responded to accurately and so represented a further limitation. This limitation could be 
reduced in future by including clinical measures of anxiety and depression such as the 
Geriatric Anxiety Scale and the Geriatric Depression Scale. This would then improve the 
detection of emotional disorders presenting as cognitive decline, and reduce this potential 
source of false positives. Such individuals also possibly make up some of the reverter group, 
as over time if their emotional disorders resolve the related cognitive difficulties may also 
improve. 
A final possible limitation also exists in the sample group involved in the present 
research. While all participants were recruited from the community, a number who 
volunteered were members of Rotary and Probus clubs. These organisations offer 
opportunities for social and cognitive activity, and so may be unrepresentative of many older 
adults in the community who lack such social support. While this group did not make up the 
majority of the sample, this might have led to an over-estimation of the rate of current 
cognitive and social activity. Similarly, a significant proportion of community dwelling older 
adults are likely to have debilitating physical health conditions, which would then impact on 
their ability to participate in research such as this. Therefore, it is likely that those who were 
willing and able to take part in the present research represent a group of physically healthy 
older adults, which may have led to an overly high rate of current physical activity. Exploring 





these is unclear from the present results. The sample were predominantly NZ European, 
which limits the generalisability of the present results to the wider New Zealand population 
where there is more ethnic diversity. While the current sample was relatively representative 
of Canterbury, it would be worthwhile trialling the measures used with a more diverse and 
nationally-representative population. In particular, it would be beneficial to gather further 
data on the applicability of SAGE to more diverse ethnic groups, as this measure has not been 
used in New Zealand before. Furthermore, it would be useful to assess whether the 
participation in stimulating activities and the types of activities are similar between ethnic 
groups. 
8.3 Summary 
 The present research demonstrated a multi-stage screening approach for the detection 
of early cognitive declines in older adults. Utilising postal cognitive screening and a 
combination of self-reports and informant-reports this screening modality demonstrated 
reasonable predictive validity for individuals meeting diagnostic criteria for MCI. The dual 
inclusion of self- and informant-reports to assess subjective declines in memory and ADLs 
has not been validated previously, yet both forms of reporting have demonstrated usefulness 
in assessing changes in cognition. The postal screening approach was followed with a 
neuropsychological battery for all participants. Previous research looking at multi-stage 
screening has neglected to validate the screening approach fully, by only testing individuals 
likely to support the screening tools (i.e., those identified as likely to have MCI), whereas this 
limitation was not present in the current research. Furthermore, the consideration of life-
course and late-life activity participation has not been explored in relation to diagnosis and 
adding to cognitive screening information. This information led to clear between-group 





 The present results provide a platform for demonstrating the utility of postal screening 
to identify likely cases of MCI amongst community dwelling older adults, and that such an 
approach can be used to inform testing for individuals most likely to need it. By removing the 
initial face-to-face contact, multi-stage screening may also allow individuals who are less 
willing to present to primary health professionals to still receive cognitive screening. Given 
the increasing prevalence of MCI and dementia, such a screening approach could reduce the 
time and costs associated with early identification. Ongoing development of interventions 
aimed at reducing the impact of cognitive decline relies on early identification of MCI, and 
novel approaches to detection will need to continue to be developed to cope with the 
increasing demand on services. The present study demonstrates the feasibility of multi-stage 
screening using postal measures as a reliable and valid method of cognitive screening, and for 
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Please give this version of the IQCODE to somebody who knows you well (e.g., spouse, 
relative, or friend) and ask them to fill it in about you. 
 
 
Name (who the questionnaire is for): ___________________________________                
                 




Now we want you to remember what your friend or relative was like 10 years ago and to 
compare it with what he/she is like now.  10 years ago was in 2004.  Below are situations 
where this person has to use his/her memory or intelligence and we want you to indicate 
whether this has improved, stayed the same, or got worse in that situation over the past 10 
years.  Note the importance of comparing his/her present performance with 10 years ago.  So 
if 10 years ago this person always forgot where he/she had left things, and he/she still does, 
then this would be considered 'Hasn't changed much'.  Please indicate the changes you have 
observed by circling the appropriate answer. 
 
Compared with 10 years ago how is this person at: 
 
   1 
 
  2     3   4   5 
1. Remembering things about 














2. Remembering things that 












3. Recalling conversations a 
few days later 
Much 
improved 








      
4. Remembering his/her 












5. Remembering what day and 
















6. Remembering where things 












7. Remembering where to find 
things which have been put in 
a different place from usual 
Much 
improved 








      
8. Knowing how to work 













9. Learning to use a new 

























      
11.  Following a story in a 
book or on TV 
Much 
improved 



































14. Handling financial matters, 














15. Handling other everyday 
arithmetic problems, e.g. 
knowing how much food to 
buy, knowing how long 














16. Using his/her intelligence 
to understand what's going on 
and to reason things through 
Much 
improved 




















Please fill in this version of the IQCODE about yourself, remembering what you have been 
like now compared to 10 years ago. 
 
Name: ___________________________________                
                 
Date of Birth: ______________                                     
 
 
Now we want you to remember what you were like 10 years ago and to compare it with what 
you are like now.  10 years ago was in 2004.  Below are situations where you had to use your 
memory or intelligence and we want you to indicate whether this has improved, stayed the 
same, or got worse in that situation over the past 10 years.  Note the importance of comparing 
your present performance with 10 years ago.  So if 10 years ago you always forgot where you 
had left things, and you still do, then this would be considered 'Hasn't changed much'.  Please 
indicate the changes you have observed by circling the appropriate answer. 
 
Compared with 10 years ago how are you at: 
 
   1 
 
  2     3   4   5 
1. Remembering things about 














2. Remembering things that 












3. Recalling conversations a 
few days later 
Much 
improved 








      
4. Remembering his/her 












5. Remembering what day and 












6. Remembering where things 
















7. Remembering where to find 
things which have been put in 
a different place from usual 
Much 
improved 








      
8. Knowing how to work 













9. Learning to use a new 

























      
11.  Following a story in a 
book or on TV 
Much 
improved 



































14. Handling financial matters, 














15. Handling other everyday 
arithmetic problems, e.g. 
knowing how much food to 
buy, knowing how long 














16. Using your intelligence to 
understand what's going on 
and to reason things through 
Much 
improved 






































General Activities Questionnaire 
 
On the following pages are brief questions about general activities at 
various points in your life. They cover: childhood (around 6 years old), 
Teenage (12 years old), Young adulthood (18 years old), Adulthood (round 40 
years), and more recent times.  
 
Quickly answer each question by circling the number representing how often 
you participated in the activity. Answer quickly but accurately, using the 
age in years to guide what activities you were involved in at those points 
in your life. 
  
Just do your best across the questions, and give you best guess if you are 
unsure. Please complete this page first. 
 
Your Name: ___________________  Date of Birth:_________  Gender: 
Male/Female 
 
Highest level of education (e.g., high school, Technical or other 
qualification, Bachelor’s degree, other degree?):____________ 
 
Age when you left school:____________ 
 
What was your major occupation (e.g., homemaker, teacher, mechanic, 
dentist, salesperson, lawyer, etc):  
___________________ 
 
What is the maximum number of adults you have ever been in charge of or 




More than 10 
 
The following are some questions about things that may have happened to you 
during your life. Please circle the answer that best applies to you. 
 
1. Have you ever suffered a head injury during which you lost consciousness 
for 20 minutes or more? 
 Yes No 
 
2. Have you ever been diagnosed with epilepsy? 
 Yes No 
 
3. Do you suffer from multiple sclerosis? 
 Yes No 
 
4. Do you suffer from any other neurological disorder? 
Yes No    
If yes please specify ____________ 
 
5. Have you ever suffered a stroke that required hospital treatment? 
 Yes No 
 
6. Have you ever been diagnosed with a psychiatric illness? 
 Yes No 






General Activities in Childhood - Age 6 
 
The first questions are about when you were 6 years old, or thereabouts. 
Please give your best recollection and circle one or the options for each. 
      
1. When you were 6, how often did you play games like tic-tac-toe, 
checkers, or other board games, cards, or word games?  
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
         
2. How often did someone in your home read to you when you were 6?      
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
         
3. How often did someone in your home tell you stories when you were 6?  
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year 
 
 





General Activities in Teens - Age 12 
      
The next questions are about when you were 12 years old, or thereabouts. 
Please give your best recollection and circle one or the options for each. 
      
1. When you were 12, about how much time did you spend reading each day? 
        1 None 
        2 Less than one hour 
        3 One to less than two hours 
        4 Two to less than three hours 
        5 Three or more hours 
 
2. When you were 12, how often did you read books? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
 
3. When you were 12, how often did you visit a library? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
 
4. When you were 12, how often did you read newspapers? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
 
5. When you were 12, how often did you read magazines? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
 
6. When you were 12, how often did you write letters? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
7 When you were 12, how often did play games like checkers or other board 
games, cards, puzzles, word games, crosswords, or any other similar games?  
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 










General Activities in Young Adulthood - Age 18 
      
The next questions are about when you were 18 years old, or thereabouts. 
Please give your best recollection and circle one or the options for each. 
      
1. When you were 18, about how much time did you spend reading each day? 
        1 None 
        2 Less than one hour 
        3 One to less than two hours 
        4 Two to less than three hours 
        5 Three or more hours 
 
2. When you were 18, how often did you read books? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
         
3. When you were 18, how often did you visit a library? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
         
4. When you were 18, how often did you read newspapers? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
5. When you were 18, how often did you read magazines? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
6. When you were 18, how often did you write letters? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
7. When you were 18, how often did play games like checkers or other board 
games, cards, puzzles, word games, crosswords, or any other similar games?  
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
 





General Activities in Adulthood - Age 40 (35-45) 
      
The next questions are about when you were 40 years old, or thereabouts. 
Please give your best recollection and circle one or the 4 options for 
each. 
      
1. When you were 40, about how much time did you spend reading each day? 
        1 None 
        2 Less than one hour 
        3 One to less than two hours 
        4 Two to less than three hours 
        5 Three or more hours 
 
 
2. When you were 40, how often did you visit a library? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
3. When you were 40, how often did you read newspapers? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
4. When you were 40, how often did you read magazines? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
5. When you were 40, how often did you read books? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
6. When you were 40, how often did you write a paragraph or more by letter 
or email? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
7. When you were 40, how often did you play games like checkers or other 
board games, cards, puzzles, word games, crosswords, or any other similar 
games?  
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 





General Activities in Present Time / Recently 
      
The following are some questions about how you spend your time presently, 
or how you have spent your time recently. Circle one or the options for 
each. 
      
1. About how much time do you spend reading each day? 
        1 None 
        2 Less than one hour 
        3 One to less than two hours 
        4 Two to less than three hours 
        5 Three or more hours 
 
2. In the last ten years, did you ever keep a diary or journal? 
        1 Yes 
        2 No 
 
 If Yes, roughly for how many years? ____ 
      
 
3. In the last year, how many times did you visit a museum or an 
exhibition? 
        1 Never 
        2 1-2 times 
        3 3-9 times 
        4 10-19 times 
        5 More than 20 times 
 
4. In the last year, how many times did you attend a concert, play, or 
musical? 
        1 Never 
        2 1-2 times 
        3 3-9 times 
        4 10-19 times 
        5 More than 20 times 
 
5. In the last year, how often did you visit a library?         
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
6. During the last year, how often did you read newspapers?         
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
7. During the past year, how often did you read magazines? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
      
 









8. During the last year, how often did you read books? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
9. During the last year, how often did you write letters? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
10. During the last year, how often did you play games like checkers or 
other board games, cards, puzzles, word games, crosswords, or any other 
similar games?  
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 Several times a year / rarely 
 
11. During the last year, how often did you do handicrafts like needlework, 
weaving, or knitting? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
12. During the last year, how often did participate in political or 
cultural group activities? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
13. During the last year, how often did you participate in courses or 
learning of some type, including community education or discussion groups? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
14. During the last year, how often did participate in sporting activities 
or play golf? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
15. During the last year, how often did you meet up with friends or 
participate in group activities? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
  









16. During the last year, how often did you exercise by walking? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
17. During the last year, how often did you listen to the radio? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
18. During the last year, how often did you do gardening, or arrange 
flowers? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
19. During the last year, how often have you taken part in artistic 
activities such as painting, drawing, or photography? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
20. During the last year, how often have you spent time helping out family, 
or working for charity? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
21. During the last year, how often did you participate in any outdoors 
activities? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
22. During the last year, how often did spend time collecting stamps or 
other items? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
23. During the last year, how often did tend to cook? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
 











24. During the last year, how often did you do chores or housework? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
25. During the last year, how often did you attend church or religious 
services? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
26. During the last year, how often did you play music or sing? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
27. During the last year, how often did you follow the stock market? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
 
28. During the last year, how often did you play bingo, or anything 
similar? 
        1 Every day or almost every day 
        2 Several times a week 
        3 Several times a month 
        4 several times a year / rarely 
     
 
END of questions 
 
 
